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chAPter 1
Introduction

9An abdominal wall hernia is an acquired defect or a weakening of an existing opening 
in the abdominal wall with an intermittent or continuous protrusion of abdominal 
contents through the opening. The word “hernia” is a Latin word, which means a 
“tear” or “rupture”.
An abdominal wall hernia occurs in humans far more frequent than in any other 
mammal. It has left an indelible mark throughout our earliest recorded history and 
is probably the penalty we pay in evolution due to the ability to distinguish ourselves 
from other mammals by walking in an erect position. The Egyptians (1500 BC), 
Phoenicians (900 BC) and ancient Greeks (400 BC) already described abdominal wall 
hernias and its (surgical) treatments through paintings, sculptures and ancient writ-
ings on papyrus. In history, various surgical and non-surgical treatments for (inguinal) 
hernia repair were used with a total ignorance of the anatomy of the groin, including 
castration, cauterization, bloodletting and tabacco enemas. It was because of publica-
tions by great anatomists and surgeons named Petit (1674 – 1750), Pott (1714 – 1788), 
Camper (1722 – 1789), Gimbernat (1734 – 1816), Richter (1742 – 1812), Hesselbach 
(1759 –1816), Bogros (1786 – 1823) and Fruchaud (1894 – 1960) which helped us to 
untangle and understand the complexity of the anatomy of the abdominal wall and 
groin.1,2 At the end of the 19th century, the Italian surgeon Bassini developed a novel 
technique for inguinal hernia repair. He reconstructed the weakened transversalis 
fascia by suturing the autologous fascial, muscular and aponeurotic layers together, 
but under significant tension.3,4 In the mid-forties, the Canadian surgeon Shouldice 
further improved this technique by suturing these layers separately. Unfortunately, 
other surgeons who used this technique could never match the low recurrence rates 
reported by both Bassini and Shouldice.5,6 Even before Shouldice was born, experi-
ments were performed using different woven grafts as reinforcement material in an 
attempt to reduce recurrence rates after inguinal hernia repair. A real breakthrough 
was the arrival of the polypropylene mesh; it was strong, biocompatible, could be 
sterilized and had a low price. By the end of the 1960s an American surgeon named 
Newman had already successfully used the polypropylene mesh in over 1600 proce-
dures.7 Despite this success, it took his colleague Irving Lichtenstein until the eight-
ies to convince the surgical world of a “tension-free” repair using a polypropylene 
mesh to reinforce the transversalis fascia without approximating the defect.8 To date 
the Lichtenstein repair is still considered the gold standard in open inguinal hernia 
surgery with recurrence rates of less than 5%, even when performed by non-experts 
hands. Over the past decades the minimally invasive laparoscopic techniques have 
made their entrance using a totally extra-peritoneal (TEP) or a trans abdominal pre-
peritoneal (TAPP) approach. These techniques are increasingly used and associated 
with less postoperative pain compared to open inguinal hernia repair.9
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ou tline of the theSiS
Abdominal wall surgery comprises the spectrum of procedures used in the treatment 
of abdominal wall hernias, including inguinal, umbilical and incisional hernias. As 
a group these are one of the more frequently performed operations worldwide and 
considered the ideal teaching surgical procedure for young trainees due to the diver-
sity of technical aspects, challenging anatomy, and its relatively low risk of serious 
complications. This is particularly true for the relatively healthy general population 
in which abdominal wall hernias are commonly found. However, there are groups 
of frail individuals prone to an abdominal wall hernia due to their age or underlying 
disease such as elderly men, premature born infants and patients with liver cirrhosis. 
In these patients, a surgical procedure should be carefully planned or sometimes even 
avoided. Both surgery and watchful waiting can lead to serious complications. In the 
following chapters groups of elderly patients, premature born infants and patients 
with liver cirrhosis – prior, during and after liver transplantation, are discussed with 
regard to the incidence of abdominal wall hernias, risk factors associated with it and 
the (surgical) management of the most common hernias in these specific groups. 
Over the last 20 years, the number of general surgical procedures being performed on 
elderly patients has increased rapidly. Despite more advanced surgical, anesthetic and 
medical techniques, older patients still continue to suffer more from postoperative 
complications compared to their younger counterparts.10,11 The incidence of inguinal 
hernias and its repair also appears to increase with age.12 Literature on this topic is 
sparse, especially in the middle-aged and elderly population. In Chapter 2 the data of 
the Rotterdam Study – a prospective cohort study that started in 1990 in a district of 
Rotterdam, are analyzed in order to determine the incidence of inguinal hernias over 
time in men aged 45 years and older, and to gain insight into potential risk factors of 
inguinal hernia in these men.
To date, there is general consensus that preventing an inguinal hernia from an 
incarceration per se is not a proper indication to perform inguinal hernia repair. In-
terestingly, more than one-third of inguinal hernias are not even symptomatic at first 
presentation. Two randomized trials were performed comparing a watchful waiting 
strategy and surgical approach in the treatment of mildly symptomatic and asymp-
tomatic inguinal hernia.13,14 Both trials reported that no superiority could be found for 
elective repair over watchful waiting with regard to pain/discomfort. They concluded 
that watchful waiting is an acceptable strategy for men with minimally symptomatic 
hernia. However, long-term results showed extremely high crossover rates, especially 
in older men.15,16 In Chapter 3 the results of a multicenter randomized clinical trial 
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are described. The value of watchful waiting compared to elective repair in men aged 
50 years and older with mildly symptomatic or asymptomatic inguinal hernia will be 
investigated.
The risk of inguinal hernia repair is not only increased in elderly men, but also in very 
young patients. Approximately 10 percent of prematurely born infants will undergo 
inguinal hernia repair before the age of 7, of whom more than half in the first year of 
life.17,18 The most important factor that contributes to the increased risk of inguinal 
hernias in premature born infants is a persistent processus vaginalis, representing 
an embryological protrusion of peritoneum that precedes the descent of the testes 
during the second trimester of pregnancy. Normally it will obliterate immediately 
after birth. If this process fails, the result is a patent processus vaginalis and birth 
of a potential congenital or indirect inguinal hernias.19,20 In these patients inguinal 
hernia repair is often postponed until a certain weight or age is reached. Surgery in 
premature born infants can be technically challenging due to comorbidities and risk 
of potential anaesthetic complications, especially in prematurely born infants with a 
very low birth weight (birth weight of 1,500g or less).21,22 Postponing surgery however 
could not only increase the risk of incarceration of contents of the hernia sac, but it 
might also lead to an even more challenging repair due to a more thickened hernia sac 
and fibrous adhesions.18,22,23 In Chapter 4 risk factors of emergency surgery in order 
to optimize inguinal hernia management and timing of repair in prematurely born 
infants are identified.
Another group of frail individuals, who are generally advised to refrain from surgery 
unless it is absolutely necessary, are patients with liver cirrhosis and particularly those 
who suffer from concommittent ascites. Overall morbidity rates are reported as high 
as 70 percent for patients with cirrhosis undergoing non-hepatic surgery.24,25 Although 
literature on this topic is abundant, it varies highly in quality and is full of individual, 
not necessarily evidence-based opinions and similarly valued underlying assumptions. 
Chapter 5 includes a systematic review to give an overview of which procedures are 
most hazardous in patients with liver cirrhosis undergoing non-hepatic surgery. 
Patients with liver cirrhosis and refractory ascites have a 20 percent risk of develop-
ing an umbilical hernia in the course of their disease.26 Despite the high incidence, 
optimal management of an umbilical hernia in patients with liver cirrhosis remains 
controversial. It is often advised not to perform umbilical hernia repair in these pa-
tients, because of the presumed high peri- and postoperative risk of complications 
such as bacterial contamination of ascites, worsening of liver function, and high 
recurrence rates after elective repair.27-29 A watchful waiting strategy, however, can 
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be complicated by incarceration or spontaneous rupture and evisceration following 
necrosis of the overlying skin. This could lead to an emergency procedure, which 
puts patients at an even greater risk for serious complications than after elective 
surgery.30,31 In Chapter 6 the postoperative outcomes of 30 consecutively performed 
umbilical hernia repairs in patients with liver cirrhosis and ascites with an expected 
time to liver transplantation of over 3 months are reported. 
Based on the results of the prospective cohort study outlined in the previous chapter, 
in Chapter 7 the study protocol of a randomized controlled trial is presented. This 
trial will compare watchful waiting with elective repair of umbilical hernias in pa-
tients with liver cirrhosis and ascites. 
Umbilical hernias that are not corrected during liver transplantation are still at 
risk for incarceration of the bowel which can result in serious morbidity or even 
death.30 Therefore, umbilical hernia repair seems to be warranted in all candidates 
for liver transplantation in which umbilical hernia repair is not already performed 
prior to the transplantation. Two approaches for umbilical hernia repair during liver 
transplantation can be used, either through a separate, umbilical incision or from 
within the abdominal cavity through the laparotomy wound used to perform the liver 
transplantation. In Chapter 8 both approaches are compared in a retrospective study. 
As mentioned previously, abdominal wall hernias such as inguinal and umbilical 
hernias can be congenital, acquired during life, or the result of an underlying disease. 
In contrast, an incisional hernia is considered a postoperative complication after 
abdominal surgery. In the general population incidences range between 11 and 20 
percent.32,33 In patients operated upon for an abdominal aortic aneurysm and in obese 
patients undergoing abdominal surgery through a midline laparotomy incidences 
of incisional hernias of more than 30 percent have been reported.34 With improved 
long-term survival after liver transplantation, incisional hernias have also become 
an increasingly diagnosed and clinically relevant complication in patients after liver 
transplantation.35,36 In Chapter 9 the incidence of incisional hernias after liver trans-
plantation with the use of a right subcostal (J-shaped) incision is reported, potential 
risk factors for incisional hernias are identified and its impact on health-related qual-
ity of life is determined. 
In Chapter 10 the (surgical) management issues of abdominal wall hernias in elderly 
patients, premature born infants and patients with liver cirrhosis are discussed ad-
ditionally providing perspectives for further research.
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Finally, in Chapter 11 and Chapter 12 (Dutch summary) the main findings of this 
thesis are summarized.
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Chapter 2
AbStrAct
Background: Prospective data on risk factors and the incidence of inguinal hernia are 
sparse, especially in an elderly population. The aim of this study was to determine the 
incidence of and risk factors for inguinal hernia. 
Methods: We analyzed data from the Rotterdam Study, a prospective cohort study that 
observed the general population aged ≥45 years of Ommoord, a district in Rotterdam, 
from baseline (1990) over a period of >20 years. Diagnoses of inguinal hernia were 
obtained from hospital discharge records and records from general practitioners. 
Multivariate regression analysis was performed to determine risk factors for inguinal 
hernia development.
Results: Among 5,780 men, with a total of 50,802 person-years, who did not have a 
hernia at baseline, 416 cases of inguinal hernia occurred (7.2%). The 20-year cumula-
tive incidence was 14%. Age-adjusted hazard ratio (HR) for inguinal hernia for men 
relative to women was 12.4 (95% CI, 9.5 – 16.3; P < .001). On multivariate analysis, the 
risk of inguinal hernia increased with advancing age (HR per 1-year increase in age, 
1.03; 95% CI, 1.02 – 1.04; P < .001). Participants with a body mass index (BMI) of 25 – 30 
kg/m2 had an HR of 0.72 (95% CI, 0.58 – 0.89; P = .003) compared with a BMI <25; a BMI 
>30 had an associated HR of 0.63 (95% CI, 0.42 – 0.94; P = .025).
Conclusion: Inguinal hernia is common in the middle-aged and elderly male population 
and its incidence increases with advancing age. Overweight or obese patients have a 
lower risk of developing an inguinal hernia.
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introduction
Inguinal hernia repair is the most frequently performed operation in general surgery. 
In 2003, approximately 770,000 inguinal hernia repairs were performed in the United 
States.1-4 The lifetime risk of undergoing inguinal hernia repair is as great as 42.5% for 
men and 5.8% for women.5-8
Etiological factors for the development of a primary inguinal hernia include not only 
the presence of a patent processus vaginalis and altered metabolism of collagen con-
nective tissue and the extracellular matrix, but seems also to result from increased 
intra-abdominal pressure.9,10 Patient-related factors that are thought to be associated 
with the development of inguinal hernia are aging, male sex, smoking, diabetes, 
physical activities, and family history.7,9-16
The incidence of inguinal hernia appears to increase with age, especially in men 
through the fifth to seventh decade of life.12,15 Excess body weight has also been 
considered to be a risk factor for the development of inguinal hernia, because it is 
believed, among other factors, to affect the intra-abdominal pressure.9 However, the 
association of obesity with inguinal hernia is still not well established. Several studies 
provided conflicting data, and some even suggest a protective effect for the develop-
ment of inguinal hernia.7,9,12,15-17 
In the United States, the prevalence of obesity increased from 27.5% in 1999 to 37.2% 
in 2010 among men between the age of 40 and 59.18,19 It is likely that both the inci-
dence and prevalence of inguinal hernia will increase globally as a result of our aging 
population, but possibly also because of increasing prevalence of obesity. Therefore, 
inguinal hernia constitutes a very relevant public health issue. Despite this public 
health issue, data from large, prospective cohort studies that evaluate the relationship 
between the incidence of inguinal hernia and risk factors are sparse, and few studies 
have focussed on the more elderly male population.12,15
The aim of our study was to analyse data within the Rotterdam Study, a prospec-
tive cohort study ongoing since 1990 in the city of Rotterdam in The Netherlands, to 
determine the incidence of inguinal hernia among middle-aged and elderly men and 
to create insight into the association of inguinal hernia with potential risk factors.
20
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mAteriAlS And methodS
The Rotterdam Study is a prospective cohort study that included individuals from the 
district of Ommoord in Rotterdam, The Netherlands, from January 1990 onwards. 
Initially, 7,983 participants out of 10,215 invitees (78%) of the Ommoord district were 
recruited (RS-I). In 2000, 3,011 participants of 4,472 invitees who had become 55 years 
of age or moved into the study district since the start of the study were added to the 
cohort (RS-II). In 2006, a further extension of the cohort was initiated in which 3,932 
subjects of 6,057 invitees between the ages of 45 to 54 were included (RS-III). By the 
end of 2008, the Rotterdam Study, therefore, comprised 14,926 subjects aged ≥45 
years with an overall response at baseline of 72.0% (14,926/20,744) for all 3 cycles (RS-I, 
RS-II, and RS-III).
The participants were all examined in detail at baseline. They were interviewed at 
home (2 hours) followed by an extensive set of examinations (a total of 5 hours) in a 
research facility in the center of their district. These examinations focused on possible 
causes of invalidating diseases in participants aged ≥45 years and were repeated every 
3–4 years in the participant characteristics that could change over time. The study 
design, objectives, and major findings of the Rotterdam Study have been described 
extensively elsewhere.20 The medical ethics committee at Erasmus University of 
Rotterdam approved the study, and written informed consent was obtained from all 
participants.
Participants in the Rotterdam Study are followed for a variety of diseases, including 
the presence of an inguinal hernia. The participants of the first cohort (RS-I) were 
interviewed at baseline and asked if they were ever diagnosed or admitted to the 
hospital owing to the presence of an inguinal hernia. In the second (RS-II) and third 
(RS-III) cohorts, questions with regard to inguinal hernia were not incorporated in the 
baseline interview. To identify all incident events of inguinal hernia since the start 
of the Rotterdam Study, International Classification of Primary Care (ICPC) codes for 
diagnosis of inguinal hernia (D89) or other hernia (incisional- and/or umbilical hernia, 
D91) were retrieved from general practitioners in the Ommoord district. In addition, 
hospital discharge records of the participants of cohort RS-I, RS-II, and RS-III with re-
gard to the diagnosis of inguinal hernia were obtained using the Landelijke Medische 
Registratie (LMR) codes, the national medical register used in The Netherlands. For all 
participants, these records were checked for cases of inguinal hernia including the 
period (far) before the point of entrance into the Rotterdam study to avoid potential 
bias in prevalent cases of inguinal hernia. Being added after the original design of 
the Rotterdam Study, the current analysis is thus classified as post-hoc. Data on body 
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mass index (BMI, kg/m2), age, sex, diagnosis of diabetes mellitus, smoking, and use of 
corticosteroid medication were collected at baseline and extracted from the cohort da-
tabase, because they were considered relevant determinants in relation to incidence 
of inguinal hernia. The presence of type 2 diabetes mellitus was defined by the use 
of antidiabetic medication or by a non-fasting or post-load plasma glucose level >11.1 
mmol/L (200 mg/dL). The use of medication was determined by questionnaire at base-
line. Drug exposure (classified by ATC code [http://www.whocc.no/atc_ddd_index/]) is 
monitored continuously since the initiation of the Rotterdam Study in 1991 by using 
computerized pharmacy records of the pharmacies in the Ommoord district. Both 
the ICPC and the LMR codes are standardized, and validity was checked by the data 
management team of the Rotterdam Study.
Statistical analysis
Prospective analyses were performed using the Cox proportional hazards (CPH) re-
gression model to identify risk factors related to the proportion of incident cases of 
primary inguinal hernia in men. Participants with a prevalent (pre-existing) inguinal 
hernia at baseline or participants who developed a recurrent/contralateral hernia 
during the study period were excluded from the analysis. Time at risk was calculated 
from the date a participant entered the Rotterdam Study to the first date a primary 
inguinal hernia was diagnosed, date of last contact, or the date of death. We used 5-, 
10-, 15-, and 20-year Kaplan-Meier estimates to infer the cumulative incidences of 
inguinal hernia over time.
Univariate regression analyses were performed to determine the relationship of inci-
dent cases of primary inguinal hernia with risk factors by analyzing each potential risk 
factor adjusted for age as a continuous variable. BMI was entered as an ordinal variable 
and was modelled using 3 categories for BMI: < 25.0, 25.0 – 30.0, and >30 kg/m2. Age 
was modelled using 3 categories: <65, 65 – 75, and >75 years. Other baseline factors that 
were adjusted for age and entered in the model were: diabetes mellitus (yes/no), steroid 
use (yes/no), smoking (never/former/current), and presence of other hernia (yes/no).
Multivariate regression analysis was performed using a CPH model to control for 
effects of multiple potential risk factors. Potential risk factors that were related to 
incident cases of primary inguinal hernia after univariate regression analyses (P <0.10) 
were included in the CPH model. All factors met the proportional hazards assumption 
of a relatively constant risk ratio through examination of -log (-log) survival curves. All 
analyses were performed using the Statistical Package for the Social Sciences version 
17.0 (SPSS Inc, Chicago, IL). Continuous data are presented as mean ± standard devia-
tion. 
22
Chapter 2
reSultS
In the Rotterdam Study, after exclusion of participants with an inguinal hernia at 
baseline (348/14,926), the overall proportion of incident cases of primary inguinal 
hernia was 3.2% (477 cases among 14,568 participants). There were 5,870 men and 
8,788 women without a prevalent (pre-existing) inguinal hernia at baseline. The 
proportion of incident cases among male participants was 7.2% (416 cases among 
5,780 participants) compared with 0.7% of primary inguinal hernia (61 cases among 
8,788) among female participants. In the 5,870 men, the 5-year cumulative incidence 
of developing inguinal hernia was 4.3% compared with 0.3% in women. The mean 
age in men was 64.7 ± 9.5 and 68.1 ± 8.6 years in women. The 10-year cumulative 
incidence was 7.9% compared with 0.7%, and for 15 years it was 11.6% compared with 
1.0%, and for 20 years it was 14.0% versus 1.8%. Adjusted for age, the hazard ratio (HR) 
for inguinal hernia for men relative to women was 12.4 (95% CI, 9.5 – 16.3; P < .001). 
Therefore, further analyses were conducted only on the 5,870 men of the Rotterdam 
Study. Baseline characteristics of the 5,870 male participants are shown in Table 1. 
Table 1. Baseline characteristics for inguinal hernia among men in the Rotterdam Study, The Netherlands 
(n = 5,780), 1990 – 2008.
Characteristic Diagnosis of inguinal hernia
(n = 416)
No inguinal hernia
(n = 5,364)
P - value
Follow-up (y) 13.0 (5.2) 9.0 (5.8) <.001
Age (y) 66.6 (8.2) 64.5 (9.5) <.001
Height (cm) 175.1 (6.6) 175.9 (7.1) .025
Weight (kg) 78.5 (11.1) 82.6 (13.0) <.001
Body mass index* 25.6 (3.1) 26.7 (3.6) <.001
Cigarette smoking, n (%) .199
Never 56 (13.5) 848 (15.8)
Former 243 (58.4) 2941 (54.8)
Current 89 (21.4) 1280 (23.9)
Corticosteroid use, n (%) 2 (0.5) 85 (1.6) .091
Diabetes Mellitus, n (%) 27 (6.5) 438 (8.2) .004
Other hernia, n (%) 1 (0.2) 38 (0.7) .525
*BMI was calculated as weight (kg)/length (m2).
Data are mean (SD) values unless otherwise specified.
The 5-, 10-, 15-, and 20-year cumulative incidence of developing an inguinal hernia 
and its association with increasing age was unadjusted; all other potential risk factors 
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and the cumulative incidence of the development of an inguinal hernia over 20 years 
were adjusted for age (Fig. 1; Table 2). The HRs for development of an inguinal hernia 
were greater for participants between the age of 65 and 75 years (HR, 1.4; 95% CI, 
1.11 – 1.70; P < .001) and for participants >75 years of age (HR, 1.9; 95% CI, 1.46 – 2.51; 
P < .001) in comparison with the reference group of participants <65 years of age.
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Figure 1. Risk of inguinal hernia by age among men in the Rotterdam Study, The Netherlands, 1990 – 2008.
The cumulative incidence the development of an inguinal hernia among men de-
creased with baseline BMI. The 20-year cumulative incidence was 17.2% in participants 
with a BMI of <25 kg/m2 and 12.3% in participants with both BMI of 25 – 30 kg/m2, and 
participants with a BMI >30 kg/m2. The HRs for the development of an inguinal hernia 
were less for participants with a BMI of 25 – 30 kg/m2 (HR, 0.71; 95% CI, 0.58 – 0.87; P 
< .001) and for participants with a BMI >30 kg/m2 (HR, 0.53: 95% CI, 0.36 – 0.79; P < 
.001) in comparison with the reference group of participants with a BMI <25 kg/m2. 
The presence of diabetes mellitus at baseline showed a cumulative incidence of 15.3% 
over 20 years for the development of inguinal hernia among men. The HR for the de-
velopment of an inguinal hernia showed a protective effect in the presence of diabetes 
mellitus, which was of borderline significance (HR, 0.68; 95% CI, 0.46 – 1.00; P = .05). 
Cigarette smoking, corticosteroid use, or the presence of another hernia at baseline 
were not associated with the development of inguinal hernia in the middle-aged and 
elderly male population of the Rotterdam Study.
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Table 2. Risk of inguinal hernia (unadjusted) over 20 years and age-adjusted hazard ratio for inguinal hernia 
among men in the Rotterdam Study, The Netherlands (n = 5,780), 1990 – 2008. 
Risk factor No. of 
participants
No. with 
inguinal hernia
Risk of inguinal 
hernia (%)
Age-adjusted 
hazard ratio*
95% CI P -  
value
Age (y) <.001
<65 3,377 204 12.2 1.0
65 – 75 1,485 141 15.6 1.4 1.1 – 1.70
>75 918 71 19.3 1.9 1.46 – 2.51
Body mass index <.001
<25 1,793 176 17.2 1.0
25 – 30 2,727 187 12.3 0.71 0.58 – 0.87
>30 747 30 12.3 0.53 0.36 – 0.79
Cigarette smoking .609
Never 904 56 17.4 1.0
Former 3,184 243 14.3 0.86 0.65 – 1.16
Current 1,369 89 12.7 0.87 0.62 – 1.21
Corticosteroid use .156
No 5,665 412 14.1 1.0
Yes 87 2 3.9 0.37 0.09 – 1.47
Diabetes Mellitus .050
No 3,581 353 14.8 1.0
Yes 465 27 15.3 0.68 0.46 – 1.00
Other hernia .593
No 5,741 415 14.0 1.0
Yes 39 1 2.6 0.59 0.08 – 4.17
*Estimated using Cox Proportional Hazards regression analysis, adjusted for age a continuous factor; the factor 
age was unadjusted.
The final CPH model for multivariate regression analysis included age, BMI and diabe-
tes mellitus (Table 3). Increased baseline age remained associated with a greater risk of 
inguinal hernia development (HR, 1.3; 95% CI, 1.02 – 1.04; P < .001). Increased baseline 
BMI had still a protective effect for inguinal hernia among middle-aged and elderly 
men; participants with a BMI of 25 – 30 kg/m2 had a HR of 0.72 (95% CI, 0.58 – 0.89; P 
= .003), and participants with a BMI >30 kg/m2 had a HR of 0.63 (95% CI, 0.42 – 0.94; 
P = .025) in comparison with the reference group of participants with a BMI <25 kg/
m2. Increased baseline BMI remained protective when included in the model as a 
continuous variable (HR, 0.93; 95% CI, 0.90 – 0.97; P < .001). Although diabetes mellitus 
seemed to show a protective effect in univariate analysis, this result did not remain 
significant after adjustment for age and BMI in the final CPH model (HR, 0.70; 95% CI, 
0.47 – 1.05; P = .086).
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Table 3. Multivariate-adjusted hazard ratio for inguinal hernia among men in the Rotterdam Study, The 
Netherlands (n = 5,780), 1990 – 2008.
Risk factor Multi - adjusted 
hazard ratio*
95% CI P value
Age (y) 1.03 1.02, 1.04 <0.001
Body mass index
<25 1.0 (Referent) -
25 – 30 0.72 0.58, 0.89 .003
>30 0.63 0.42, 0.94 .025
Diabetes Mellitus
No 1.0 (Referent) -
Yes 0.7 0.47, 1.05 .086
diScuSSion
This study showed a 20-year cumulative incidence of inguinal hernia in 5,870 middle-
aged and elderly men of the Rotterdam Study of 14.0%. The age-adjusted HR for the 
development of inguinal hernia was 12 times greater among men. This study also 
demonstrated that being overweight or obese was associated with decreased inci-
dence of inguinal hernia. Advancing age was a significant risk factor for development 
of an inguinal hernia in middle-aged and elderly men, but no relationship could be 
determined between diabetes mellitus and inguinal hernia development.
These are relevant findings, because inguinal hernia repair is the most performed 
procedure in general surgery. In 2003, approximately 777,000 inguinal hernia repairs 
were performed in the United States.1-4 Others have reported that the lifetime risk of 
undergoing inguinal hernia repair is greatest for the adult male population, especially 
in the final decades of life.5-8,12,15 Obesity is also considered to be a risk factor for in-
guinal hernia.9 In the United States, the prevalence of obesity increased from 27.5% 
in 1999 to 37.2% in 2010 among men between the age of 40 and 59.18,19 Surprisingly, 
the relationship between obesity and inguinal hernia is still not well established; even 
a protective effect has been suggested.7,9,12,15-17 Therefore, it can be argued that ow-
ing to ageing of the population and increasing prevalence of obesity, inguinal hernia 
constitutes a relevant public health issue.
The theory that collagen quality of collagen and collagen metabolism are important 
in the development of (direct) inguinal hernia is widely accepted.21 In the elderly 
population, the balance between the formation and degradation of collagen seems 
to be shifted, favouring a decrease in connective tissues, resulting in less collagen 
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cross-linking and, therefore, less strength and stability of the collagen fibres.22,23 In 
addition, data on skin biopsies of elderly patients have demonstrated an increase in 
matrix metalloproteases 2 and 9 (MMP) and a decrease in the tissue inhibitors of metal-
loproteinases 1 and 2 (TIMP), which play a role in this collagen degeneration.24,25 These 
changes may increase the risk of developing an inguinal hernia with advancing age.26 
The current study provides data on the 5-, 10-, 15-, and 20-year cumulative incidence 
of development of an inguinal hernia in middle-aged and elderly men and the associa-
tion of inguinal hernia with increasing baseline age. The HR in male participants aged 
>75 years almost doubled in comparison with participants <65 years, supporting the 
theory described herein.
The hypothesis that individuals who are overweight or obese are more likely to develop 
inguinal hernia has been questioned by several studies.7,9,12,15-17 Our study contributes 
to these previous findings and provides data on the 20-year cumulative incidence of 
development of an inguinal hernia among middle-aged and elderly and an association 
with decreasing baseline BMI; the HR of the development of an inguinal hernia was 
decreased by almost half in men with a BMI >30 kg/m2 compared with men with a 
BMI <25 kg/m2. 
To date, only two prospective cohort studies have been performed that evaluate 
the relationship between inguinal hernia and potential risk factors.12,15 Both studies 
demonstrated an “unexpected” relationship between overweight or obese male par-
ticipants and a decreased risk of inguinal hernia. It was hypothesized in these studies 
that the lesser incidence of inguinal hernia in participants with increased body weight 
could be explained by a decreased chance of diagnosis of inguinal hernia in these 
participants on physical examination. 
In 2007, Ruhl et al15 examined risk factors for inguinal hernia among US adults aged 
25 – 74 years who participated in the National Health and Nutrition Examination 
Survey I Epidemiologic Follow-up Study (1971 -1975) and were followed through 1992 
– 1993. They demonstrated in multivariate analysis that a greater incidence of ingui-
nal hernia among men was associated with increasing baseline age and the presence 
of concomitant hiatal hernia, whereas black race, being overweight and obesity were 
associated with a lesser incidence. Although the conclusions drawn from that study 
support our data with respect to age and BMI, the National Health and Nutrition Ex-
amination Survey I study focused only on the adult US population aged 25 – 74 years, 
whereas the present study focused more on the elderly male population. Furthermore, 
as mentioned by the authors, the follow-up occurred only 10 and 20 years after the 
baseline examination. Two recently published papers based on a retrospective review 
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of all inguinal hernia performed on adult US residents of Olmsted County, Minnesota, 
supported these findings.8,17 
In 2008, Rosemar et al examined risk factors for inguinal hernia in a community-based 
sample of middle-aged Swedish men who were followed-up from baseline (1970 – 
1973) until 2004. The conclusion drawn from that study was that middle-aged Swedish 
men who are overweight or obese also had a lesser incidence of inguinal hernia. A 
decreased risk was noted with advancing age and among heavy smokers. Although 
this study supports the results of both the study by Ruhl et al and the current study, 
this Swedish study only analyzed middle-aged men and only allowed identification 
of participants who were hospitalized for inguinal hernia, whereas the current study 
included middle-aged and elderly men and diagnoses of inguinal hernia not only from 
hospital discharge records, but also from the medical files of general practitioners.
Although our study confirms the previous findings of the 2 earlier mentioned cohort 
studies, our study provides insight into the association of inguinal hernia with po-
tential risk factors of a middle-aged and elderly male population in Western Europe. 
Our study has limitations. The Rotterdam Study contains data of 3 cohorts (RS I, RS 
II, and RS III); in the first cohort it was asked explicitly if participants had a known 
inguinal hernia, which was not the case for the other 2 cohorts, which may have led to 
potential differences in prevalent cases of inguinal hernia between the cohorts. In an 
attempt to compensate for this potentially huge bias, all 3 cohorts were checked for 
a diagnosis of inguinal hernia through records of hospitals and general practitioners, 
including the period (far) before entrance into the Rotterdam Study. Therefore, this 
possibility should have biased the results only minimally. Because case definition was 
based on records of hospitals and general practitioners, and a questionnaire was only 
used for the first cohort, participants with asymptomatic inguinal hernia could have 
been missed and case ascertainment may have been incomplete; confirmation of 
hernia diagnoses by physical examination or ultrasonography within the Rotterdam 
Study was not possible. These limitations also played a role in the other 2 mentioned 
cohort studies. Another limitation is that the protective effect of BMI in relation to 
inguinal hernia development could also be attributable to the fact that diagnosing an 
inguinal hernia can be more difficult in overweight or obese patients owing to their 
obesity.12,15 Therefore, imaging should be incorporated in future studies. 
In conclusion, this large prospective cohort study that provides evidence for risk fac-
tors of inguinal hernia in middle-aged and elderly West-European males by confirming 
previous findings of an increased risk of developing an inguinal hernia with advanc-
ing age and lesser risk of inguinal hernia in overweight and obese male participants.
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AbStrAct
Objective: To compare if watchful waiting is non-inferior to elective repair in men aged 
50 years and older with mildly symptomatic or asymptomatic inguinal hernia.
Background: The role of watchful waiting in elderly male patients with mildly symp-
tomatic or asymptomatic inguinal hernia is still not well established.
Methods: In this non-inferiority trial we randomly assigned men aged 50 years and 
older with mildly symptomatic or asymptomatic inguinal hernia to either elective 
inguinal hernia repair or watchful waiting. Primary endpoint was the mean difference 
in a 4-point pain/discomfort score at 24 months of follow-up. Using a 0.20-point dif-
ference as a clinically relevant margin, it was hypothesized that watchful waiting was 
non-inferior to elective repair. Secondary endpoints included quality of life, event-free 
survival and crossover rates.
Results: Between January 2006 and August 2012, 528 patients were enrolled of whom 
496 met the inclusion criteria: 234 were assigned to elective repair and 262 to watch-
ful waiting. The mean pain/discomfort score at 24 months was 0.35 (95% CI 0.28 to 
0.41) in the elective repair group and 0.58 (95% CI 0.52 to 0.64) in the watchful waiting 
group. The difference of these means (MD) was -0.23 (95% CI -0.32 to -0.14). In the 
watchful waiting group 93 patients (35.4%) eventually underwent elective surgery and 
6 patients (2.3%) received emergent surgery for strangulation/incarceration. Postopera-
tive complication rates and recurrence rates in these 99 operated individuals were 
comparable to individuals originally assigned to the elective repair group (8.1% vs. 
15.0%; P = 0.106; 7.1% vs. 8.9%; P = 0.668, respectively). 
Conclusions: Our data could not rule out a relevant difference in favor of elective repair 
with regard to the primary endpoint. Nevertheless, in view of all other findings, we 
feel that our results justify watchful waiting as a reasonable alternative compared to 
surgery in men aged 50 years and older.
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introduction
Inguinal hernia repair is one of the most frequently performed surgical procedures 
worldwide constituting a major economic burden on the healthcare sector.1,2 The 
incidence of inguinal hernia increases with age, especially in men from the fifth to 
the seventh decade of life.3,4 Interestingly, in this population more than one-third 
of inguinal hernia is reported to be mildly symptomatic or asymptomatic at first 
presentation.5-7
Surgical tradition advocated that inguinal hernia should be repaired to prevent a 
hernia complication, even if presented as asymptomatic.5,8 To date, the general con-
sensus states that prevention of incarceration of inguinal hernia per se is not a proper 
indication to perform surgery. Chronic postoperative inguinal pain has become an 
increasingly important issue after inguinal hernia repair with reported incidences of 
approximately 12% after open tension-free repair.9,10
Until now 2 randomized clinical trials have been published, comparing a watchful 
waiting strategy and surgical approach in treatment of mildly symptomatic and as-
ymptomatic inguinal hernia. Both trials reported that no superiority could be found 
for elective repair over watchful waiting with regard to pain/discomfort, concluding 
that watchful waiting is an acceptable strategy for men with minimally symptomatic 
hernia.11,12 The long-term results, however, showed crossover rates to 72% in patients 
who were initially treated conservatively, even rising to 79% in patients over 65 years 
old.5,13 The authors concluded that most patients will develop symptoms over time and 
recommend surgical repair for medically fit patients with a painless inguinal hernia.
The objective of this study was to determine the non-inferiority of watchful waiting 
to elective repair in men aged 50 years and older with mildly symptomatic or asymp-
tomatic inguinal hernia.
methodS
eligibility criteria
Men aged 50 years and older with a mildly symptomatic or asymptomatic inguinal 
hernia (pain/discomfort score 1 or 0) were eligible for inclusion. We utilized a 4-point 
pain/discomfort score that was also used in the trial by Fitzgibbons et al.11 The level 
of pain/discomfort was determined by the selection of one of the following 4 options:
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0) no pain or discomfort due to the hernia when working, exercising or performing 
any of a patient’s usual activities;
1) mild pain or discomfort due to the hernia when working and exercising that does 
not prevent a patient from performing his usual activities;
2) moderate pain or discomfort due to the hernia when working, exercising, and 
performing any of a patient’s usual activities;
3) severe pain or discomfort due to the hernia when working, exercising, and perform-
ing any of a patient’s usual activities.
Excluded were those with a bilateral, scrotal or femoral hernia or those classified as 
American Society of Anaesthesiologist (ASA) class 4. We have only included men in 
the present study because the incidence of inguinal hernia exceeds that of women by 
far. Men with a first recurrent inguinal hernia were not excluded. An inguinal hernia 
was confirmed on physical examination. Confirmation of the diagnosis with the use 
of ultrasonography was optional, not mandatory. Patients were recruited from 29 
community and academic centers in the Netherlands and two Belgian centers. Study 
enrolment commenced on January 1, 2006. The last patients were included on August 
31, 2012. All included patients provided written informed consent. Detailed informa-
tion on the randomization procedure, data collected during follow-up, and ethical 
considerations and monitoring can be found in the Supplementary Appendix II.
follow-up
Patients assigned to surgery underwent repair as soon as possible after randomiza-
tion (preferably within 4 to 8 weeks). Patients in both treatment groups were invited 
for follow-up at 3, 12, 24, and 36 months at the outpatient clinic of each participat-
ing center. During these follow-up visits patients underwent physical examination. 
Independent trial coordinators conducted the follow-up visits at 3, 12, 24, and 36 
months. Surgery was performed at the surgical department of the involved center. 
In consultation of the patient, the surgeon determined the operation technique used 
for inguinal hernia repair. Patients who were randomly assigned to watchful waiting 
were given written instructions to recognize a hernia complication (incarceration or 
strangulation) after randomization. 
Primary and secondary endpoints
The primary endpoint was the mean difference in the 4-point pain/discomfort score 
between patients assigned to watchful waiting and elective repair after a follow-up 
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period of 24 months. Secondary endpoints were: 1) health-related quality of life 
measured at baseline, 3, 12, 24 and 36 months, 2) the overall 3-year crossover rate 
in patients assigned to watchful waiting and 3) the overall 3-year event-free survival 
between the two treatment groups, defined as survival free from moderate or severe 
pain (pain/discomfort score of 2 or higher), hernia complication (incarceration or 
strangulation), ischemic orchitis and recurrent hernia. Health-related quality of life 
was assessed by the Short-Form 36 (SF-36) questionnaire, from which we have used the 
mean physical component scores (PCS) and the mean mental component scores (MCS) 
between the treatment groups at the different points in time; the EuroQol-5D (EQ-5D) 
questionnaire was also assessed at baseline, 3, 12, 24, and 36 months of follow-up.14,15 
The EQ-5D included a visual analogue scale (VAS) to rate overall health status on a 
scale of 0 (worst imaginable health state) to 100 (best imaginable health state).
Sample size calculation and statistical analysis
The power calculation was based on the difference in mean pain/discomfort score 
between groups after a 24-month follow-up period. To show non-inferiority, the lower 
limit of the two-sided 95% CI for the difference (elective repair minus watchful wait-
ing) should not exceed the pre-specified non-inferiority margin. The determination 
of the non-inferiority margin was based on clinical and statistical considerations, for 
which a margin of 0.20 points after 24 months was chosen. This required the accrual 
of 528 patients (2x220 + 20%) at a power of 80% to take into account a potential loss 
to follow-up of 20%.
Percentages were compared between groups using the chi-square test or Fisher’s exact 
test. Comparison of continuous data was done with use of the Mann–Whitney test. 
Time to event was calculated from the date of randomization until an event occurred; 
patients were considered censored if they died, were lost to follow-up or completed 
follow-up without any event with a maximum of 36 months (length of the study pe-
riod). Overall 3-year event-free survival was calculated and compared with the use of 
Kaplan-Meier curves. The Kaplan-Meier method was also used to estimate the overall 
3-year crossover rate among patients assigned to watchful waiting. The log-rank test 
was used for the univariate comparisons. For the differences in the 4-point pain/
discomfort score a mixed model with an unstructured covariance matrix was used to 
allow for correlations within individuals over time. In addition, the analysis for the 
primary endpoint was stratified for men aged 50 to 65 years and 65 years and older, 
participating centers, and duration of inguinal hernia present at baseline. Statistical 
analysis was performed with SPSS software, version 20.0 (IBM Corp. 2011, Armonk, 
NY) and SAS software (PROC MIXED), version 9.3 (SAS Institute Inc, Cary, NC).
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reSultS
Study population
From January 2006 through August 2012, 528 patients were enrolled in the study 
of whom 258 were assigned to elective repair and 270 to watchful waiting. Study 
follow-up ended in August 2014. A total of 24 patients who were assigned to surgery 
were not included in the analysis: 21 patients withdrew consent immediately after 
randomization and 3 patients did not meet the inclusion criteria including 1 patient 
with a femoral hernia, 1 with a bilateral hernia, and 1 patient with a lipoma. A total of 
8 patients who were assigned to watchful waiting were not included in the analysis: 
4 patients withdrew consent and 4 patients did not meet the inclusion criteria includ-
ing 1 patient with a femoral hernia, 1 with a lipoma, and 2 patients were excluded 
because they were younger than 50 years of age (Figure 1).
528 Underwent randomization
258 Were assigned to elective
inguinal hernia repair
270 Were assigned to watchful
waiting
226 Underwent elective repair
8 Crossed to watchful waiting
163 Were treated conservatively
99 Crossed to surgery
21 Withdrew consent
3 Did not meet the inclusion criteria
4 Withdrew consent
4 Did not meet the inclusion criteria
234 Were included in the
analysis
262 Were included in the
analysis
Figure 1. Study enrollment.18 
Baseline characteristics and hernia details were balanced between the two groups 
(Table 1, 2). The mean age of the population was 65.1 years (SD 8.3) and the mean BMI 
was 24.9 kg/m2 (SD 2.7). A total of 463 out of 496 men (93.3%) with mildly symptomatic 
or asymptomatic inguinal hernia were referred to the hospital by their general practi-
tioner; 473 of 496 men (95.4%) presented with a primary inguinal hernia and 23 men 
(4.6%) had a first recurrence. An ultrasound was performed in 267 of 496 (53.8%) of the 
study population, and a radiologist was able to confirm the diagnosis in 241 (90.3%) of 
ultrasonographies.
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Table 1. Baseline characteristics of patients aged 50 years and older with mildly symptomatic or asymptom-
atic inguinal hernia, according to treatment group.
Characteristic
Watchful waiting
(n = 262)
Elective repair
 (n = 234)
Age – yr (mean, SD) 65.2 (8.3) 65.0 (8.2)
BMI* – kg/m2 (mean, SD) 24.8 (2.7) 25.0 (2.7)
Smoking – n (%)
Current
Former
None
Not reported
50 (19.1)
112 (42.7)
83 (31.7)
17 (6.5)
47 (20.1)
104 (44.4)
73 (31.2)
10 (4.3)
Packyears – yr (median, range) 5.0 (90.0) 7.3 (90.0)
ASA* classification – n (%)
1
2
3
Not reported
152 (58.0)
92 (35.1)
15 (5.7)
3 (1.2)
139 (59.4)
79 (33.8)
12 (5.1)
4 (1.7)
Cardiovascular system – n (%)
Angina
Hypertension
MI*
Cardiac arrhythmia
Other
Not reported
4 (1.5)
47 (17.9)
8 (3.1)
12 (4.6)
5 (1.9)
2 (0.8)
4 (1.7)
38 (16.2)
8 (3.4)
10 (4.3)
7 (3.0)
3 (1.3)
TIA* or stroke – n (%)
Not reported
10 (3.8)
2 (0.8)
5 (2.1)
3 (1.3)
Diabetes Mellitus – n (%)
Not reported
16 (6.1)
2 (0.8)
17 (7.3)
3 (1.3)
Medication – n (%)
Aspirin
Anticoagulants
Not reported 
33 (12.6)
33 (12.6)
3 (1.2)
28 (12.0)
22 (9.4)
6 (2.7)
Pulmonary system – n (%)
COPD*
Chronic cough
Other
Not reported
13 (5.0)
2 (0.8)
3 (1.2)
2 (0.8)
9 (3.8)
2 (0.9)
5 (2.1)
3 (1.3)
Gastro-intestinal system – n (%)
Liver cirrhosis
Constipation
Not reported 
2 (0.8)
4 (1.5)
2 (0.8)
-
1 (0.4)
3 (1.3)
Back problems – n (%)
Not reported
12 (4.6)
2 (0.8)
16 (6.8)
3 (1.3)
Urinary tract – n (%)
Prostate cancer
BPH*
Urinary complaints
Other
Not reported
5 (1.9)
15 (5.7)
6 (2.3)
2 (0.8)
2 (0.8)
3 (1.3)
17 (7.3)
2 (0.9)
2 (0.9)
3 (1.3)
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Primary and secondary endpoints 
The mean 4-point scale pain/discomfort scores at baseline, 3, 12, 24, and 36 months 
for the two treatment groups are presented in Figure 2; the changes from baseline 
are shown in table 3. The mean pain/discomfort score at months 3, 12 and 24, i.e. 
the primary endpoint according to the protocol, was 0.35 (95% CI 0.28 to 0.41) in the 
elective repair group and 0.58 (95% CI 0.52 to 0.64) in the watchful waiting group. The 
difference of these means (MD) was -0.23 (95% CI -0.32 to -0.14). Similar results were 
found after adjustment for the stratification factors at randomization (men aged 50 
to 65 years or 65 years and older, participating centers, duration of inguinal hernia 
present at baseline), 0.29 vs 0.51 (MD -0.22, 95%CI -0.31 to -0.13). The widths of these 
95% CIs indicate that a difference of means greater than 0.20 in favor of elective repair 
cannot be excluded.
In the subgroups of men aged 50 to 65 years and men aged 65 years and older similar 
results were found: in men aged 50 to 65 years the mean 4-point pain/discomfort 
score was 0.57 for patients assigned to watchful waiting and 0.34 for patients assigned 
to elective repair (MD, -0.23; 95% CI, -0.36 to -0.11); in men aged 65 years and older 
the adjusted mean 4-point pain/discomfort score was 0.58 for patients assigned to 
watchful waiting and 0.36 for patients assigned to elective repair (MD, -0.22; 95% CI, 
-0.36 to -0.09).
Table 1. Baseline characteristics of patients aged 50 years and older with mildly symptomatic or asymptom-
atic inguinal hernia, according to treatment group. (continued)
Characteristic
Watchful waiting
(n = 262)
Elective repair
 (n = 234)
Health status – n (%)
Independent
Partly dependent
Totally dependent
Not reported
252 (96.2)
4 (1.5)
2 (0.8)
4 (1.5)
228 (97.4)
2 (0.9)
-
4 (1.7)
Education – n (%)
Not reported
245 (93.5)
15 (5.7)
220
13 (5.6)
Employment – n (%)
Paid work
Retirement
Unemployed
Unfit for work
Volunteer work
Domestic chores
Not reported
93 (35.5)
143 (54.6)
1 (0.4)
8 (3.1)
6 (2.3)
5 (1.9)
6 (2.3)
82 (35.0)
123 (52.6)
4 (1.7)
5 (2.1)
3 (1.3)
4 (1.7)
13 (5.6)
*BMI = body mass index, ASA = American Society of Anesthesiologists, MI = myocardial infarction, TIA = 
transient ischemic attack, COPD = chronic obstructive pulmonary disease, BPH = benign prostate hyperplasia.
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Figure 2. Mean 4-point pain score (error bars represent standard error of the mean) at various time points af-
ter inclusion according to treatment arm (closed circles: watchful waiting, open circles: elective hernia repair).
For the secondary endpoints, mean changes compared to baseline and mean differ-
ences between treatment groups for different measures of quality of life are presented 
in Table 3. At 3 months of follow-up the mean PCS score showed better results in the 
group assigned to watchful waiting compared with the group assigned to surgery 
(51.37 vs. 49.05; P < 0.001). However, at 12 and 24 months the mean difference in PCS 
scores of the SF-36 were in favor of the elective repair group.
The mean EQ5D scores at 24 months were slightly higher in patients assigned to 
elective repair compared with patients assigned to watchful waiting (0.91 vs. 0.90; MD, 
0.04, 95% CI; 0.01 to 0.07; P = 0.009). At 3 months the mean VAS score rating overall 
health status was 87.02 in the elective repair group and 80.97 in the group assigned to 
watchful waiting (MD, 5.59, 95% CI; 3.78 to 7.40; P <0.001).
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Table 2. Hernia details of patients aged 50 years and older with mildly symptomatic or asymptomatic ingui-
nal hernia, according to treatment group. 
Characteristic
Watchful waiting
(n = 262)
Elective repair
 (n = 234)
Referral – n (%)
General practitioner
Other specialist
No referral
Not reported
244 (93.1)
9 (3.4)
-
9 (3.4)
219 (93.6)
8 (3.4)
1 (0.4)
6 (2.7)
Time of presence at inclusion – n (%)
≤ 3 months
> 3 months
133 (50.8)
129 (49.2)
118 (50.4)
116 (49.6)
Inguinal hernia – n (%)
Primary 
1st Recurrence 
249 (95.0)
13 (5.0)
224 (95.7)
10 (4.3)
Side – n (%)
Left
Right 
Not reported
123 (46.9)
138 (52.7)
1 (0.4)
108 (46.2)
126 (53.8)
-
Enlargement – n (%)
Not reported
47 (17.9)
14 (5.3)
42 (17.9)
10 (4.3)
Reducibility – n (%)
Spontaneously 
Easy
With diffi culty
Not reported
171 (65.3)
82 (31.3)
3 (1.2)
6 (2.3)
159 (67.9)
67 (28.6)
2 (0.9)
6 (2.7)
Positive family history* – n (%)
Not reported
26 (9.9)
2 (0.8)
25 (10.7)
3 (1.3)
Ultrasonography – n (%)
Diagnosis confi rmed – n (%)
Type – n (%)
Medial
Lateral
Unclear
Not reported
Diameter – mm (mean, SD)
Sagittal 
Transverse
150 (57.3)
134/150 (89.3)
72/150 (48.0)
43/150 (28.7)
22/150 (14.7)
13/150 (8.7)
17.9 (11.4)
19.2 (9.4)
117 (50.0)
107/117 (91.5%)
58/117 (49.6)
29/117 (24.8)
23/117 (19.7)
7/117 (6.0)
18.9 (11.7)
20.5 (11.3)
* Positive family history of abdominal wall hernia (i.e. inguinal, umbilical and epigastric hernia).
Intention-to-treat analysis showed a mean follow-up of 32.5 months (SD 7.5) for the elec-
tive repair group and 32.9 months (SD 6.7) for the group assigned to watchful waiting 
(P = 0.558). The 3-year cumulative incidence of patients with 1 or more event was 17.5% 
(41/234) in the elective repair group (25 individuals reported moderate or severe pain, 
1 hernia complication, 1 ischemic orchitis, 20 recurrent hernias) compared with 20.6% 
(54/262) in the group assigned to watchful waiting (69 individuals reported moderate 
or severe pain, 7 hernia complications occurred in 6 individuals, 7 recurrent hernias); 
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the overall 3-year Kaplan Meier (KM) event-free survival was 80.9% after elective repair 
compared to 77.2% after watchful waiting (hazard ratio (HR), 1.20; 95% CI, 0.80 to 1.80; 
P = 0.377), which is presented in Supplementary Figure 3. The 3-year cumulative (KM 
estimate of 39.5%) crossover rate to hernia repair in patients who were initially assigned 
to watchful waiting was 37.8% (99/262); The crossover rate did not differ between the 
groups stratifi ed for men aged 50 to 65 years or men aged 65 years and older (38.2% vs. 
37.0%). The 3-year cumulative incidence (KM of estimates 9.9% and 7.8%; HR, 1.25; 95% 
CI, 0.53 to 2.96; P = 0.610) of a recurrent inguinal hernia was 8.9% (20/226) in the elective 
repair group compared with 7.1% (7 out of 99) in the group assigned to watchful waiting 
and crossed to surgery (P = 0.668). Recurrence rates were comparable between different 
surgical techniques, type of mesh, and participating centers.
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No. at risk
WW 262 225 203 137
ER 234 210 180 133
Figure 3. The estimated overall 3-year event-free survival among patients aged ≥50 years with mildly symp-
tomatic or asymptomatic inguinal hernia assigned to watchful waiting (WW) and elective repair (ER), accord-
ing to intension-to-treat analysis.
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The 3-year cumulative incidence of death was comparable between the two treatment 
groups; 3.0% (7/234) of patients died who were assigned to elective repair and 3.1% 
(8/262) of patients who were assigned to watchful waiting (P = 1.000). None of the 
deaths was hernia-related. 
Table 3. Mean baseline values and mean changes from baseline according to treatment group for measures 
of quality of life.
Measure of 
Pain/ Quality of Life
Watchful waiting
(n = 262)
Elective repair
 (n = 234)
Mean Difference
 
P Valuea
4-point pain/discomfort scorec  
Baseline 0.44 (0.38 ; 0.50) 0.51 (0.44 ; 0.58)
3 months +0.21 (0.11; 0.31)b -0.19 (-0.30 ; -0.09)b -0.41 (-0.55 ; -0.26) <0.001
12 months +0.11 (0.01 ; 0.21)b -0.15 (-0.24 ; -0.06)b -0.26 (-0.40 ; -0.13) <0.001
24 months +0.07 (-0.03 ; 0.17) -0.16 (-0.26 ; -0.06)b -0.23 (-0.37 ; -0.09) 0.001
36 months +0.06 (-0.04 ; 0.16) -0.26 (-0.36 ; -0.16)b -0.33 (-0.47 ; -0.18) <0.001
EQ-5Dd 
Baseline 0.92 (0.89 ; 0.94) 0.90 (0.87 ; 0.93)
3 months -0.02 (-0.03 ; 0.00) 0.04 (0.03 ; 0.07)b 0.06 (0.04 ; 0.09) <0.001
12 months -0.02 (-0.04 ; 0.00)b 0.03 (0.01 ; 0.05)b 0.05 (0.02 ; 0.08) <0.001
24 months -0.02 (-0.04 ; 0.00) 0.01 (0.00 ; 0.04) 0.04 (0.01 ; 0.07) 0.009
36 months -0.01 (-0.03 ; 0.00) 0.01 (0.00 ; 0.04) 0.03 (0.00 ; 0.05) 0.055
VASe
Baseline 83.52 (81.34 ; 85.70) 83.98 (81.95 ; 86.01)
3 months -2.55 (-3.76 ; -1.34)b 3.04 (1.65 ; 4.43)b 5.59 (3.78 ; 7.40) <0.001
12 months -2.36 (-4.89 ; -1.05)b -0.36 (-1.95 ; 1.22) 1.99 (-0.16 ; 4.14) 0.069
24 months -2.25 (-4.92 ; -0.75)b -0.82 (-2.49 ; 0.85) 1.43 (-1.78 ; 3.63) 0.203
36 months -1.72 (-4.69 ; -0.23)b -0.67 (-2.28 ; 0.94) 1.05 (-1.10; 3.19) 0.339
SF-36 PCSe 
Baseline 51.28 (50.06 ; 52.50) 51.27 (50.16 ; 52.38)
3 months 0.09 (-0.79 ; 0.97) -2.22 (-3.27 ; -1.18)b -2.31 (-3.66 ; -0.96) <0.001
12 months -0.86 (-1.58 ; -0.15)b 1.44 (0.62 ; 2.25)b 2.29 (1.24 ; 3.36) <0.001
24 months -0.98 (-1.85 ; -0.12)b 0.79 (-0.12 ; 1.71) 1.77 (0.53 ; 3.02) 0.005
36 months -0.43 (-1.31 ; 0.45) -0.05 (-0.99 ; 0.90) 0.38 (-0.89 ; 1065) 0.555
SF-36 MCSe 
Baseline 55.96 (54.79 ; 57.13) 56.56 (55.37 ; 57.75)
3 months 0.17 (-0.68 ; 1.02) -0.10 (-1.10 ; 0.89) -0.27 (-1.56 ; 1.02) 0.679
12 months 0.03 (-0.77 ; 0.84) -0.22 (-1.15 ; 0.70) -0.26 (-1.47 ; 0.96) 0.676
24 months -0.17 (-0.99 ; 0.64) -1.15 (-2.01 ; -0.29)b -0.98 (-2.16 ; 0.21) 0.106
36 months -1.16 (-1.99; -0.33)b -0.02 (-0.92 ; 0.87) 1.14 (-0.08 ; 2.35) 0.067
Abbreviations: EQ-5D, the EuroQol-5D questionnaire; VAS, Visual Analogue Scale; SF-36, the 36-item short 
form health survey score; PCS, physical component score; MCS, mental component score. 
Values between parentheses represent 95% CIs.
a: P values represent the difference between the two treatment groups for pain or measures of quality of life;
b: Mean change compared to baseline is statistically significant (P  <0.05);
c: Expressed on a 0 (no pain) to 3 (severe pain) point scale;
d: Expressed on a 0 (worst) to 1 (best) point scale;
e: Expressed on a 0 (worst) to 100 (best) point scale.
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inguinal hernia repair
In men assigned to elective repair 8 out of 234 patients (3.4%) did not undergo surgery; 
7 patients decided immediately after randomization that they did not want to be 
operated on, and 1 patient was considered to be medically unfit for surgery due to 
progression of his comorbidities prior to the operation. In men assigned to watchful 
waiting 99 out of 262 patients (37.8%) crossed to hernia repair during the 36-month 
study period; 90 because of some degree of pain or discomfort, 6 because of a hernia 
complication, 1 because of cosmetic reasons and 2 for reasons unknown. Of the 6 
patients who had a hernia complication, 5 men (1.9%) had an acutely painful groin 
without bowel obstruction due to an incarcerated hernia for which they underwent 
emergency surgery. In 1 patient (0.4%) an acute repair was performed because of a 
strangulated hernia. In none of those patients a resection of the bowel had to be per-
formed. The median time between randomization and surgery was 7.0 weeks (range 
67.0) for patients assigned to elective repair and 41.0 weeks (range 158.0) for patients 
assigned to watchful waiting and crossed to surgery. 
Perioperative data of patients assigned to elective repair and patients assigned to 
watchful waiting who crossed to surgery were comparable and are provided in Table 
4. The mean operation time was 45.7 minutes (SD 15.3) in the elective repair group, as 
compared to 47.4 minutes (SD 20.2) in the crossover group. Most surgeons performed 
Lichtenstein open tension-free repairs: 176 out of 226 repairs (77.9%) in patients who 
were assigned to elective repair and 69 out of 99 repairs (69.7%) in patients assigned 
to watchful waiting and crossed to surgery. In both groups more than half of patients 
were treated in day-care; one morbidly obese patient of the crossover group was ad-
mitted for observation at the intensive care unit due to respiratory distress and was 
discharged from the hospital after two days. 
The total number of peri- and postoperative complications that occurred within one 
month are summarized in Table 5. A total of 66 peri- and postoperative complications 
were reported in 42 patients; the total number of patients with 1 or more postoperative 
complications was 34 out of 226 patients (15.0%) assigned to elective repair compared 
with 8 out of 99 patients (8.1%) assigned to watchful waiting and crossed to hernia 
repair (P = 0.106). In the elective repair group 1 patient was converted during surgery 
from laparoscopic to open repair and one patient needed a reoperation because of tes-
ticular ischemia; in the crossover group 1 patient had a cardiac arrest before surgery 
during the anaesthetic induction. During follow-up a reoperation was performed in 
7 out of 226 patients (3.1%) assigned to elective repair: 2 because of continuing pain/
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discomfort, 1 because of ischemic orchitis and 4 because of a recurrent hernia of 
which 1 patient underwent emergency surgery because of incarceration. In the cross-
over group 5 out of 99 patients (5.0%) underwent a reoperation because of a recurrent 
hernia of which one was preceded by incarceration necessitating emergency repair.
Table 4. Perioperative data of patients aged 50 years and older assigned to elective repair and patients who 
crossed to surgery after initial watchful waiting strategy.
Crossed to surgery
(n = 99)
Elective repair
(n = 226)
Operation time – min (mean, SD) 47.4 (20.2) 45.7 (15.3)
Operation technique – n (%)
Lichtenstein
TEP*
TAPP*
Plug and Patch
PHS
Pre-peritoneal mesh repair
Type of repair not reported
69 (69.7)
11 (11.1)
2 (2.0)
4 (4.0)
1 (1.0)
9 (9.1)
3 (3.0)
176 (77.9)
24 (10.6)
9 (4.0)
3 (1.3)
3 (1.3)
10 (4.4)
1 (0.4)
Type of mesh – n (%)
Flat mesh
Three-dimensional mesh
Mesh type not reported
64 (64.6)
9 (9.1)
26 (26.3)
180 (79.6)
14 (6.2)
32 (14.2)
Experience, procedures – n (%)
<10
10-25
>25
Not reported
3 (3.0)
3 (3.0)
40 (40.4)
53 (53.5)
16 (7.1)
18 (8.0)
116 (51.3)
76 (33.6)
Type of anesthesia  – n (%)
Local
Spinal
General
Not reported
13 (13.1)
36 (36.4)
30 (30.3)
20 (20.2)
20 (8.8)
107 (47.3)
91 (40.3)
8 (3.5)
Nyhus classification*  – n (%)
Type I
Type II
Type III
Type IV
No hernia (lipoma)
Not reported
8 (8.1)
14 (14.1)
38 (38.4)
4 (4.0)
1 (1.0)
34 (34.3)
38 (16.8)
46 (20.4)
111 (49.1)
10 (4.4)
1 (0.4)
20 (8.8)
Nerve identification  – n (%)
No identification
1) Ilioinguinal nerve
2) Iliohypogastric nerve
3) Branch of genitofemoral nerve
Nerve 1 & 2
Nerve 1 & 3
Nerve 2 & 3
Nerve 1, 2 & 3
Not reported
7 (7.1)
20 (20.2)
1 (1.0)
-
6 (6.1)
6 (6.1)
-
6 (6.1)
46 (46.5)
8 (3.5)
59 (26.1)
2 (0.9)
2 (0.9)
21 (9.3)
14 (6.2)
2 (0.9)
34 (15.0)
76 (33.6)
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Table 4. Perioperative data of patients aged 50 years and older assigned to elective repair and patients who 
crossed to surgery after initial watchful waiting strategy. (continued)
Crossed to surgery
(n = 99)
Elective repair
(n = 226)
Transsection of the nerve  – n (%)
No transsection
1) Ilioinguinal nerve
2) Iliohypogastric nerve
3) Branch of genitofemoral nerve
Nerve 1 & 2
Nerve 1 & 3
Nerve 2 & 3
Nerve 1, 2 & 3
Not reported
35 (35.4)
12 (12.1)
2 (2.0)
-
4 (4.0)
-
-
-
46 (46.5)
126 (48.1)
19 (8.4)
4 (1.8)
3 (1.3)
2 (0.9)
2 (0.9)
1 (0.4)
1 (0.4)
68 (30.1)
Closure of subcutis – n (%)
Not reported
70 (70.7)
19 (19.2)
163 (72.1)
32 (14.2)
Closure of skin – n (%)
Staples
Intra-cutaneous
Continuous
Interrupted
Continuous, intra-cutaneous
Strips
Not reported
-
81 (81.8)
2 (2.0)
-
1 (1.0)
-
15 (15.2)
5 (2.2)
180 (79.6)
11 (4.7)
2 (0.9)
11 (4.9)
1 (0.4)
16 (7.1)
Level of operation difficulty – n (%)
Easy
Moderate
Hard
Not reported
31 (31.3)
50 (50.5)
4 (4.0)
14 (14.1)
94 (41.6)
111 (49.1)
5 (2.2)
16 (7.1)
Hospital admission – n (%)
None
Surgical department
Intensive care unit
Not reported
57 (57.6)
10 (10.1)
1 (1.0)
31 (31.3)
150 (66.4)
33 (14.6)
-
43 (19.0)
Peri-operative antibiotics – n (%)
Not reported
12 (12.1)
51 (51.5)
42 (18.6)
53 (23.5)
*TEP = total extra-peritoneal repair, TAPP = trans-abdominal pre-peritoneal repair, PHS =  prolene hernia 
system, Nyhus classification19 : I) indirect inguinal hernia with normal internal ring, II) indirect inguinal hernia 
with dilated internal ring, III) direct inguinal hernia/posterior wall defect, and IV) recurrent hernia.
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diScuSSion
This multicenter randomized trial in men aged 50 years and older with mildly symp-
tomatic or asymptomatic inguinal hernia could not rule out a relevant difference in 
favor of elective repair for the pain/discomfort scores after a follow-up of 24 months. 
The 95% CI of the difference of means ranged from -0.32 to -0.14. A difference of 0.20 or 
greater cannot be excluded and, therefore, our trial is inconclusive in this respect. For 
secondary endpoints the different measures of quality of life and the mean changes 
over time compared to baseline and study groups were slightly in favor of surgery. 
Table 5. Total number of perioperative complications in patients aged 50 years and older assigned to elective 
repair and patients who crossed to surgery after initial watchful waiting strategy.
 
Event
Elective repair
(n= 226)
Crossed to surgery
 (n= 99)
Complications during surgery – n (%)
Damage to epigastric or testicular vessels 2 (0.9) 3 (3.0)
Unintended nerve damage 2 (0.9) 1 (1.0)
Conversion to open repair 1 (0.4) -
Peritoneal defect 3 (1.3) -
Bradycardia during surgery 1 (0.4) -
Cardiac arrest during anesthetic induction - 1 (1.0)
Direct postoperative complications – n (%)
Bleeding 2 (0.9) 2 (2.0)
Reoperation:
Testicular ischemia 1 (0.4) -
Urinary retention requiring catheterization 2 (0.9) -
Infection 2 (0.9) 1 (1.0)
Seroma 1 (0.4) -
Post-operative complications (≤ 1 month) – n (%)
Wound infection 2 (0.9) -
Hematoma
Wound
Scrotal
Femoral
10 (4.4)
8 (3.5)
2 (0.9)
-
1 (1.0)
-
Seroma 10 (4.4) 1 (1.0)
Urinary tract infection 3 (1.4) -
Urinary retention requiring catheterization 2 (0.9) -
Pain during ejaculation 2 (0.9) -
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The differences, however, were too small to be clinically relevant. With regard to 
the crossover rate approximately 60% of men assigned to watchful waiting did not 
need surgery during follow-up. In the group who did cross to surgery this was mostly 
driven by in an increase in symptoms – only in 2.3% of the patients crossed over it 
was due to an emergency setting such as incarceration. However, even these acutely 
performed procedures were without any negative sequelae. For example, no bowel 
resection had to be performed due to a prolonged state of ischemia. Although the 
difference in complication rate between the two groups is not significant, our study 
was not powered to find a relevant difference in complication rate. We feel that it 
should be communicated with the patient however, that watchful waiting could result 
in the necessity of an emergent repair later on, and that there is currently no evidence 
that an emergency procedure puts one at risk for permanent health disadvantages. 
Similar results were reported by two earlier published trials.5,13 No differences were 
found in postoperative complication rates and recurrence rates for patients assigned 
to elective repair and patients initially assigned to watchful waiting and crossed over 
to surgery. The recurrence rates reported in our study were high. About 9% in patients 
assigned to elective repair and 7% in operated patients initially assigned to watchful 
waiting. However, no difference in recurrence rates could be found between different 
surgical techniques, types of mesh, and participating centers. In both groups one re-
operation was performed because of a hernia complication in a recurrent hernia. This 
shows that not only patients who were treated conservatively but also patients with 
a failed hernia repair are at risk for emergency surgery. As such these results justify 
watchful waiting as a reasonable alternative compared to surgery in the treatment 
of mildly symptomatic or asymptomatic inguinal hernia in men aged 50 years older.
Our results contribute to earlier published trials as the outcome measure and size 
of our study allowed for the detection of smaller but perhaps clinically relevant 
differences in pain/discomfort and quality of life during a certain period of time. It 
enables surgeons to discuss the potential benefits of inguinal hernia repair in men 
aged 50 years and older who are actually burdened by pain/discomfort preoperatively. 
Even if inguinal hernia were corrected, it would still not completely eliminate the 
risk of emergent repair owing to recurrent hernias. For patients who are too frail for 
surgery it can be argued that watchful waiting is a valid option as it rarely leads to an 
emergency operation.
In 2006 Fitzgibbons et al.11 randomly assigned men aged 18 years and older with 
minimally symptomatic hernia to either open tension-free repair or watchful waiting. 
Similar to our study a 4-point scale was used as primary endpoint to measure the 
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mean difference in pain/discomfort score at 24 months, which was presented as a 
dichotomous variable. In contrast, we decided to use a more comprehensive manner 
by presenting pain/discomfort over time as a continuous variable enabling us to pro-
vide more detailed data between the two treatment groups and compared to baseline. 
Moreover, as Fitzgibbons et al.11 included men aged 18 years and older, we focussed on 
men aged 50 years and older allowing us to draw more definite conclusions for this 
clinically relevant subgroup. The Fitzgibbons trial showed no significant difference 
in pain/discomfort and change in PCS from baseline between groups at two years of 
follow-up, concluding that watchful waiting is as an acceptable option for men with 
minimally symptomatic inguinal hernia.
In 2006 a second trial was published by ‘O Dwyer et al.12, in which male patients aged 
55 years and older with asymptomatic hernia were randomized to either operation or 
observation. The primary endpoint was the mean difference in VAS scores rating pain/
discomfort between treatment groups at 12 months of follow-up. No difference was 
observed between operation and observation with regard to the primary endpoint. 
Although this study did focus on patients aged 55 years and older, the sample size was 
small and the follow-up was limited.
Recently both studies published long-term results that showed crossover rates of 72% 
and 68% in patients who were initially treated conservatively after 7.5 and 10-years 
of follow-up respectively. It was also found that older men crossed over to surgery at 
a considerably higher rate than younger men.5,13 Although we still have to wait for 
long-term data, subgroup analysis of our data found no differences in crossover rates 
between men aged 50 to 65 years or men aged 65 years and older.
This study has to be interpreted in light of limitations. This study allowed surgeons 
to use different operation techniques, which might have hampered the comparability 
between groups. In contrast this provided us with a better reflection of daily practice 
as both endoscopic and open repairs were allowed. Analytical adjustments were made 
for participating centers in the comparison of mean pain/discomfort scores over time 
to eliminate hospital preferences for different operation techniques. Secondly, less 
endoscopic repair and more spinal anesthesia were used compared to the general 
Dutch population who underwent inguinal hernia repair in 2005.16 Nowadays endo-
scopic hernia repair is increasingly used and associated with less postoperative pain 
compared to open techniques, which perhaps makes surgical repair more appealing.17 
Furthermore local or regional anesthetics can be advantageous in treatment of older 
patients with multiple comorbidities.16 Thirdly, Fitzgibbons et al.5 and Chung et al.13 
already mentioned in their discussion that the answer to the high crossover rates in 
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both trials were to be explained by the recruitment process and the fact that elderly 
patients might have a tendency to minimize their symptoms more than younger 
patients. Because of this, elderly patients become eligible for the trial more easily 
despite having more advanced disease. This not only affects the generalizability, it 
also explains for the higher crossover rates in those studies. As in the trial by Fitzgib-
bons et al.5,11 the majority of our patients were referred to the clinic by their general 
practitioner because of concern about the hernia after which they were invited to 
participate in the trial. Therefore it may not be valid to extrapolate the results of 
our trial to the entire population of men aged 50 years and older with mildly and 
asymptomatic inguinal hernia. Long-term follow-up will be needed to confirm these 
hypotheses stated by our colleagues. Finally from a policy maker perspective, it is not 
immediately clear if a relatively small reduction in pain scores over time is worth the 
potentially extra costs of performing surgery, especially when pain is minimal.
Our data could not rule out a relevant difference in favor of elective repair with regard 
to the primary endpoint. Nevertheless, in view of all other findings, we feel that our 
results justify watchful waiting as a reasonable alternative compared to surgery in 
male patients aged 50 years and older.
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randomization procedure
Patients were registered in an online database (Trial Online Process (TOP), designed 
and managed by HOVON data center, Rotterdam, The Netherlands) in which each pa-
tient received a unique trial code. The randomization process was performed during 
the first visit at the outpatient clinic of each participating center by telephone (block 
randomization) and later on by a computer-based randomization service in TOP. Pa-
tients were randomly assigned to watchful waiting or elective repair. Randomization 
was stratified for participating centers, age (men aged 50 to 65 years or 65 years and 
older) and for the duration the inguinal hernia was present at baseline (3 months or 
less and more than 3 months).
data collected during follow-up
§ Patient’s characteristics at baseline: body mass index (BMI), smoking status, health 
status, ASA classification, education level, and type of employment. 
§ Comorbidities at baseline: The cardiovascular system (i.e., history of angina, hyper-
tension requiring medication, history of myocardial infarction, history of cardiac 
arrhythmia, diabetes mellitus, history of transient ischemic attack (TIA) or stroke, 
medication usage (i.e., aspirin, anticoagulants), history of other cardiovascular 
disease (i.e., history of valve insufficiencies, abdominal aortic aneurysm (AAA), 
coronary artery bypass graft surgery (CABG))); The pulmonary system (i.e., chronic 
obstructive pulmonary disease (COPD), chronic cough, other pulmonary disease 
(i.e., history of lung embolism, sarcoidosis)); The digestive system (i.e., constipa-
tion, cirrhotic liver disease with ascites) and urinary tract (i.e., prostate cancer, 
benign prostate hyperplasia (BPH), urinary complaints, history of other diseases 
of the urinary tract (i.e., cancer of the bladder, history of prostatitis, or nephritic 
diseases)); musculoskeletal system (back problems: rheumatic diseases, herniated 
disc, back pain).
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§ Hernia details at baseline: inguinal hernia (primary or recurrence), hernia side, 
hernia enlargement (past 6 weeks), reducibility, referent physician, the duration 
of inguinal hernia present at baseline (3 months or less and more than 3 months), 
positive family history of abdominal wall hernia, ultrasonography at baseline (i.e., 
hernia type, diameter of the defect). 
§ Perioperative data: operation time, operation technique (i.e., Lichtenstein repair, 
total extra-peritoneal (TEP) repair, trans-abdominal pre-peritoneal (TAPP) repair, 
plug and patch repair, prolene hernia system (PHS), pre-peritoneal mesh repair 
(Kugel or Ugahary hernia repair)), type of mesh (flat mesh (i.e., polypropylene, 
polyester, large pore lightweight mesh), three-dimensional mesh (i.e. plug&patch 
repair, bilayered mesh, memory-ring patch)), surgical experience (less than 10, 10 
to 25 and more than 25 procedures), type of anaesthesia, Nyhus classification19, 
identification of the nerves (i.e., iliohypogastric nerve, ilioinguinal nerve, and/or 
the genital branch of the genitofemoral nerve), nerve handling, closure of the 
subcutis, closure of the skin, difficulty of the procedure, perioperative complica-
tions (i.e., damage to the vas deferens, epigastric or testicular vessels, nerve injury, 
peritoneal/hernia sac defects, cardiovascular or anesthetic complications), peri-
operative use of antibiotics, post-operative complications (i.e., wound infection, 
hematoma, seroma, ischemic orchitis, urinary retention requiring catheterization, 
urinary tract infection requiring antibiotics, epididymitis requiring antibiotics, 
reoperation, pain during ejaculation), hospitalization.
§ Long-term complications (i.e., hernia complication (incarceration, strangulation), 
hernia complication requiring intervention, moderate or severe pain (pain/discom-
fort score of 2 or higher), recurrence, reoperation, crossover rates).
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AbStrAct
Background: Common surgical knowledge states that inguinal hernia repair in prema-
ture infants should be postponed until they reach a certain weight or age. Optimal 
management, however, is still under debate. The objective of this study was to collect 
evidence for the optimal management of inguinal hernia repair in premature infants.
Study Design: In the period between 2010 and 2013, data for all premature infants with 
inguinal hernia who underwent hernia correction within 3 months after birth in the 
Erasmus MC – Sophia Children’s Hospital, Rotterdam were analyzed. Primary outcome 
measure was the incidence of incarceration and subsequent emergency surgery. In a 
multivariate analysis, Cox proportional hazards model served to identify independent 
risk factors for incarceration requiring an emergency procedure.
Results: A total of 142 premature infants were included in the analysis. The median 
follow-up was 28 months (range 15 to 39 months). Seventy-nine premature infants 
(55.6%) presented with a symptomatic inguinal hernia; emergency surgery was per-
formed in 55.7%. Complications occurred in 27.3% of emergency operations versus 
10.2% after elective repair; recurrences occurred in 13.6% versus 2.0%, respectively. 
Very low birth weight (≤ 1,500g) was an independent risk factor for emergency sur-
gery, with a hazard ratio of 2.7 in the Cox proportional hazards model.
Conclusion: More than half of premature infants with an inguinal hernia have incar-
ceration. Those with very low birth weight have a 3-fold greater risk of requiring 
an emergency procedure than heavier premature infants. Emergency repair results 
in higher recurrence rates and more complications. Elective hernia repair is recom-
mended, particularly in premature infants with a very low birth weight.
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introduction
Inguinal hernia repair is the most frequently performed surgical procedure in neo-
nates, especially in children born preterm. Up to 9.0% of children born preterm will 
undergo inguinal hernia repair before the age of 7 years, of whom more than half in 
the first year of life.1,2 Factors that contribute to the increased risk of inguinal hernia 
in premature infants include a persistent processus vaginalis, male sex, gestational 
age, low birth weight, and prolonged mechanical ventilation.2,3
The optimal timing of inguinal hernia repair in premature infants is not clear. Com-
mon surgical knowledge is that it should be postponed until a certain weight or 
age is reach, because of technical challenges (particularly in very low birth weight 
[VLBW] premature infants), comorbidities, and potential anesthetic and surgical com-
plications.4-7 Conservative treatment, however, can be complicated by incarceration, 
followed by ischemia of the bowel and ovarian or testicular atrophy necessitating 
emergency repair in these fragile newborns, who are probably at even greater risk 
of complications in an emergency setting compared with an elective repair. In addi-
tion, delaying repair could increase the difficulty of the procedure because repeated 
herniation and reduction might result in a thickened hernia sac and fibrous adhesions 
between the hernia sac and the spermatic cord.2,8
The objective of this study was to collect evidence for the optimal management of 
inguinal hernia repair in premature infants by comparing the outcomes of emergency 
procedures with the outcomes of elective repair, and by identifying the risk factors for 
inguinal hernia in premature infants who become acutely symptomatic.
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methodS
A retrospective cohort study was performed at the Erasmus MC – Sophia Children’s 
Hospital, a tertiary academic paediatric hospital in Rotterdam, The Netherlands. The 
Sophia Children’s hospital is 1 of 6 referral hospitals for premature infants (ie, gesta-
tional age less than 37 weeks) in the Netherlands. Each referral hospital has its own 
unique region; Erasmus MC – Sophia Children’s Hospital covers a population of >4.5 
million inhabitants.
All premature infants operated on for an inguinal hernia within 3 months after 
birth between January 2010 and December 2013 were included. They were identified 
from the electronic hospital data systems and medical charts using Centraal Orgaan 
Tarieven Gezondheidszorg codes (unilateral inguinal hernia repair, CTG335700; bilat-
eral inguinal hernia repair, CTG335701; incarcerated inguinal hernia repair without 
bowel resection, CTG335702; incarcerated inguinal hernia repair with bowel resec-
tion, CTG334639; recurrent inguinal hernia repair, CTG335710).
According to the hernia management chosen, two groups were distinguished: prema-
ture infants who underwent elective inguinal hernia repair and premature infants 
who needed an emergency procedure because of incarceration of contents in the 
hernia sac. Premature infants that presented with a symptomatic inguinal hernia at 
our emergency department that could not be manually reduced were operated on 
within 24 hours, and were defined as cases of incarcerated hernia with subsequent 
emergency surgery. A pediatric surgeon examined all premature infants at time of 
first presentation. In our hospital, an open technique was used for all primary inguinal 
hernia repairs; in case of a recurrence, hernia repair was performed using a laparo-
scopic approach. Time at risk was calculated from the date of first presentation at our 
hospital until the date of either elective repair or emergency procedure. Prolonged 
mechanical ventilation was defined as mechanical ventilation that was continued 
after the initial procedure was completed. Patient characteristics and clinical data 
were collected retrospectively in the search for potential risk factors. They included: 
§ Patient’s demographics (ie, sex, gestational age, and weight at birth).
§ Preoperative comorbidities associated with the pulmonary system (i.e. history of 
apnea, Infant Respiratory Distress Syndrome [IRDS], bronchopulmonary dysplasia, 
preoperative mechanical ventilation); cardiovascular system (ie, history of bra-
dycardia, cardiac anomalies [atrial septal defect, ventricular septal defect, valve 
abnormalities, Tetralogy of Fallot], intraventricular haemorrhage); and digestive 
system (ie, GERD and necrotising enterocolitis).
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§ Factors associated with the inguinal hernia (ie, palpable testis, hydrocele, incar-
ceration, emergency procedure, other concurrent hernia such as umbilical hernia); 
hernia characteristics (ie, type of hernia such as uni-/bilateral; hernia side, ie, right, 
left, or bilateral); and presence of a contralateral hernia or orchidopexy during 
procedure).
§ Perioperative data (ie, gestational age at repair; weight at repair; type of procedure, 
ie, open or laparoscopic; duration of procedure; type of anaesthesia; duration of 
anaesthesia; type of ventilation; duration of ventilation; and re-intubation).
§ Postoperative data (ie, major complications, such as bowel resection, recurrence, 
testicular atrophy, spermatic cord injury; minor complications, such as haema-
toma, hydrocele, wound infection, high testicle; length of postoperative hospital 
stay; length of postoperative neonatal ICU stay, and prolonged mechanical ventila-
tion). 
Statistical analysis 
SPSS software, version 21.0 (IBM Corp) was used for all statistical analyses. Chi-square 
and Mann-Whitney U tests were used to compare risk factors for emergency repair and 
elective repair in premature infants. Univariate regression analyses were performed 
to determine the relationship of incident cases of incarceration requiring emergency 
surgery with risk factors by analysing each potential risk factor separately. Multivari-
ate regression analyses were performed using a Cox proportional hazards model to 
control for effects of multiple potential risk factors. Potential risk factors that were re-
lated to cases of incarceration requiring an emergency procedure or that were known 
in literature (ie, male sex, gestational age, weight of birth, pulmonary comorbidities, 
and mechanical ventilation) were included in the Cox proportional hazards model. A 
p-value of less than 0.05 was considered statistically significant.
reSultS
Between 2010 and 2013, one hundred and forty-two premature infants underwent 
inguinal hernia repair within 3 months after birth. One hundred and twenty-two 
(83.6%) were male, mean gestational age was 33 weeks + 4 days (SD 20 days), mean 
birth weight was 1,859g (SD 589g), and median time to follow-up was 28 months (in-
terquartile range 15 to 39 months). Preoperatively, 43 (29.5%) patients had a history of 
apnea of prematurity, 29 (19.9%) had IRDS, 53 (36.3%) required mechanical ventilation, 
and 12 (8.2%) had bronchopulmonary dysplasia. Nineteen (13%) patients had a cardiac 
anomaly and 21 (14.4%) had a history of bradycardia. Of all premature infants, 11 
(7.5%) had GERD, necrotizing enterocolitis developed in 4 (2.7%), 8 (5.5%) had intraven-
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tricular haemorrhage, and 22 (15.1%) patients presented with a concurrent umbilical 
hernia. Mean duration of herniotomy was 29 min (SD 15 minutes), mean duration 
of anaesthesia was 82 min (SD 32 minutes), and 13 (9.2%) premature infants were 
operated on after the initial procedure for an inguinal hernia on the contralateral side. 
During follow-up, two premature infants died after 13 and 14 months, respectively. 
None of the deaths were related to the procedure for inguinal hernia repair.
emergency repair
A total of 79 (55.6%) premature infants presented with a symptomatic inguinal hernia 
at our emergency room, 35 (43.3%) of those hernias could be reduced manually and 
44 (55.7%) could not be reduced and required an emergency procedure. Mean time 
between first presentation at our hospital and emergency surgery was 2.5 days (SD 
5.7 days) compared with 18.2 days (SD 11.0 days) for elective repair. Potential risk fac-
tors for emergency surgery and elective repair after univariate analysis are presented 
in Table 1. The postoperative complications rate for emergency surgery was 27.3% 
vs only 10.2% for elective repair (P = 0.013), and recurrence rates of inguinal hernia 
were significantly higher after emergency surgery (13.6% vs 2.0%; P = 0.011). Data on 
postoperative complications are presented in Table 2. Univariate regression analysis 
showed that gestational age (hazard ratio [HR] = 0.98; P = 0.003), IRDS (HR = 2.1; P = 
0.027), and preoperative mechanical ventilation (HR = 2.5; P = 0.006) were associated 
with an emergency procedure. Premature infants with a very low birth weight (VLBW, 
≤ 1,500g) had a 3-fold greater risk of incarceration with a subsequent emergency set-
ting (HR = 3.0, 95% CI, 1.7 – 5.5; P < 0.001). The risk was 70.0% in the VLBW group 
compared with 23.7% in the group premature infants above 1,500g (Fig. 1). When we 
controlled for possible confounding variables in the multivariate regression analysis 
(male sex, gestational age, birth weight, IRDS, preoperative mechanical ventilation), 
VLBW remained an independent risk factor for incarceration requiring an emergency 
procedure (HR = 2.7; 95% CI, 1.1 – 6.4, P = 0.027). None of the other variables included 
in the multivariate regression analysis were found to be statistically significant.
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Table 1. Patient and hernia characteristics and comorbidities of premature infants with inguinal hernia who 
underwent hernia correction within 3 months after birth at the Erasmus MC – Sophia Children’s Hospital, 
Rotterdam, The Netherlands between 2010 and 2013.
Emergency procedure
(n = 44)
Elective repair
(n = 98)
p-value
Patient characteristics
Birth weight, g, mean (SD) 1638 (584) 1977 (561) 0.003*
Gestational age at birth, wk, mean (SD) 32.3 (3.5) 34.2 (2.3) 0.005*
Male sex, n (%) 41 (93.2%) 81 (82.7%) 0.120
Comorbidities, n (%)
Cardiac anomalies 8 (19.5%) 11 (12.1%) 0.290
Bradycardia 11 (26.8%) 10 (11.0%) 0.037*
IVH 4 (9.8%) 4 (4.4%) 0.254
IRDS 14 (34.1%) 15 (16.5%) 0.039*
BPD 9 (22.0%) 3 (3.3%) 0.001*
Apneas 19 (46.3%) 24 (26.4%) 0.028*
Preoperative MV 14 (56.1%) 11 (33.0%) 0.004*
NEC 2 (4.9%) 2 (2.2%) 0.588
GERD 5 (12.2%) 6 (6.6%) 0.316
Umbilical hernia 6 (14.3%) 16 (17.0%) 0.804
Hernia characteristics, n (%)
Left side 12 (27.3%) 35 (35.7%) 0.600
Right side 21 (47.7%) 40 (40.8%)
Bilateral 11 (25.0%) 23 (23.5%)
Palpable Testes 27 (61.4%) 67 (68.4%) 0.447
Hydrocele 10 (22.7%) 15 (15.3%) 0.342
*Statistically significant. P-values are 2-sided. For dichotomous variables chi-square test was performed and for 
continuous variables Mann-Whitney U test was performed. IVH, intraventricular haemorrhage; IRDS, infant 
respiratory distress syndrome; BPD, bronchopulmonary dysplasia; MV, mechanical ventilation; NEC, necrotis-
ing enterocolitis.
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Table 2. Peri- and postoperative data and complications of premature infants with inguinal hernia who 
underwent hernia correction within 3 months after birth at the Erasmus MC – Sophia Children’s Hospital, 
Rotterdam, The Netherlands between 2010 and 2013.
Emergency procedure
(n = 44)
Elective repair
(n = 98)
p-value
Peri- and postoperative data
Gestational age at repair, wk, mean (SD) 39.6 (4.0) 43.8 (2.9) < 0.001*
Weight at repair, g, mean (SD) 3021 (883) 3889 (862)  < 0.001*
NICU stay, d, mean (SD)
Hospital stay, d, mean (SD)
4.7 (9.0)
6.8 (16.3)
2.2 (4.8)
3.5 (6.7)
0.085
0.210
Prolonged MV, n (%) 11 (25.0%) 2 (2.0%) < 0.001*
Reintubation, n (%) 5 (11.4%) 2 (2.0%) 0.030*
Orchidopexy during initial repair, n (%) 5 (11.4%) 6 (6.1%) 0.316
Contralateral repair after initial repair, n (%) 8 (18.2%) 5 (5.1%) 0.023*
Duration of anaesthesia, min, mean (SD) 95 (35) 76 (28) 0.001*
Time of herniotomy, min, mean (SD) 34 (16) 26 (14) 0.005*
Major complications, n (%) 8 (18.2%) 4 (4.1%) 0.009*
Bowel resection 2 (4.5%) - 0.094
Recurrence repair 6 (13.6%) 2 (2.0%) 0.011*
Testicular atrophy 2 (4.5%) 2 (2.0%) 0.588
Spermatic cord injury - 2 (2.0%) 1.000
Minor complications, n (%) 8 (18.2%) 8 (8.2%) 0.092
Haematoma 2 (4.5%) 4 (4.1%) 1.000
Hydrocele 6 (13.6%) 4 (4.1%) 0.070
Wound infection - - -
High testicle 2 (4.5%) 2 (2.0%) 0.588
Total complications, n (%) 12 (27.3%) 10 (10.2%) 0.013*
*Statistically significant. P-values are 2-sided. For dichotomous variables chi-square test was performed. The 
number of premature infants with one or more complications are presented in bold type for the different sub-
categories (minor, major, and total). MV, mechanical ventilation; NICU, neonatal ICU. 
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Figure 1. Hazard function. Risk of incarceration requiring emergency surgery by weight of birth (≤1,500g or 
>1,500g) among premature infants. VLBW, very low birth weight. 
diScuSSion
The current study reports that elective inguinal hernia repair is safe and successful in 
most premature infants and is associated with fewer complications. It also reports that 
postponing inguinal hernia repair in premature infants results in an incarceration 
requiring emergency correction in one-third of patients, and that emergency sur-
gery in those premature infants is associated with a signifi cantly higher incidence 
of postoperative complications as compared with elective repair. This appears to be 
particularly true for VLBW premature infants, as they were found to have a 3-fold 
greater risk of incarceration. 
These are relevant results in the light of the fact that confl icting published data have 
made it hard to draw defi nite conclusions on the optimal management of inguinal 
hernia in premature infants. Although the levels of prematurity and dysmaturity are 
associated with high incidence of inguinal hernia, it is the technical challenges and 
risk of perioperative complications in these fragile newborns make us reluctant to per-
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form early elective repair.9,10 Many pediatric surgeons prefer to perform herniotomy 
when infants born prematurely reach a certain weight or age. Although this more 
conservative approach can minimize the risk of surgical and anaesthetic complica-
tions, it might also increase the risk of incarceration forcing an emergency procedure 
with potentially more negative sequelae compared with early elective repair.2,11,12
Earlier research on this issue resulted in contradictory outcomes.2,4-6,9,10,12 However, 
none of the earlier studies performed a multivariate regression analysis to identify 
independent risk factors. In 2011, Lautz et al2 compared premature neonates who 
presented with an incarcerated or non-incarcerated inguinal hernia and they provided 
data on timing for inguinal hernia repair. In this retrospective study they found a 
2-fold greater risk of incarceration when repair is delayed beyond 40 weeks of gesta-
tional age. This result, however, was not corrected for multiple factors and, therefore, 
a gestational age beyond 40 weeks cannot be considered as an independent risk factor 
for incarceration.
The incarceration rate in the current study population is one of the highest described 
in literature.2,3,10 This can be explained by the fact that the Erasmus MC – Sophia 
Children’s Hospital is a tertiary academic pediatric hospital. It covers a population 
of >4.5 million inhabitants and is the only hospital of its region that is allowed to 
perform inguinal hernia repair in premature infants – both in the emergency setting 
and for the elective operation. More than half of all premature infants that presented 
with a symptomatic inguinal hernia that could not be manually reduced and required 
emergency surgery within 24 hours, resulting in a complication rate of 27.3%, which 
renders early elective repair more appealing. The use of contralateral inguinal explora-
tion in premature infants is another topic still under debate.13 In literature, incidences 
of metachronous inguinal hernia vary up to 18.6%.14,15 In our study, the incidence 
of contralateral hernia after initial repair was considerably higher after emergency 
surgery (18.2%) compared with elective repair (5.1%). Because in this study, both the 
elective and emergency repairs were performed with an open procedure, this differ-
ence could not be explained by a difference in techniques used, as they (emergency vs 
elective repair) bear the same risk of overlooking a metachronous hernia. However, 
meticulous clinical examination of the contralateral side and its registration are still 
mandatory. 
The current study has several shortcomings, most of which are attributable to the 
retrospective design. Selection bias could have occurred, as no protocol on timing of 
repair is available in our hospital for premature infants. In addition, the premature 
infants could have been diagnosed with an inguinal hernia earlier in a different hospi-
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tal, resulting in a delay between diagnosis and first presentation in our hospital. This 
makes it difficult to draw general conclusions on the actual timing of repair.
Keeping these limitations in mind, this retrospective cohort shows that more than 
half of premature infants with an inguinal hernia experience incarceration, and that 
VLBW have a 3-fold greater risk of requiring an emergency procedure than heavier pre-
mature infants. Because emergency repair results in higher recurrence rates and more 
complications, it can even be argued that this particular group of premature infants 
should be operated on during their birth hospitalization. A multicenter, randomised 
controlled trial comparing direct and delayed inguinal hernia repair in premature 
infants should be conducted, stratifying for weight of birth (≤1,500g or >1,500g), to 
provide more evidence on optimal timing in this fragile group of patients. Until then, 
elective hernia repair, particularly in VLBW premature infants, is recommended.
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AbStrAct
Background: The aim of this study was to systematically review morbidity and mortal-
ity after non-hepatic surgery in patients with liver cirrhosis.
Methods: Comprehensive searches were conducted in PubMed, Embase and the Co-
chrane Library for articles using the words: liver failure, hepatic insufficiency, liver 
cirrhosis, cirrhosis, cirrhotic, surgical procedures, operative complications, operative 
mortality, postoperative complications, surgical complication, surgical risk, and her-
nia. 
Results: Forty-six out of 5247 articles were selected after the initial search. The level of 
evidence provided in these articles varied greatly. Non-hepatic surgery of patients with 
liver cirrhosis resulted in an increased risk of postoperative morbidity and mortality 
compared with similar surgery of non-cirrhotic patients. Cholecystectomy, umbilical 
and inguinal hernia repair were associated with the lowest increased morbidity and 
mortality, whereas pancreatic, cardiovascular, and trauma surgery were correlated 
with the highest. The preoperative model for end stage liver disease (MELD) and 
Child-Turcotte-Pugh (CTP) scores appeared to be predictive of postoperative risks. The 
presence of portal hypertension and surgery in an emergency setting were associated 
with even higher mortality and morbidity rates.
Conclusion: This systematic review of the literature showed that, in patients with liver 
cirrhosis who undergo non-hepatic surgery, postoperative morbidity and mortality 
rates varied greatly depending on the severity of the cirrhosis and the surgical proce-
dure. The majority of procedures can be safely performed in patients with low MELD 
scores and CTP grade A liver cirrhosis without portal hypertension.
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introduction
Hepatic surgery of patients with liver cirrhosis is associated with high morbid-
ity and mortality.1,2 Considerably more debate, however, concerns the increased 
postoperative risk in patients with liver cirrhosis undergoing non-hepatic surgery.3 
Literature shows overall mortality rates as high as 45% in patients with liver cirrhosis 
undergoing non-hepatic surgery.4 It is, however, not clear which patients with liver 
cirrhosis are most at risk, and which procedures are most hazardous. This presumed 
increased risk often results in the advice to avoid surgery in this particular group of 
patients unless absolutely necessary.5,6 Refraining from elective surgery in patients 
with cirrhosis, however, can result in emergency surgery which is associated with 
probably an even greater risk of morbidity and mortality in this vulnerable group of 
patients.7-9 Emergency surgery in patients with liver cirrhosis has been shown to be 
associated with considerably longer post-operative hospitalization, higher morbidity, 
and a 7-fold increased risk of mortality compared to elective surgery.9 In addition, 
patients with liver cirrhosis have been shown to undergo emergency surgery more 
often than patients without cirrhosis, and approximately 10% of all cirrhotic patients 
will require both elective and emergency surgery in the last years of their lives.2,10 
This implies that proper recommendations are required in patients with liver cir-
rhosis who have to undergo surgery. However, current recommendations for surgery 
in these patients are mostly derived from retrospective studies.1,2 Literature on this 
topic is abundant but varies in quality and is full of individual, non-evidence-based 
opinions and assumptions. This study aims to review systematically morbidity and 
mortality accompanying non-hepatic surgery in patients with liver cirrhosis and will 
provide a risk assessment that enables the counseling of patients with liver cirrhosis 
undergoing non-hepatic surgery. 
methodS
literature search strategy
A systematic search of MEDLINE, PubMed, Embase and the Cochrane library was 
performed for articles relevant to non-hepatic surgery in patients with liver cirrhosis, 
published between January 1990 and July 2011. To give accurate information and 
provide the best clinical evidence, literature before 1990 was not included in this 
systematic review. The following search terms were used to search all databases: liver 
failure, hepatic insufficiency, liver cirrhosis, cirrhosis, cirrhotic, surgical procedures, 
surgical complications, operative mortality, postoperative complications, surgical risk, 
and hernia. The following types of studies were excluded: interviews, case-reports, 
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letters, comments and editorials, papers on infants or adolescents, and papers written 
in a language other than English. Manual reference checks of included papers were 
performed to supplement the electronic searches.
Search strategy: medline
(Hepatic Insufficiency[mesh] OR Liver Cirrhosis[mesh] OR Liver Cirr*[tw] OR 
liver insufficien*[tw] OR hepatic insufficien*[tw] OR Cirrhosis[tw] OR Cirrhotic[tw] OR 
Cirrosis[tw] OR Cirrotic[tw]) AND (Surgical Procedures, Operative/complications[mesh] OR 
Surgical Procedures, Operative/mortality[mesh] OR Postoperative Complications[mesh] 
OR surgical complication*[tw] OR surgical risk*[tw] OR Surgery complication*[tw] OR 
Surgery risk*[tw] OR operative complications[tw] OR postoperative complication*[tw] OR 
hernia[mh] OR hernia*[tw]) AND (English[lang]) NOT (editorial[pt] OR letter[pt] OR case 
reports[pt] OR comment[pt] OR interview[pt]) NOT (Child[mesh] NOT adult[mesh])
Search strategy: embase
(‘liver failure’/exp OR ‘Liver Cirrhosis’/exp OR ((Liver NEXT/1 Cirr*) OR (liver NEAR/3 
insufficien*) OR (hepatic NEAR/3 insufficien*) OR Cirrhosis OR Cirrhotic OR Cirrosis OR 
Cirrotic):de,ab,ti) AND (((Postoperative OR surgical OR Surgery OR operative) NEAR/3 
(Complication* OR risk* OR safety)):de,ab,ti OR hernia/exp OR hernia:de,ab,ti) AND 
([English]/lim) NOT ([editorial]/lim OR [letter]/lim OR [note]/lim) NOT ([Child]/lim NOT 
[adult]/lim)
literature screening
Studies were evaluated for inclusion by two independent researchers (BG, PJK) ac-
cording to relevance to the subject. A random check was performed by a third person 
(GK). Study selection was accomplished through 3 phases of study screening. In phase 
1, studies were selected on the basis of title. Keywords were “management”, “surgi-
cal risk”, “cirrhosis”, and “surgery”. If the following types of studies (interviews, case 
series, non-human, experimental, case-reports, letters, comments, editorials, papers 
on infants/adolescents, and papers written in a language other than English) were 
identified, they were excluded. In phase 2, abstracts were reviewed for relevance, and 
reviews, randomized controlled trials (RCTs), prospective cohort and large retrospec-
tive studies were selected and full-text articles were obtained. If good quality studies 
were lacking, smaller, retrospective or lesser quality studies were selected. In phase 
3, full-text articles were reviewed. Included were studies that described management 
of patients with liver cirrhosis undergoing elective or non-hepatic emergency surgery. 
The studies had to describe one or more of the following outcome measures to be 
eligible for inclusion: severity of liver disease, type of surgical procedure, overall mor-
bidity or mortality. Selected studies were categorized in one of the following groups 
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of non-hepatic surgery: surgical risk assessment, gastrointestinal surgery, abdominal 
wall surgery, cardio-thoracic and vascular surgery, trauma and orthopedic surgery, 
and other types of surgical procedures. Any discrepancies in inclusion were resolved 
by discussion between the reviewers under the supervision of a third person. 
data extraction and critical appraisal
The level of evidence of each paper was established on the basis of the Oxford Centre 
for Evidence-Based Medicine Level of Evidence scale.11 The quality of the randomized 
controlled trials was assessed using the Jadad-criteria.12 All aspects of the Preferred 
Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement were 
followed.13
reSultS
Initial literature search revealed 5247 papers; 180 were selected on the basis of title 
because only articles of non-hepatic surgery in patients with liver cirrhosis were 
selected. After screening abstracts for relevance, 116 studies were excluded. After full 
text reading and assessment of the quality of the included papers, another 19 papers 
were excluded. One article was included after searching references. Finally, this sys-
tematic review was based on a total of 46 papers. Four reviews, 6 RCTs, 4 prospective 
studies and 32 retrospective studies were included. Studies were categorized into 6 
groups. The PRISMA flow diagram for systematic reviews is presented in Figure 1.13 
Level of evidence of included papers and complication rates of different non-hepatic 
surgical procedures are presented in Table 1. 
Surgical risk assessment
In the category of surgical risk assessment 5 retrospective studies were identified. 
All studies had level of evidence 2B. Overall postoperative morbidity in cirrhotic 
patients was 30.1% for different general surgical procedures. Mortality within 30 days 
of surgery was 11.6% for any type of procedure.1 Patients with cirrhosis undergoing 
cholecystectomy, colectomy, coronary artery bypass graft (CABG), or abdominal aortic 
aneurysm (AAA) repair had a 3.4-fold, 3.7-fold, 8.0-fold and 5.0-fold greater risk of 
mortality when compared to non-cirrhotic patients. Patients with cirrhosis and portal 
hypertension who underwent the same procedures had a 12.3-fold, 14.3-fold, 22.7-
fold and a 7.8-fold greater risk of mortality when compared to non-cirrhotic patients.3 
Laparoscopic procedures for various surgical indications had an overall morbidity and 
mortality of 16% and 0.6%, respectively.14 Length of hospital stay and total hospital 
costs were higher with increased severity of liver disease for all operations.3 Model 
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of End-stage Liver Disease (MELD) score was shown to be predictive and helpful for 
counseling patients prior to surgery.10 Patients with a MELD score <8 who underwent 
elective surgery for various indications had a mortality of 5.7% compared with >50% 
in patients with a MELD score >20.15
Phase 1:
Publications identified by search
n = 5247
Phase 2:
Abstracts screened for relevance
n = 180
Phase 3:
Fulltext review for final inclusion
n = 64
Included studies:
Risk assessment, n = 5
Gastrointestinal, n = 12
Abdominal wall, n = 10
Cardiothoracic & vascular, n = 9
Trauma & orthopedic, n = 6
Other types of surgery, n = 4
Studies excluded based on
relevance, n = 5067
Studies excluded based on
abstract relevance and quality,
n = 116
Studies excluded based on
fulltext, n = 19
Included based on reference lists,
n = 1
Figure 1. PRISMA flow chart of the literature search.
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Chapter 5
gastrointestinal surgery in patients with liver cirrhosis
In the group of gastrointestinal surgery 1 review, 1 meta-analysis, 5 randomized 
controlled trials, and 6 retrospective studies were identified with levels of evidence 
ranging between 2A and 3B.
Cholecystectomy was the most frequently performed surgical procedure in patients 
with liver cirrhosis.3 Open cholecystectomy in patients with cirrhosis resulted in mor-
bidity rates ranging between 30% and 35% compared with morbidity rates after lapa-
roscopic cholecystectomy ranging between 13% and 33%. No mortality was described 
after laparoscopic cholecystectomy; mortality rates after open cholecystectomy varied 
between 0% and 7.7%.16-18 Morbidity rates after laparoscopic cholecystectomy in pa-
tients with cirrhosis without the use of clips was between 8.3% and 25.0% compared 
to rates between 15% and 35% for laparoscopic cholecystectomy with the use clips.19,20 
Compared with open cholecystectomy, laparoscopic cholecystectomy in cirrhotic 
patients was associated with fewer bleeding complications, shorter operating time, 
and shorter hospital stay.21 However, laparoscopic cholecystectomy in cirrhotic pa-
tients had higher conversion rates during the procedure, longer surgical time, and 
more frequent bleeding complications compared to non-cirrhotic patients.21 One 
study showed that open cholecystectomy in alcoholic cirrhotic patients had a 11-fold 
increased risk of 30-day mortality compared to open cholecystectomy of non-alcoholic 
cirrhotic patients.22 
The estimated hazard ratio (HR) for mortality after colectomy was found to be 3.7 in 
cirrhotic patients, and 14.3 in patients with portal hypertension.3 Overall morbidity af-
ter colorectal surgery in cirrhotic patients was shown to be 43%. In-hospital mortality 
after elective colorectal surgery was found to be 14% in cirrhotic and 29% in patients 
with cirrhosis and portal hypertension compared to 5% in non-cirrhotic patients (odds 
ratio (OR) 3.91 and 11.3, respectively). Emergency colorectal surgery led to an even 
higher mortality rate of 20.9% in cirrhotic patients, and 35.8% in patients with portal 
hypertension. Cirrhotic patients undergoing emergency surgery had a higher mor-
tality rate compared to elective surgery (OR 2.40). Patients with portal hypertension 
and cirrhosis undergoing emergency surgery had an even higher mortality rate (OR 
5.88).3,23
Overall morbidity after radical gastric surgery was shown to be 56% with a morbidity 
of 53.3% in patients with Child-Turcotte-Pugh (CTP) grade A liver cirrhosis and 67.7% 
in patients with CTP B liver cirrhosis.24
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Open appendectomy in cirrhotic patients resulted in a 30-day mortality of 9% compared 
to 0.7% in non-cirrhotic patients.25 Laparoscopic approach for an acute appendicitis in 
cirrhotic patients was shown to be superior with regard to postoperative pain (VAS 
scores, 35/100 vs. 60/100) and postoperative complications (wound infection: 0% vs. 5% 
and hemorrhage: 0% vs. 5%).26
Overall morbidity after pancreatic surgery was shown to be 69% in cirrhotic patients 
versus 44% in non-cirrhotic patients. Major morbidity varied greatly (47% vs. 22%) as 
did the number of reoperations (34% vs. 12%). This resulted in a longer ICU stay and 
a prolonged hospital stay in cirrhotic patients. Morbidity rates in patients with CTP 
grade A and CTP grade B liver cirrhosis were 67% and 100%, respectively. Mortality 
rates in patients with CTP grade A and grade B liver cirrhosis ranged between 3% and 
100%, respectively.5
Abdominal wall surgery in patients with liver cirrhosis
In the group of abdominal wall surgery 1 review combined with a survey, 1 random-
ized controlled trial, 3 prospective studies and 5 retrospective studies were identified 
with levels of evidence ranging between 2B and 3B. It was shown that 20% of patients 
with liver cirrhosis will develop an umbilical hernia.8,27 Overall morbidity after elec-
tive umbilical hernia repair varied between 7% and 20%. Overall mortality varied 
between 0% and 5.5%.7-9,27 Conservative management of umbilical hernia in patients 
with cirrhosis and ascites resulted in higher mortality compared to elective repair.8,27 
Elective umbilical hernia repair in cirrhotic patients was shown to be safe and was not 
associated with higher complication rates than in non-cirrhotic patients. Emergency 
umbilical hernia repair, however, was associated with higher complication rates com-
pared to elective repair in cirrhotic patients.7-9,27 High CTP score, presence of ascites, 
symptomatic hernia, and emergency surgery were associated with a worse outcome.7,28 
Uncontrolled ascites was shown to result in a relative risk of 8.51 for umbilical hernia 
recurrence.28 Recurrence of umbilical hernia was found to be lower after mesh repair 
(2.7%) compared to suture repair (14.2%). In this study, mesh repairs were more likely 
to become infected (16.2% vs. 8.5%) but the difference was not statistically significant.29 
In the same study, no significant differences were noted in the rate of other early 
postoperative complications such as transient ascitic fluid leakage. Umbilical hernia 
repair was shown to be safe under local anesthesia in patients with cirrhosis.29
Postoperative complications and long-term recurrence after inguinal hernia repair in 
cirrhotic patients did not differ compared to non-cirrhotic patients. Overall complica-
tion rates after inguinal hernia repair ranged between 6.3% and 10.9% in cirrhotic 
patients compared to 6.8% in non-cirrhotic patients. Overall mortality ranged between 
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0% and 0.8%. Elective repair of symptomatic inguinal hernia in patients with cirrhosis 
was recommended.30 Even in patients with advanced and decompensated cirrhosis.31 
However, one study reported an overall mortality of 2.7% after inguinal hernia repair 
compared to 0.7% in non-cirrhotic patients (OR of 4.4).32 Complication rates after 
inguinal hernia repair were shown to be independent of the CTP score.30-32 Inguinal 
hernia repair outcomes were relatively unaffected in the presence of ascites.9,33 In-
guinal hernia repair in cirrhotic patients was shown to be a safe procedure under 
local or general anesthesia with the use of a polypropylene mesh whereas repair of 
a symptomatic inguinal hernia improved quality of life, particularly in patients with 
grade CTP C cirrhosis, and patients with refractory ascites.31
cardio-thoracic and vascular surgery in patients with liver cirrhosis
In the group of cardiac-thoracic and vascular surgery 2 reviews, 1 prospective study 
and 6 retrospective studies were identified with levels of evidence ranging between 
2B and 5.
Postoperative morbidity rates in patients with CTP A, B, and grade C liver cirrhosis 
undergoing elective cardio-vascular surgery have been shown to be 25% to 50% 100%, 
and 100%, respectively. The consensus among these clinical studies is that patients 
with CTP A cirrhosis tolerate cardiac operations. No mortality was observed among 
patients with CTP A cirrhosis undergoing elective cardiac surgery irrespective of the 
use of a cardiopulmonary bypass (CPB). Patients with more advanced cirrhosis (CTP 
B or C cirrhosis), however, had a significantly higher mortality rate (50-100%) after 
placement of a cardiopulmonary bypass.34-36
Patients with cirrhosis undergoing CABG had an increased risk of mortality (17 vs. 
3%; OR 6.67), complications (43 vs. 28%; OR 1.99), and longer hospitalization and costs 
compared in non-cirrhotic patients. Predictors of mortality included age >60 years 
(OR 2.21), female gender (OR 1.92), ascites (OR 3.80), and congestive heart failure (OR 
1.75). Mortality rate was 7.7% in patients with fewer than two complications compared 
in 59% for those with two or more complications (OR 17.48). Hospital volume and 
off-pump CABG did not affect mortality.37 No difference in adjusted in-hospital mor-
tality was found between patients with cirrhosis undergoing percutaneous coronary 
intervention (PCI), conventional CABG or off-pump CABG compared to non-cirrhotic 
patients.38 
No intraoperative or 30-day mortality was recorded after elective open infrarenal AAA 
repair. No significant differences in terms of major perioperative complications were 
observed between cirrhotic patients and controls. Operating time and the need for in-
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traoperative blood transfusion were significantly higher in cirrhotic patients. Length 
of hospitalization was nearly doubled in cirrhotic patients. CTP grade B was associated 
with higher need for intraoperative blood transfusions. The estimated survival at 2 
years was 77.4% in cirrhotic and 97.8% in non-cirrhotic patients. Both patients with 
CTP B cirrhosis (100%) died within 6 months. CTP B cirrhosis and a MELD score >10 
were associated with reduced midterm survival rates. MELD score ≥10 was associated 
with reduced midterm survival rates with an estimated survival at 2 years of 0% in 
patients with CTP B cirrhosis compared to 84.4% in CTP A cirrhosis. Patients with 
MELD <10 compared to MELD ≥10 had an estimated survival of 90% versus 47.6%.6 
Lung surgery in cirrhotic patients with Non-Small Cell Lung Cancer (NSCLC) had an 
overall morbidity and mortality between 13.5 - 29.5% and 2.7% - 6.5%, respectively. 
Overall 1-, 3- and 5-year survival ranged between 77.3% to 87.8%, 57.0% to 59.9%, and 
37.6% to 45.6%, respectively.39-41
trauma and orthopedic surgery in patients with liver cirrhosis
In the group of trauma and orthopedic surgery, 6 retrospective studies were identified 
with levels of evidence ranging between 2B and 3B. Overall mortality of general cir-
rhotic trauma patients was 12% and 6% for the non-cirrhotic group (OR 5.65). ARDS, 
trauma-associated coagulopathy, and septic complications were significantly more 
common among patients with liver cirrhosis. Overall severe complication rate for the 
two groups was 10 and 4%, respectively (OR 2.05). For the subgroup of patients who 
underwent a laparotomy for trauma, the mortality rate increased to 40% compared to 
15% in non-cirrhotic patients (OR 4.35).42 
These results were supported by another study that focussed only on laparotomies in 
cirrhotic trauma patients. The overall mortality for patients with cirrhosis undergoing 
laparotomy for trauma was significantly higher compared to non-cirrhotic patients 
(45% vs. 24%, HR 7.60). Mortality for patients with an Injury Severity Score ≤15 was 
29% for cirrhotic patients and 5% in non-cirrhotic patients; in patients with an Injury 
Severity Score of 16–25 mortality was 56% and 11%, respectively. Overall complication 
rate was 45% in cirrhotic patients and 23% in the non-cirrhotic group, but this result 
was not statistically significant. Longer ICU stay and higher hospital costs were report-
ed in patients with cirrhosis undergoing trauma surgery compared to non-cirrhotic 
patients.4 Analysis by ROC curve identified cirrhotic patients undergoing laparotomy 
for blunt abdominal trauma with a MELD score ≥17 as the best cut-off value for pre-
dicting postoperative death. Postoperative mortality of patients with MELD <17 was 
6.2% compared with 85.7% in patients with a MELD score ≥17.43
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In patients undergoing elective total hip arthroplasty (THA) or elective total knee 
arthroplasty (TKA), significant adverse outcomes (including major complications such 
as hepatic decompensation, and mortality) occurred in 20.7% of cirrhotic compared to 
3.2% in non-cirrhotic patients. No significant differences were found between elective 
THA and TKA. However, 80% of cirrhotic patients undergoing emergency THA second-
ary to a fracture had major complications with a mortality rate of 60%.44 These results 
were supported by another study that reported a 30-day complication rate of 26.7% 
in cirrhotic patients undergoing elective THA.45 Overall complication rate after TKA 
was also significantly higher among patients with cirrhosis than in control patients, 
but no perioperative mortality was reported.46 Advanced liver cirrhosis was associated 
with a higher risk of complications.44,45 Major complications occurred in 14.3%, 28.6%, 
and 100% of cirrhotic patients with CTP A, B and C cirrhosis, respectively. Death oc-
curred in 4.76%, 14.3%, and 100% of cirrhotic patients with CTP A, B, and C cirrhosis, 
respectively, but these results were statistically insignificant.44
First-time prosthetic hip infection (PHI) was described in 9.5% of patients with liver 
cirrhosis. Debridement with retention of the prosthesis (DWROP) was the initial treat-
ment and cured the infection in 29% of the patients. Excision arthroplasty (EA) was 
required in 79% and eradicated PHI in 92% of cases. Recurrent PHI occurred in 30% of 
cirrhotic patients who had a re-implantation. Patients who developed hepatic decom-
pensation after re-implantation had a significantly higher risk of recurrent PHI (RR 
7.5).47
other types of surgical procedures in patients with liver cirrhosis
In the group of splenectomy and transurethral resection of the prostate (TURP) 4 ret-
rospective studies were identified with levels of evidence ranging between 2B and 3B.
Overall morbidity among cirrhotic patients after splenectomy was shown to range 
between 17.7% and 33%. No mortality was reported in patients with grade CTP A and 
grade B liver cirrhosis.48,49 Mortality rate in patients with CTP grade C liver cirrhosis 
was shown to be 66.7%.48-50 Overall survival rate after splenectomy of patients with 
cirrhosis was 83.3% at 1 year, and 62.7% at 2 years of follow-up. The survival rate of 
patients with CTP C cirrhosis was 80.0% at 1 year, and 60.0% at 2 years of follow-up. 
Postoperatively, portal pressure decreased after splenectomy in most patients by a 
mean of 4.7 mmHg.48
TURP in patients with cirrhosis was accompanied with a 30-day mortality of 6.7% 
compared to 2% in non-cirrhotic patients (OR 3.0).51
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diScuSSion
Our review of the literature showed that patients with liver cirrhosis who undergo 
non-hepatic surgery, exhibit postoperative morbidity and mortality rates that vary 
greatly depending on the severity of liver cirrhosis and the nature of the surgical 
procedure. Both CTP and MELD scores were shown to be predictive of postoperative 
morbidity and mortality in these patients. Portal hypertension and emergency sur-
gery in patients with liver cirrhosis were associated with even higher morbidity and 
mortality rates irrespective of the surgical procedure compared to elective surgery. 
Patients with portal hypertension and cirrhosis undergoing emergency surgery had 
the highest mortality rates. A laparoscopic approach was often preferred over an open 
procedure.
Cholecystectomy and abdominal wall surgery in patients with cirrhosis were associ-
ated with the lowest morbidity and mortality and with the least increase in morbidity 
and mortality compared to non-cirrhotic patients. Laparoscopic cholecystectomy had 
better outcomes compared to an open approach. Elective umbilical hernia repair in 
cirrhotic patients was associated with low morbidity and mortality rates and had com-
parable postoperative mortality rates as non-cirrhotic patients. In umbilical hernia 
repair, emergency repair was associated with higher morbidity and mortality rates. 
Wait-and-see approach for patients with cirrhosis and umbilical hernia was shown 
to result in high mortality and morbidity but no RCT was conducted to compare that 
strategy to elective repair. Uncontrolled ascites was associated with umbilical hernia 
recurrence. It was also shown that elective umbilical hernia repair with mesh was 
safe and effective and no difference in surgical site infection or ascitic leakage was 
noted when compared to suture repair. Local anesthesia was found to have potential 
for umbilical and inguinal hernia surgery in cirrhotic patients but no RCT has been 
performed comparing different anesthesia techniques. Gastrointestinal surgery, 
appendectomy, colorectal surgery, gastric surgery and pancreatic surgery showed 
increased risks of morbidity and mortality. Patients with CTP grade A cirrhosis were 
shown to undergo pancreatic surgery with slightly increased morbidity and mortality 
compared to non-cirrhotic patients, but those who had CTP grade B and C liver cirrho-
sis were at increased risk of postoperative death. Comparable high risks were reported 
in patients with CTP grade B and C liver cirrhosis who underwent emergency trauma 
surgery, particularly laparotomy in trauma or (emergency) vascular surgery. It was 
recommended that all cirrhotic trauma patients undergoing laparotomy should be 
admitted to the ICU irrespective of severity of injuries. It was also shown that patients 
with CTP A cirrhosis were tolerating cardiac operations rather well but for patients 
with more severe cirrhosis, these operations should be considered most hazardous. No 
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difference in adjusted in-hospital mortality was found between patients with cirrhosis 
undergoing other cardiac surgery, such as PCI, conventional CABG or off-pump CABG. 
Literature of non-hepatic surgery in cirrhotic patients is abundant and varies with 
respect to the level of evidence. However, the majority is not of sufficient quality to 
allow for solid conclusions. Quality assessment of the studies showed that studies 
with the highest level of evidence often did not provide data on severity of cirrhosis 
expressed in MELD or CTP scores. Therefore only morbidity and mortality rates in 
patients with cirrhosis compared to non-cirrhotic patients could be extracted from the 
literature. Studies that provided clinical data on CTP or MELD were often retrospec-
tive, limited in sample size, and prone to patient selection, resulting in lower levels of 
evidence. All these studies however did show worse outcomes for patients with more 
severe liver cirrhosis. 
Future studies should focus on risk assessment for specific surgical procedures related 
to MELD or CTP scores in patients to improve decision-making and patient counsel-
ing. Secondly, the preventive effect of portal decompression through preoperative 
transjugular intrahepatic portosystemic shunting (TIPS) to allow non-hepatic surgery 
in selected patients with liver cirrhosis and portal hypertension should be studied. 
Several case studies show conflicting effects of this technique.52,53 Furthermore, RCTs 
are needed that randomize cirrhotic patients with a surgically treatable diagnosis to 
a “wait-and-see” approach or the actual operation in an elective setting. In such trials, 
patients should also be stratified for MELD or CTP scores. 
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Summary
This review assesses systematically literature on morbidity and mortality after non-he-
patic surgery in patients with liver cirrhosis. Level of evidence provided in the articles 
varied greatly. Non-hepatic surgery in patients with cirrhosis resulted in increased 
postoperative morbidity and mortality compared to similar surgery in non-cirrhotic pa-
tients. Cholecystectomy and umbilical and inguinal hernia correction were associated 
with the least increased morbidity and mortality, whereas pancreatic, cardiovascular, 
and trauma surgery were correlated with the highest risks. The preoperative MELD 
and CTP scores appeared to be predictive of postoperative risks. Portal hypertension 
and surgery in an emergency setting were associated with extra increased mortality 
and morbidity rates. The majority of non-hepatic surgical procedures can be safely 
performed in patients with low MELD scores or CTP grade A liver cirrhosis without 
portal hypertension. RCTs in this field are, however, often lacking. This implies that 
many important clinical questions remain unanswered; among them: the value of 
preventive preoperative measures such as TIPS placement to reduce risks in cirrhotic 
patients with portal hypertension and elective operation versus wait-and-see approach 
in cirrhotic patients with for instance abdominal wall hernias.
Practice points
§ MELD and CTP scores of cirrhotic patients predict outcomes in non-hepatic sur-
gery.
§ Majority of non-hepatic surgery in patients with CTP grade A liver cirrhosis with-
out portal hypertension is safe.
§ Avoid emergency surgery in cirrhotic patients.
research agenda
§ Assess risks for specific surgical procedures related to MELD or CTP scores of pa-
tients in all future studies.
§ Assess the preventive effect of portal decompression through preoperative TIPS 
in patients with liver cirrhosis and portal hypertension who have to undergo non-
hepatic surgery. 
§ Randomize cirrhotic patients with a surgically treatable diagnosis to a “wait-and-
see” approach or the actual operation in an elective setting stratified for MELD or 
CTP score. 
88
Chapter 5
referenceS
 1. Ziser A, Plevak DJ, Wiesner RH, Rakela J, Offord KP, Brown DL. Morbidity and mortality in 
cirrhotic patients undergoing anesthesia and surgery. Anesthesiology 1999; 90(1): 42-53.
 2. Millwala F, Nguyen GC, Thuluvath PJ. Outcomes of patients with cirrhosis undergoing 
non-hepatic surgery: risk assessment and management. World J Gastroenterol 2007; 13(30): 
4056-63.
 3. Csikesz NG, Nguyen LN, Tseng JF, Shah SA. Nationwide volume and mortality after 
elective surgery in cirrhotic patients. J Am Coll Surg 2009; 208(1): 96-103.
 4. Demetriades D, Constantinou C, Salim A, Velmahos G, Rhee P, Chan L. Liver cirrhosis 
in patients undergoing laparotomy for trauma: effect on outcomes. J Am Coll Surg 2004; 
199(4): 538-42.
 5. Warnick P, Mai I, Klein F, et al. Safety of pancreatic surgery in patients with simultaneous 
liver cirrhosis: a single center experience. Pancreatology 2011; 11(1): 24-9.
 6. Marrocco-Trischitta MM, Kahlberg A, Astore D, Tshiombo G, Mascia D, Chiesa R. Outcome 
in cirrhotic patients after elective surgical repair of infrarenal aortic aneurysm. J Vasc Surg 
2011; 53(4): 906-11.
 7. Gray SH, Vick CC, Graham LA, Finan KR, Neumayer LA, Hawn MT. Umbilical hernior-
rhapy in cirrhosis: improved outcomes with elective repair. J Gastrointest Surg 2008; 12(4): 
675-81.
 8. Eker HH, van Ramshorst GH, de Goede B, et al. A prospective study on elective umbilical 
hernia repair in patients with liver cirrhosis and ascites. Surgery 2011.
 9. Carbonell AM, Wolfe LG, DeMaria EJ. Poor outcomes in cirrhosis-associated hernia repair: 
a nationwide cohort study of 32,033 patients. Hernia 2005; 9(4): 353-7.
 10. Northup PG, Wanamaker RC, Lee VD, Adams RB, Berg CL. Model for End-Stage Liver 
Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. 
Annals of Surgery 2005; 242(2): 244-51.
 11. Jeremy Howick ICJLL, Paul Glasziou, Trish Greenhalgh, Carl Heneghan, Alessandro 
Liberati, Ivan Moschetti, Bob Phillips, Hazel Thornton, Olive Goddard and Mary Hodg-
kinson. OCEBM Levels of Evidence Working Group. OCEBM Levels of Evidence Working Group 
“The Oxford 2011 Levels of Evidence” Oxford Centre for Evidence-Based Medicine.
 12. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized 
clinical trials: is blinding necessary? Control Clin Trials 1996; 17(1): 1-12.
 13. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic 
reviews and meta-analyses of studies that evaluate health care interventions: explanation 
and elaboration. Ann Intern Med 2009; 151(4): W65-94.
 14. Cobb WS, Heniford BT, Burns JM, Carbonell AM, Matthews BD, Kercher KW. Cirrhosis is 
not a contraindication to laparoscopic surgery. Surg Endosc 2005; 19(3): 418-23.
 15. Teh SH, Nagorney DM, Stevens SR, et al. Risk factors for mortality after surgery in 
patients with cirrhosis. Gastroenterology 2007; 132(4): 1261-9.
89
 16. El-Awadi S, El-Nakeeb A, Youssef T, et al. Laparoscopic versus open cholecystectomy in 
cirrhotic patients: a prospective randomized study. Int J Surg 2009; 7(1): 66-9.
 17. Hamad MA, Thabet M, Badawy A, et al. Laparoscopic versus open cholecystectomy in 
patients with liver cirrhosis: A prospective, randomized study. Journal of Laparoendoscopic 
and Advanced Surgical Techniques 2010; 20(5): 405-9.
 18. Ji W, Li LT, Wang ZM, Quan ZF, Chen XR, Li JS. A randomized controlled trial of laparo-
scopic versus open cholecystectomy in patients with cirrhotic portal hypertension. World 
J Gastroenterol 2005; 11(16): 2513-7.
 19. Bessa SS, Abdel-Razek AH, Sharaan MA, Bassiouni AE, El-Khishen MA, El-Kayal el SA. 
Laparoscopic cholecystectomy in cirrhotics: a prospective randomized study comparing 
the conventional diathermy and the harmonic scalpel for gallbladder dissection. J 
Laparoendosc Adv Surg Tech A 2011; 21(1): 1-5.
 20. El Nakeeb A, Askar W, El Lithy R, Farid M. Clipless laparoscopic cholecystectomy using 
the Harmonic scalpel for cirrhotic patients: a prospective randomized study. Surg Endosc 
2010; 24(10): 2536-41.
 21. Puggioni A, Wong LL. A metaanalysis of laparoscopic cholecystectomy in patients with 
cirrhosis. J Am Coll Surg 2003; 197(6): 921-6.
 22. Thulstrup AM, Sorensen HT, Vilstrup H. Mortality after open cholecystectomy in patients 
with cirrhosis of the liver: a population-based study in Denmark. Eur J Surg 2001; 167(9): 
679-83.
 23. Nguyen GC, Correia AJ, Thuluvath PJ. The impact of cirrhosis and portal hypertension 
on mortality following colorectal surgery: a nationwide, population-based study. Dis Colon 
Rectum 2009; 52(8): 1367-74.
 24. Jeong SH, Ahn HS, Yoo MW, et al. Increased morbidity rates in patients with heart disease 
or chronic liver disease following radical gastric surgery. J Surg Oncol 2010; 101(3): 200-4.
 25. Poulsen TL, Thulstrup AM, Sorensen HT, Vilstrup H. Appendicectomy and perioperative 
mortality in patients with liver cirrhosis. Br J Surg 2000; 87(12): 1664-5.
 26. Tsugawa K, Koyanagi N, Hashizume M, et al. A comparison of an open and laparoscopic 
appendectomy for patients with liver cirrhosis. Surg Laparosc Endosc Percutan Tech 2001; 
11(3): 189-94.
 27. Marsman HA, Heisterkamp J, Halm JA, Tilanus HW, Metselaar HJ, Kazemier G. Manage-
ment in patients with liver cirrhosis and an umbilical hernia. Surgery 2007; 142(3): 372-5.
 28. McKay A, Dixon E, Bathe O, Sutherland F. Umbilical hernia repair in the presence of 
cirrhosis and ascites: results of a survey and review of the literature. Hernia 2009; 13(5): 
461-8.
 29. Ammar SA. Management of complicated umbilical hernias in cirrhotic patients using 
permanent mesh: randomized clinical trial. Hernia 2010; 14(1): 35-8.
 30. Oh HK, Kim H, Ryoo S, Choe EK, Park KJ. Inguinal hernia repair in patients with cirrhosis 
is not associated with increased risk of complications and recurrence. World J Surg 2011; 
35(6): 1229-33; discussion 34.
90
Chapter 5
 31. Patti R, Almasio PL, Buscemi S, Fama F, Craxi A, Di Vita G. Inguinal hernioplasty improves 
the quality of life in patients with cirrhosis. American Journal of Surgery 2008; 196(3): 373-8.
 32. Hansen JB, Thulstrup AM, Vilstup H, Sorensen HT. Danish nationwide cohort study of 
postoperative death in patients with liver cirrhosis undergoing hernia repair. Br J Surg 
2002; 89(6): 805-6.
 33. Belghiti J, Durand F. Abdominal wall hernias in the setting of cirrhosis. Semin Liver Dis 
1997; 17(3): 219-26.
 34. Bizouarn P, Ausseur A, Desseigne P, et al. Early and late outcome after elective cardiac 
surgery in patients with cirrhosis. Annals of Thoracic Surgery 1999; 67(5): 1334-8.
 35. Hayashida N, Aoyagi S. Cardiac operations in cirrhotic patients. Ann Thorac Cardiovasc Surg 
2004; 10(3): 140-7.
 36. Modi A, Vohra HA, Barlow CW. Do patients with liver cirrhosis undergoing cardiac 
surgery have acceptable outcomes? Interact Cardiovasc Thorac Surg 2010; 11(5): 630-4.
 37. Shaheen AA, Kaplan GG, Hubbard JN, Myers RP. Morbidity and mortality following 
coronary artery bypass graft surgery in patients with cirrhosis: a population-based study. 
Liver Int 2009; 29(8): 1141-51.
 38. Marui A, Kimura T, Tanaka S, et al. Coronary revascularization in patients with liver 
cirrhosis. Ann Thorac Surg 2011; 91(5): 1393-9.
 39. Iwasaki A, Shirakusa T, Okabayashi K, et al. Lung cancer surgery in patients with liver 
cirrhosis. Ann Thorac Surg 2006; 82(3): 1027-32.
 40. Iwata T, Inoue K, Nishiyama N, et al. Long-term outcome of surgical treatment for non-
small cell lung cancer with comorbid liver cirrhosis. Ann Thorac Surg 2007; 84(6): 1810-7.
 41. Iwata T, Inoue K, Nishiyama N, et al. Factors predicting early postoperative liver cirrhosis-
related complications after lung cancer surgery in patients with liver cirrhosis. Interact 
Cardiovasc Thorac Surg 2007; 6(6): 720-30.
 42. Georgiou C, Inaba K, Teixeira PG, et al. Cirrhosis and trauma are a lethal combination. 
World J Surg 2009; 33(5): 1087-92.
 43. Lin BC, Fang JF, Wong YC, Hwang TL, Hsu YP. Management of cirrhotic patients with 
blunt abdominal trauma: Analysis of risk factor of postoperative death with the Model 
for End-Stage Liver Disease score. Injury 2011.
 44. Cohen SM, Te HS, Levitsky J. Operative risk of total hip and knee arthroplasty in cirrhotic 
patients. J Arthroplasty 2005; 20(4): 460-6.
 45. Hsieh PH, Chen LH, Lee MS, Chen CH, Yang WE, Shih CH. Hip arthroplasty in patients 
with cirrhosis of the liver. J Bone Joint Surg Br 2003; 85(6): 818-21.
 46. Shih LY, Cheng CY, Chang CH, Hsu KY, Hsu RW, Shih HN. Total knee arthroplasty in 
patients with liver cirrhosis. J Bone Joint Surg Am 2004; 86-A(2): 335-41.
 47. Hsieh PH, Ueng SW, Lee MS, Shih HN, Huang KC. Prosthetic hip infection in patients 
with liver cirrhosis: an outcome analysis. Int J Infect Dis 2010; 14(12): e1054-9.
91
 48. Imura S, Shimada M, Utsunomiya T, et al. Impact of splenectomy in patients with liver 
cirrhosis: Results from 18 patients in a single center experience. Hepatol Res 2010; 40(9): 
894-900.
 49. Wang Y, Zhan X, Zhu Y, Xie Z, Zhu J, Ye Z. Laparoscopic splenectomy in portal hyperten-
sion: A single-surgeon 13-year experience. Surgical Endoscopy and Other Interventional 
Techniques 2010; 24(5): 1164-9.
 50. Tomikawa M, Hashizume M, Akahoshi T, et al. Effects of splenectomy on liver volume 
and prognosis of cirrhosis in patients with esophageal varices. Journal of Gastroenterology 
and Hepatology 2002; 17(1): 77-80.
 51. Nielsen SS, Thulstrup AM, Lund L, Vilstrup H, Sorensen HT. Postoperative mortality in 
patients with liver cirrhosis undergoing transurethral resection of the prostate: a Danish 
nationwide cohort study. BJU Int 2001; 87(3): 183-6.
 52. Kim JJ, Dasika NL, Yu E, Fontana RJ. Cirrhotic patients with a transjugular intrahepatic 
portosystemic shunt undergoing major extrahepatic surgery. J Clin Gastroenterol 2009; 
43(6): 574-9.
 53. Azoulay D, Buabse F, Damiano I, et al. Neoadjuvant transjugular intrahepatic portosys-
temic shunt: a solution for extrahepatic abdominal operation in cirrhotic patients with 
severe portal hypertension. J Am Coll Surg 2001; 193(1): 46-51.

chAPter 6
A prospective study on elective umbilical 
hernia repair in patients with liver cirrhosis 
and ascites
 
 
H.H. Eker 
G.H. van Ramshorst 
B. de Goede 
H.W. Tilanus 
H.J. Metselaar 
R.A. de Man 
J.F. Lange 
G. Kazemier
Surgery. 2011 Sep;150(3): 542-6
94
Chapter 6
AbStrAct
Background: Patients with both cirrhosis and ascites have a 20% risk of developing um-
bilical hernia. A retrospective study from our center comparing conservative manage-
ment of umbilical hernia with elective repair in these patients showed a significant 
risk of mortality as a result of hernia incarceration in conservatively treated patients. 
The goal of this study was to assess the safety and efficacy of elective umbilical hernia 
repair in these patients prospectively.
Methods: Patients with liver cirrhosis and ascites presenting with an umbilical hernia 
were included in this study. For all patients, the expected time to liver transplantation 
was more than 3 months, and they did not have a patent umbilical vein in the hernia 
sac. The following data were collected prospectively for all patients: Child-Pugh-
Turcotte (CPT) classification, model for endstage liver disease (MELD) score, kidney 
failure, cardiovascular comorbidity, operation-related complications, and duration of 
hospital stay. Mortality rates were registered in hospital records and verified in gov-
ernment records during follow-up. Mortality rates were registered in hospital records 
and verified in government records during follow-up. On completion of the study, 
a retrospective survey was performed to search for any patients who met the study 
inclusion criteria but were left out of the study cohort.
Results: In total, 30 patients (25 males) underwent operation at a mean age of 58 years 
(standard deviation [SD] ± 9 years). Of these 30 patients, 6 were classified as CPT grade 
A (20%), 19 (63%) as grade B, and 5 (17%) as grade C. The patients’ median MELD score 
was 12 (interquartile range [IQR], 8–16). In 10 (33%) of the 30 patients hernia repair 
was performed with mesh. The median duration of hospital stay was 3 days (IQR, 2–4). 
None of the patients were admitted to the intensive care unit. Postoperative complica-
tions included pneumonia and decompensation of cirrhosis (1 case each), resulting 
in prolonged hospital stay for those 2 patients. After a median follow-up period of 
25 months (IQR, 14–34), 2 (7%) of the 30 patients died; neither of the deaths were 
attributable to the umbilical hernia repair. A total of 2 patients suffered recurrence. 
Conclusion: Elective umbilical hernia repair is safe and the preferred approach in cir-
rhotic patients with ascites.
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introduction
Patients with liver cirrhosis and ascites have a risk of 20% of developing an umbilical 
hernia in the course of their disease.1 Possible factors that contribute to the develop-
ment of umbilical hernia in these patients include increased intra-abdominal pressure 
due to ascites, weakening of the abdominal fascia and muscle wasting as a result of 
poor nutritional status, and dilation of the umbilical vein that enlarges the preexistent 
supra-umbilical fascial opening in patients with portal hypertension.2 
Although the incidence of umbilical hernia is high in cirrhotic patients, an optimal 
treatment strategy is unclear. For many years, surgical dogma dictated a “wait and 
see” approach, and surgical repair of umbilical hernia was limited to patients who 
developed complications.3-7 Conservative management, however, can be complicated 
by bowel incarceration or spontaneous rupture from necrosis of overlying skin and 
subsequent peritonitis. Such conditions force emergency repair in patients who are 
then at a greater risk of developing complications in an emergency setting than after 
elective surgery.2,8-10
This scenario appears to be particularly true in circumstances of acute removal of large 
amounts of ascites, such as large-volume paracentesis after transjugular intrahepatic 
portosystemic shunt (TIPS) or liver transplantation. Both of these procedures result in 
an acute decrease in the diameter of the fascial defect. In these instances, abdominal 
contents inside the hernia sac can become incarcerated.7 
Currently, the natural course of umbilical hernia in patients with ascites is largely un-
known, particularly in patients waiting liver transplantation, and prospective studies 
in this field are lacking.6,8,11 A recent retrospective study from our center comparing 
conservative management of umbilical hernia in these patients with elective repair 
showed a significant risk of mortality resulting from hernia incarceration in conser-
vatively treated patients.8 
After this study was completed, the treatment strategy of patients with liver cirrhosis 
and ascites with an umbilical hernia was changed at our center from “wait and see” 
to an elective repair protocol. The objective of this study was to evaluate the results 
of this protocol of elective umbilical hernia repair in patients with concurrent ascites 
and liver cirrhosis prospectively.
96
Chapter 6
methodS
Between July 2004 and May 2010, all patients in the Erasmus University Medical Center 
with umbilical hernia, cirrhosis, and ascites were included in this study and followed 
prospectively. Liver failure with cirrhosis was diagnosed on clinical, biochemical, or 
histologic findings. Ascites was diagnosed with ultrasonography or computed tomog-
raphy, and umbilical hernia was diagnosed on clinical examination. 
All patients included in the study were scheduled for elective hernia repair unless 
their expected waiting time for a liver transplantation was less than 3 months or 
a patent umbilical vein was present in the wall of their hernia sac. Patients with 
an expected waiting time for transplantation of less than 3 months or in whom a 
patent umbilical vein was found on ultrasonography or computed tomography were 
excluded from the study. 
Elective hernia correction was carried out after optimal management of ascites with 
2 diuretics (spironolactone [Aldactone; GD Searle/Pfizer, New York, NY] and furose-
mide [Lasix; Sanofi-Aventis, Paris, France]), early nutritional support, and intravenous 
albumin to increase patients’ serum albumin to greater than 30 g/L. No large-volume 
paracentesis was performed preoperatively. All patients who underwent elective and 
acute umbilical hernia repair within the study period at our institution were identi-
fied retrospectively to ensure that no patients who met the inclusion criteria were 
excluded from the final study cohort. The primary goal of the study was to investigate 
safety of elective umbilical hernia repair in cirrhotic patients. 
The following data were collected prospectively for all patients: age, sex, nicotine 
and alcohol use, malignancy, chronic obstructive pulmonary disease, diabetes mel-
litus, chronic steroid use, primary or recurrent umbilical hernia, hernia size, serum 
bilirubin (μmol/L), serum albumin (g/L), serum creatinine (μmol/L), international 
normalized ratio, hepatic encephalopathy, Child-Pugh- Turcotte (CPT) classification, 
model for end-stage liver disease (MELD) score at the time of surgery, cardiovascular 
comorbidity, American Society of Anesthesiologists (ASA) score, presence of hernia 
strangulation or incarceration, use of mesh in hernia repair, mesh positioning, 
simultaneous liver transplantation, perioperative and postoperative complications, 
admission to the intensive care unit, and duration of hospital stay. 
Mortality rates were registered in hospital records and verified in government re-
cords during follow-up. All patients were invited for clinical examination by 1 of the 
authors at the outpatient clinic to diagnose recurrence after a minimum follow-up 
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of 6 months. Statistical analyses were carried out with the SPSS statistical software 
package (SPSS Inc, Chicago, IL). The chi-square test and the Mann-Whitney U test were 
used for categorical and continuous variables, respectively. Values were considered 
statistically significant at 2-sided P values less than .05. Data were described as median 
and interquartile range (IQR).
reSultS
Patient characteristics (Table 1). A total of 30 consecutive patients (25 males, 5 females) at 
a median age of 58.3 years (IQR, 51–65) were included in the elective repair protocol. 
Of these 30 patients, 7 (23%) were classified as CPT grade A, 18 (60%) as grade B, and 5 
(17%) as grade C. The median MELD score was 12 (IQR, 8–16). Of the 30 patients, 6 (20%) 
had an ASA score of class II, 20 (67%) were class III, and 4 (13%) were class IV. A total of 
53% of the patients were on the waiting list for liver transplantation.
Table 1. Patient characteristics.
N = 30
Male, n (%) 5 (83)
Median age, y 58.3 (51–65)* 
Primary umbilical hernia, n (%) 28 (93)
Recurrent umbilical hernia, n (%) 2 (7)
CPT classification, n (%)
 A 7 (23)
 B 18 (60)
 C 5 (17)
MELD score, median 12 (8–16)* 
ASA class, n (%)
 I 0 (0)
 II 6 (20)
 III 20 (67)
 IV 4 (13)
IQR, Interquartile range; CPT, Child-Pugh-Turcotte; MELD, model for end-stage liver disease; ASA, American 
Society of Anesthesiologists. *Data in parentheses represents interquartile range.
Comorbidities of patients in the protocol (Table 2). At the time of hernia repair, 6 (20%) of 
the 30 patients in the protocol reported smoking, and 7 (23%) had alcohol abuse noted 
in their medical history. Only 1 (3%) patients had a malignancy related to the liver. Of 
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the 30 patients, 6 (20%) reported chronic steroid use, and 6 (20%) suffered from type 2 
diabetes mellitus.
Table 2. Comorbidities of patients included in the protocol.
Elective repair
(N = 30)
Smoking, n (%) 6 (20)
Alcohol abuse, n (%) 7 (23)
Malignancy, n (%) 1 (3)
Chronic steroid use, n (%) 6 (20)
Diabetes, n (%) 6 (20)
Operation characteristics and postoperative course (Table 3). All hernia repairs were per-
formed in an elective setting with an open technique and under general anesthesia. 
In all patients, the presence of ascites was confirmed. In 10 (33%) of the 30 patients 
hernia repair was performed with a flat heavy weight polypropylene mesh. The use 
of mesh for hernia repair was at surgeon’s discretion. Of these 10 repairs, 5 meshes 
were placed using the intraperitoneal (onlay) technique and 5 were placed with the 
preperitoneal (inlay) technique. Peritoneal tears that occurred during dissection of the 
hernial sac were closed with absorbable sutures. 
Table 3. Perioperative outcomes.
Elective repair 
(N = 30)
Operative time, min 79 (66–94)* 
Defect size, mm 15 (9)†
Mesh repair, n (%) 10 (33)
Duration of hospital stay, d 3 (24)* 
ICU admission, n (%) 0 (0)
* Data are presented as median (interquartile range).
† Data are presented as mean (standard deviation). 
Postoperatively, 2 patients experienced complications that necessitated prolonged 
hospital stay: 1 developed pneumonia and the other patient underwent decompensa-
tion of cirrhosis. The median hospital stay was 3 days (IQR, 2–4). None of the patients 
were admitted to the intensive care unit. 
At a median follow-up of 10 months, 2 (7%) of the 30 patients died: 1 died from bacte-
remia associated with cholangitis and hepatorenal syndrome, and the other patient 
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committed suicide during follow-up. None of the deaths were assumed attributable to 
the umbilical hernia repair. After a median follow-up of 25 months (IQR, 14–34), 2 (7%) 
of the 30 patients suffered a recurrence. Both underwent the primary hernia repair 
without the use of mesh. No notable correlations could be found between either CPT 
classifications or MELD scores with postoperative complications and recurrences (P = 
.06 and P = .17, respectively).
Retrospective review. In the retrospective review, 163 patients were identified who un-
derwent umbilical hernia repair at our institution during the study period. Of these 
163 patients, 30 were in the protocol and are described above. Of the 133 patients not 
included in the protocol, 127 were not eligible for the study, but 6 of these patients 
had ascites and liver cirrhosis and should have been considered for inclusion in the 
protocol.
Of these 6 patients, 4 were not included in the study even though they met the inclu-
sion criteria; they later underwent elective correction and did not experience any 
negative sequelae. The remaining 2 patients were excluded from the study because 
they were diagnosed with a patent umbilical vein and planned to undergo hernia 
correction during liver transplantation.
Unfortunately, the hernia correction proved to be unsuccessful for both patients. One 
of the patients developed an incarcerated umbilical hernia 3 months after transplan-
tation, which was corrected successfully without negative sequelae, but the other 
patient was readmitted to the hospital 2 months after liver transplantation, also with 
an incarcerated umbilical hernia. In this case, the complication resulted in multiple 
organ failure and the patient’s death.
diScuSSion
In this prospective single-center study, the safety of umbilical hernia repair in cir-
rhotic patients with ascites was investigated in a series of 30 consecutive patients. 
All patients underwent operations in an elective setting. Previous retrospective stud-
ies4,8 have demonstrated that conservative treatment of umbilical hernia in cirrhotic 
patients is associated with considerable morbidity and mortality. Hence, prospective 
series, such as this one, are needed to assess the safety and efficacy of elective umbili-
cal hernia repair in this specific group of patients. 
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Patients with an expected waiting time to liver transplantation of less than 3 months 
were excluded from this study. The risk of an additional operation for these patients 
who typically have high MELD scores was considered greater than the risk of waiting 3 
months until transplantation, because the hernia would be corrected during the trans-
plantation procedure. Furthermore, patients with a patent umbilical vein were also 
excluded from the study. The repair of an umbilical hernia necessitates the complete 
freeing of the umbilical ring and the ligation of a possibly reopened umbilical vein. 
This reopened umbilical vein can be an important outflow for the portal circulation in 
patients with severe portal hypertension. If the vein is ligated during umbilical hernia 
repair, the outflow of the portal circulation is hampered, which can lead to acute 
portal vein thrombosis, subsequent acute failure of the liver necessitating emergency 
liver transplantation.2,12 
In our study group, the incidence of complications after elective repair was low (7%) 
compared to complication rates reported in the literature (43%).8 Other studies also 
have demonstrated that postoperative outcome in cirrhotic patients is correlated with 
the patient’s CPT classification and, especially, with their MELD score.11,13,14 In our 
series, however, no significant correlations were found between either a patient’s CPT 
classification or MELD score and their postoperative outcome, but this finding could 
be due to the relatively low number of patients in our study. 
In this study, elective hernia correction was carried out after optimal management of 
ascites by the use of diuretics, early nutritional support, and intravenous albumin to 
increase the patient’s serum albumin to greater than 30 g/L. More invasive interven-
tions to optimize the condition of the patient are possible, such as staged and con-
comitant peritoneovenous shunting in combination with hernia repair, preoperative 
placement of TIPS to control portal hypertension, or mechanical ascites management 
by temporary placement of peritoneal dialysis catheters to allow drainage of post-
operative ascites.1,15,16 None of these more invasive therapeutic modalities, however, 
were used preoperatively in this study.
At long-term follow-up, recurrences were found in 2 patients, both of whom had un-
dergone primary hernia repair without the use of prosthetic mesh. The incidence of 
recurrences after umbilical hernia repair can be diminished markedly by using mesh, 
as demonstrated in this patient group and other studies.17-19 
With the use of mesh, the chance of leakage of ascites is increased in cirrhotic patients; 
such leakage can lead to infection of the mesh and, more rarely, bacterial peritonitis. 
As a result, many surgeons may be reluctant to use mesh for umbilical hernia repair 
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in this patient group. In most cases, bacterial infection of meshes made of polypro-
pylene or polyester can be treated with antibiotics, and removal of the mesh is rarely 
required.20,21 Infection of the mesh was not observed in our series, nor are we aware of 
any studies in the literature in which an increased risk of mesh infection was observed 
in cirrhotic patients. 
Of the 6 patients identified from the retrospective check for missed patients at our 
institution, 2 were considered for inclusion but excluded because of they had a patent 
umbilical vein. Both patients should have undergone elective umbilical hernia repair 
during the liver transplantation procedure, but this was mistakenly not performed 
with devastating results in 1 of the 2 patients. 
Performing umbilical hernia repair simultaneously with liver transplantation appears 
to be the optimal setting by avoiding complications associated with an extra admis-
sion and the use of general anesthesia. Due to organ shortages, however, the waiting 
time for transplantation has increased considerably, exposing patients on the waiting 
list to a greater risk of developing incarceration of the hernia. This situation leads to 
an increase in the need for emergency – rather than elective – repairs. 
Considering this fact, one could argue that elective repair of symptomatic umbilical 
hernia even in patients on the waiting list for transplantation is the safer strategy. 
Randomized studies, however, must be performed to create sufficient evidence for 
such a policy. Our results of elective umbilical hernia repair in cirrhotic patients are 
very encouraging and provide sufficient evidence to set up a randomized, controlled 
trial on this topic. 
Before such trials are undertaken, however, one needs to consider that the repairs car-
ried out in our study were performed at a liver transplantation center with consider-
able experience with this patient group. The multidisciplinary approach of preopera-
tive, perioperative, and postoperative care may be responsible for the positive results 
of our study. For this reason, implementation of umbilical hernia repair in cirrhotic 
patients in other centers should also focus on the overall management of care.
In conclusion, elective umbilical hernia repair is a safe approach and seems preferable 
over conservative treatment in selected cirrhotic patients. We have reported the first 
prospective data that advocate elective umbilical hernia repair in cirrhotic patients. A 
prospective, randomized clinical trial is needed to support our findings, and thereby 
reach a greater level of evidence to encourage implementation of this treatment 
strategy in other liver transplantation centers.
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AbStrAct
Background: The optimal management of patients with umbilical hernia and liver cir-
rhosis is not clear. The general surgical opinion is that umbilical hernia in patients 
with liver cirrhosis and ascites should not be corrected, because of the presumed high 
operative risks and high recurrence rates after elective repair. Conservative treatment, 
however, can also have severe complications resulting in emergency repair. In these 
patients such operations carry an even greater risk of complications than compared 
to elective operations. To date, no randomized controlled trial has been conducted on 
this subject.
Methods/Design: our trial is a multi-center, randomized controlled trial designed to 
compare watchful waiting to elective repair of umbilical hernia in patients with liver 
cirrhosis and ascites. The primary endpoint consists of a composite endpoint of overall 
morbidity related to the treatment of umbilical hernia after 24 months of follow-up. 
Secondary endpoints will include: cumulative hernia recurrence rate, classification 
of complications obtained during follow-up, postoperative pain and quality of life. A 
total of 100 patients will be randomized between the two groups. Patients will visit 
the outpatient clinic at 2-3 weeks and after 3, 12 and 24 months of follow-up.
Conclusion: This study will provide level 1b evidence to support the preference for 
either conservative treatment or elective repair of umbilical hernia in patients with 
liver cirrhosis and ascites.
Trial registration: Clinicaltrials.gov: NCT01421550
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introduction
Patients with liver cirrhosis complicated with ascites have a 20% risk of developing an 
umbilical hernia in the course of their disease.1 Possible factors that contribute to the 
development of umbilical hernia in these patients include increased intra-abdominal 
pressure due to ascites, weakening of the abdominal fascia and muscle wasting as a 
result of a poor nutritional status, and dilatation of the umbilical vein that enlarges 
the preexistent supra-umbilical fascial opening in patients with portal hypertension.2
Optimal management of an umbilical hernia in patients with liver cirrhosis remains 
controversial. It is often advised that surgical correction of an umbilical hernia in 
patients with ascites should not be performed before liver transplantation. In those 
patients a “wait-and-see” approach is recommended, because of the presumed in-
creased surgical risks and high recurrence rates after elective repair.3-5 Conservative 
treatment, however, can be complicated by incarceration or spontaneous rupture 
and evisceration following necrosis of the overlying skin. This requires an emergency 
repair which puts patients at greater risk of complications – even greater than after 
elective repair.6-8 If a patient is a candidate for liver transplantation and repair has 
not been performed prior to transplantation, umbilical hernia correction should be 
performed during liver transplantation because of the reported risk of postoperative 
strangulation of the bowel in uncorrected umbilical hernia resulting in serious mor-
bidity and death.8
One specific group of patients still warrants conservative treatment of umbilical 
hernia or repair only during liver transplantation: patients with a patent umbilical 
vein. A reopened umbilical vein can be an important route of outflow for the portal 
circulation in patients with severe portal hypertension. In these patients, elective 
repair without liver transplantation has been reported to result in acute portal vein 
thrombosis and subsequent liver failure necessitating an emergency liver transplanta-
tion because of ligation of the umbilical vein during hernia repair.2,7,9
Because of all these increased risks, liver cirrhosis, particularly in the presence of 
portal hypertension was initially considered an absolute contraindication for elective 
umbilical hernia repair. Despite this widespread belief, some small retrospective and 
prospective series have shown good results with elective umbilical hernia repair for 
patients with liver cirrhosis.6-8 However, no randomized controlled trial on this issue 
has been published. 
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The CRUCIAL trial was designed to determine the optimal management of umbilical 
hernia in patients with liver cirrhosis and ascites.
objective
The objective of the CRUCIAL trial is to compare conservative treatment (watchful 
waiting) to elective repair of umbilical hernia in patients with liver cirrhosis and 
ascites. We hypothesize that elective repair of umbilical hernia will result in a signifi-
cant reduction of overall complication rate and improved quality of life compared to 
conservative treatment in patients with liver cirrhosis and ascites.
Primary endpoint will be a composite endpoint of the overall morbidity related to 
the treatment of umbilical hernia after 24 months of follow-up. Secondary endpoints 
include cumulative hernia recurrence rate, classification of complications obtained 
during follow-up, and assessment of pain and quality of life. 
methodS And Study deSign 
Study design
The CRUCIAL trial has been designed as a prospective, multi-center, randomized 
controlled trial, in which conservative treatment is compared t0 elective repair of 
umbilical hernia in patients with liver cirrhosis and ascites.
The design of this protocol is in accordance with the CONSORT guideline.10 Approval 
of the Medical Ethical Committee Erasmus MC, Rotterdam, The Netherlands, was 
obtained. In total a 100 patients will be included in this study. Patients will be ran-
domized in one of two groups of 50 patients each. Group 1 includes patients with 
liver cirrhosis and ascites that will undergo elective umbilical hernia repair; group 2 
includes patients with cirrhosis and ascites that will receive conservative treatment 
with regard to their umbilical hernia. 
Randomization will be done in the Erasmus Medical Center for each participating 
center. Patients are randomly allocated to either conservative treatment or elective 
repair by means of sealed, numbered envelopes and will be opened in sequence. The 
randomization procedure will be stratified for participating center and for Model of 
End-stage Liver Disease (MELD) score ≤15 and >15. Blinding for the allocation is not 
possible in this study for the study participants, evaluators and surgeons. 
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Patients will visit the outpatient clinic after 2-3 weeks and after 3, 12 and 24 months. 
At 12 months of follow-up ultrasound imaging will be performed to detect recurrent 
umbilical hernia. All patients will be asked to fill out the Short-Form 36 (SF-36) and 
EuroQol (EQ-5D) to assess quality of life and a Visual Analogue Scale (VAS) to assess 
pain preoperatively and during follow-up.
Participants 
All patients with liver cirrhosis and ascites who have a concurrent umbilical hernia 
will be assessed for eligibility. Informed consent is mandatory. Before eligible patients 
can be included, ultrasound imaging will be performed to determine the size of the 
umbilical hernia and the presence of a patent umbilical vein. If the umbilical vein is 
either closed or open, but the diameter doesn’t exceeds 5 mm, the patient is permit-
ted to participate in the CRUCIAL trial. 
Umbilical hernia repair will also be performed in patients who are allocated to con-
servative treatment group and develop a symptomatic umbilical hernia during follow-
up. Simultaneous umbilical hernia repair will be performed if a patient will undergo 
abdominal surgery or a liver transplantation before the umbilical hernia correction is 
performed as stated in the flowchart (Fig. 1).
Inclusion criteria are defined as follows:
§ Primary umbilical hernia 
§ Liver cirrhosis 
§ Ascites (proven or treated)
§ Age ≥ 18 years
§ Signed Informed consent
Exclusion criteria:
§ Recurrent umbilical hernia
§ Midline laparotomy in the medical history
§ ASA (American Society of Anaesthesiologists) score IV or above
§ Incarcerated umbilical hernia necessitating an emergency procedure
§ The presence of a patent umbilical vein larger than 5mm 
§ Expected time to liver transplantation more than 3 months
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interventions 
Preoperative work-up
Elective repair of the umbilical hernia will be performed within 8 weeks after the 
randomization procedure. Prior to the randomization procedure, ultrasound imaging 
will be performed to determine the presence of a patent umbilical vein. Patients who 
undergo elective repair of the umbilical hernia will be admitted to the hospital two 
days prior to the procedure. The presence of tense ascites (i.e. more than 5 liters) will 
be treated with diuretic therapy or with drainage, and if necessary, albumin levels will 
be corrected until > 30 g/L.
intra-operative procedure
All repairs of the umbilical hernia, either elective repair or emergency surgery af-
ter conservative treatment, will take place using a method for which consensus is 
reached by all participating centers. This includes a para-umbilical incision, dissection 
(avoiding resection) of the hernia sac and restoration of the sac and its contents into 
the abdominal cavity. Intra-operative resection of the sac must be recorded on the pa-
tient’s operation report. Repair should take place using non-absorbable monofilament 
sutures combined with a flat polypropylene mesh placed preferably in the on-lay posi-
tion or in the pre-peritoneal plane.11 The overlap achieved in repair should be at least 
3 cm’s in each direction of the circular mesh. Closure of the subcutaneous tissue and 
skin may be achieved using a method chosen by the individual surgeon. If a patient 
with liver cirrhosis and concurrent umbilical hernia will undergo liver transplanta-
tion during follow up, repair should also take place using preferably non-absorbable 
monofilament sutures combined with a flat polypropylene mesh placed in the on-lay 
position or in the pre-peritoneal plane.
The preferred method of anaesthesia in the current trial is general anaesthesia. The 
use of local or spinal anaesthesia is permitted if there are contra-indications for gen-
eral anaesthesia. Single dose Kefzol® (Cefazoline) should be administered as antibiotic 
prophylaxis 10 to 30 minutes preoperatively. Furthermore, routine administration of 
thrombosis prophylaxis should be considered in the form of bodyweight adjusted Low 
Molecular Weight Heparin.
Case record form (intra-operative procedure) asks for completion of all fields noted, 
such as technical details of procedure (incision, size of the defect and the use of mesh 
and drains), duration of procedure, complications during procedure, thrombosis pro-
phylaxis, intravenous antibiotics and method used for anaesthesia.
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In mesh hernia repair the umbilical defect should not be enlarged during the repair 
procedure. If the surgeon sees need to enlarge the umbilical defect during the opera-
tion (which is not the preferred procedure) the enlargement of the defect must be 
noted in the operation report. The surgeon is permitted to close the fascia defect using 
sutures if possible in a “tension free fashion” to protect the mesh from contact with 
umbilical skin. In order to protect the viscera it is possible to place omentum or the 
remains of the hernia sac between viscera and mesh. The use of drains is permitted. 
Closure of the subcutaneous tissue and skin may be achieved using a method chosen 
by the individual surgeon.
Peri-operative management of clotting disorders
Without signs of bleeding complications, prolonged prothrombin time (PT) or a plate-
let count below 30 should not be corrected.12 If necessary, for instance in bleeding 
complications, correct PT/INR with low-volume coagulation factor concentrates, like 
co-fact®. Preferably not with FFP’s because of a fluid overload side effect, potentially 
leading to more bleeding complications because of a rise venous pressure.13
Postoperative procedure
Post-operative analgesics may consist of tramadol 50 mg three times daily and 
paracetamol four times daily 500 mg (or equivalent) administered orally for six days 
after surgery. Surgical wounds are examined for signs of haematoma and seroma. 
Albumine levels should be >30 g/L before the patient is allowed to return home. 
Diuretics controls and post-operative care will be performed at the outpatient clinic of 
the department of Hepatology. Postoperative care will be in close collaboration with 
a specialized hepatologist and concordant with good standard of care for operated 
patients with liver cirrhosis. 
outcome measures
Primary endpoint in this study is a composite endpoint of the overall morbidity (per-
centage of patients with at least one hernia-related complication) after 24 months of 
follow-up. Overall morbidity, which is divided in minor and major complications, can 
be found in Table 1. 
Secondary endpoints are: cumulative recurrence of umbilical hernia after repair in 
the separate groups, and grading of the primary endpoint (overall morbidity) with 
use of the Landelijke Heelkundige Complicatie Registratie (LHCR) grading tool; per 
patient the maximal observed grade will be determined and compared between the 
two groups. Pain will be evaluated with VAS and quality of life will be evaluated with 
SF-36 and EQ-5D questionnaires.
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All complications defined in Table 1, both conservative treatment and elective repair, 
will be scored with the LHCR for grading complications in surgical patients (Table 2). 
The following surgical procedures will not be scored as complications: liver trans-
plantation, elective or emergency repair of the umbilical hernia. In each patient the 
maximal observed grade will be determined and compared between the two groups.
Table 2. The Landelijke Heelkundige Complicatie Registratie (LHCR) grading tool.
Grade Description of complications
0 No health disadvantage, no real complication
1 Temporary health disadvantage, recovery without (re) operation
2 Recovery after (re) operation
3 (likely) permanent damage or invalidity 
4 Death 
Sample size calculation
Group sizes are based on chi-square  tests with alpha = 0.05, a power of 90% and are 
based on an expected decrease in overall complication rate at 2-years from 50 to 15% 
due to elective umbilical hernia repair.8 This requires 42 patients per treatment group. 
Accounting for approximately 15% dropout during the trial and 5% lost to follow-up, a 
total of 50 patients per group need to be recruited. 
Table 1. Minor and major complications. 
Minor complication Major complication
Superficial/deep SSI Mortality 
Seroma Evisceration 
Pneumonia Strangulation
Haematoma Incarceration
Urinary tract infection Bowel ischemia 
Non-closure of surgical wound at 4 weeks Necrosis/rupture of the overlying skin of the 
umbilical hernia
Postoperative leakage of ascites more than 2 
weeks after surgery
Liver failure
Infectious ascites 
Decompensated cirrhosis
Organ space SSI
Unexpected ICU admissions related to umbilical 
hernia or umbilical hernia repair
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Statistical analysis
Hundred patients with an umbilical hernia will be included in the study. Patients will 
be randomized in one of two groups of 50 patients each stratified by center and MELD 
≤15 and >15. Data will be analyzed on an “intention to treat” basis.
Categorical variables will be presented as numbers (percentage). Continuous variables 
will be presented as medians (range). Categorical variables will be compared using 
the Chi-square test. Continuous variables will be compared using the Mann-Whitney 
U test. 
Kaplan-Meier curves will be constructed to determine the cumulative complication 
rate of the umbilical hernia in the two study arms (elective repair versus conservative 
treatment). Comparison will be done using the LOGRANK test. Quality of life will be 
compared using Repeated measurements ANOVA. The Mann-Whitney U test will be 
used for the analysis of the maximal observed grade per patient according to the LHCR 
grading tool. 
Patients with liver cirrhosis and ascites
(Expected time to liver transplantation ≥ 3 months)
Elective umbilical hernia
repair Conservative treatment
Recurrent umbilical hernia Symptomatic or complicatedumbilical herniayes yes
no
Abdominal surgery, including
liver transplantation
no
Conservative treatment
yes
Umbilical hernia repair Umbilic l hernia repair
Umbilical hernia repair
a
Figure 1. Flowchart.
114
Chapter 7
All analyses will be conducted using SPSS (version 17.0, SPSS Inc, Chicago, USA). P-
values <0.05 (two-sided) will be considered statistically significant.
clinical follow-up and data collection
Morbidity will be assessed after 2-3 weeks (routine follow-up). In addition at 3, 12 and 
24 months post-operative follow-up will be performed. The investigator will examine 
and discuss with the patients if there are any complaints related to the umbilical 
hernia. The patient will undergo ultrasound imaging at the 12-month follow-up to 
detect recurrent hernias. The patients are asked to complete a SF-36 and EQ-5D ques-
tionnaire (as part of the quality of life evaluation) at baseline, 3, 6, 12 and 24-months 
of follow-up. VAS will be employed to evaluate pain at baseline and after 3, 6, 12 and 
24 months. In addition VAS will be done directly postoperative and at day 1 until 6 in 
operated cases for an umbilical hernia. 
The operative data will be collected during surgery and filled out immediately after 
the operation by the investigator through an online case record form. The follow-up 
data will also be collected by the investigator, using the same system. The case record 
forms are only accessible by logging in to a specially designed and secured website 
(https://www.crucialtrial.nl). All personal data is coded. A data check will be performed 
by comparing the patient records with the completed case record forms manually. 
Only the coordinating investigator and the principal investigator have access to the 
coding system. All data are imported into a secured database on a server of our insti-
tution and are managed by the coordinating investigator, according to the hospital 
guidelines. All data will analyzed in collaboration with the trial statistician at the end 
of the trial.
monitoring
Adverse events are defined as any undesirable experience occurring to a subject dur-
ing a clinical trial, whether or not considered related to the investigational interven-
tion. All adverse events reported spontaneously by the subject or observed by the 
investigator or his staff will be recorded. A serious adverse event (SAE) is any untoward 
medical occurrence that results in death; is life threatening (at the time of the event); 
requires hospitalization or prolongation of existing inpatients’ hospitalization; results 
in persistent or significant disability or incapacity; is a new event of the trial likely 
to affect the safety of the subjects, such as an unexpected outcome. All SAEs will be 
reported to the accredited Medical Ethical Committee (MEC) that approved the pro-
tocol, according to the requirements of that MEC. Serious Adverse events are major 
complications, unforeseen ICU admissions related to umbilical hernia or umbilical 
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hernia repair and reoperations. Adverse Events are minor complications, prolonged 
admission, readmission related to elective repair or conservative treatment. 
An independent data and safety monitoring committee will evaluate the progress 
of the trial and will examine safety parameters every 6 months. All involved physi-
cians will repetitively be asked to report any potential adverse events caused by the 
study protocol. These adverse events will be listed and discussed with the monitoring 
committee. The monitoring committee can ask for a full report in order to discuss a 
specific adverse event. A copy of this report will be sent to the central ethics board 
and to the involved physicians. All deceased patients will be evaluated by the safety 
committee for cause of death and possible trial related serious adverse effects. Every 
death will be reported to the central ethics board and the local ethics board. The Data 
Safety Monitoring Board will consist of an epidemiologist/statistician, a hepatologist 
and an independent surgeon.
diScuSSion
Management of umbilical hernia in patients with liver cirrhosis is a subject of de-
bate.8,14,15 Historically, elective hernia repair was deemed hazardous for patients with 
an umbilical hernia, because of the presumed increased surgical risks and the high 
recurrence rates after repair. Instead, watchful waiting was often advised, particularly 
in patients with asymptomatic umbilical hernia.3,4
More recent publications have shown that patients who are treated conservatively are 
at risk of developing complications of the hernia due to incarceration, rupture of the 
overlying skin or recurrent infections of ascites.6-8 To date, no randomized controlled 
trial on this matter has been conducted. The CRUCIAL trial will provide level 1b evi-
dence to support the preference for either conservative treatment or elective repair of 
umbilical hernia in patients with liver cirrhosis and ascites.
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AbStrAct
Purpose: Patients with liver cirrhosis scheduled for liver transplantation often pres-
ent with a concurrent umbilical hernia. Optimal management of these patients is 
not clear. The objective of this study was to compare the outcomes of patients who 
underwent umbilical hernia correction during liver transplantation through a sepa-
rate infra-umbilical incision with those who underwent correction through the same 
incision used to perform the liver transplantation. 
Methods: In the period between 1990 and 2011, all 27 patients with umbilical hernia 
and liver cirrhosis who underwent hernia correction during liver transplantation 
were identified in our hospital database. In 17 cases, umbilical hernia repair was 
performed through a separate infra-umbilical incision (separate incision group) and 
10 were corrected from within the abdominal cavity without a separate incision (same 
incision group). Six patients died during follow-up; no deaths were attributable to 
intra-operative umbilical hernia repair. All 21 patients who were alive visited the 
outpatient clinic to detect recurrent umbilical hernia. 
Results: One recurrent umbilical hernia was diagnosed in the separate incision group 
(6%) and four (40%) in the same incision group (p = 0.047). Two patients in the same 
incision group required repair of the recurrent umbilical hernia; one of whom un-
derwent emergency surgery for bowel incarceration. The one recurrent hernia in the 
separate incision group was corrected electively. 
Conclusion: In the event of liver transplantation, umbilical hernia repair through a 
separate infra-umbilical incision is preferred over correction through the same inci-
sion used to perform the transplantation.
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introduction
Patients with liver cirrhosis complicated with ascites have a 20% risk of developing an 
umbilical hernia in the course of their disease.1 Possible factors that contribute to the 
development of umbilical hernia in these patients include increased intra-abdominal 
pressure due to ascites, weakening of the abdominal fascia and muscle wasting as a 
result of poor nutritional status, and dilatation of the umbilical vein that enlarges the 
pre-existent supra-umbilical fascial opening in patients with portal hypertension.2 
Optimal treatment of an umbilical hernia in patients with liver cirrhosis remains 
controversial. It is often advised that surgical correction of an umbilical hernia before 
liver transplantation (LT) in patients with ascites should not be performed. In those 
patients a “wait-and-see” approach is recommended, because of the presumed high 
surgical risks and high recurrence rates after elective repair.3-5 Conservative manage-
ment, however, can be complicated by incarceration or spontaneous rupture and 
evisceration following necrosis of the overlying skin. This requires an emergency 
repair which puts patients at greater risk of complications – greater than after an elec-
tive correction.6-8 If a patient is a candidate for LT and repair has not been performed 
prior to LT, umbilical hernia correction should be performed during transplantation, 
because of the reported risk of postoperative strangulation of the bowel in an uncor-
rected umbilical hernia resulting in serious morbidity or death.8 
Two techniques for hernia repair during LT are most commonly used, either through 
a separate infra-umbilical incision or from within the abdominal cavity through the 
same incision used to perform the liver transplantation. The decision, however, of 
which technique for umbilical hernia repair during LT should be used, is based on 
the surgeon’s personal preference; no studies on this matter have been published as 
yet. The objective of this study is to evaluate which of the two techniques to repair an 
umbilical hernia during LT is to be preferred. 
methodS
Patient records between the period 1990 and 2011 at Erasmus University Medical 
Center were screened for the combined search terms liver cirrhosis, umbilical hernia 
and liver transplantation. Patients were included in the analysis when the following 
inclusion criteria were met: End-stage liver disease, scheduled for liver transplanta-
tion and an umbilical hernia confirmed by physical examination which was repaired 
during LT. 
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According to the hernia correction technique chosen during LT, two patient groups 
were identified: patients who underwent umbilical hernia repair through a separate 
infra-umbilical incision (separate incision group) and patients who underwent umbili-
cal hernia correction from within the abdominal cavity without a separate incision 
(same incision group). The choice of technique for umbilical hernia repair was made at 
the surgeon’s discretion. All fascia defects were closed using interrupted PDS sutures. 
The two techniques to correct the umbilical hernia during LT were not standardized. 
Surgical records were reviewed to identify the type of incision used to correct the um-
bilical hernia and to identify the type of hernia repair, either primary suture or mesh 
repair. The occurrence of local wound complications related to the umbilical hernia 
repair and the presence of ascites during LT were also retrieved from the records. 
Patients identified in this search were followed at our institution; they all underwent a 
physical examination and if necessary an additional ultrasonography of the umbilical 
region to detect hernia recurrence.
This retrospective cohort study used SPSS 17.0 (SPSS Inc., Chicago, IL, USA) for sta-
tistical analysis. Chi-square test and Mann-Whitney U- test were used for categorical 
and continuous variables. Mean follow-up (defined as time from LT to death, hernia 
correction or date of physical examination or ultrasound), age, sex, and labMELD score 
were compared between the two groups. The values are expressed as mean ± standard 
deviation (SD) or percentages. The Chi-squared test was used to assess the difference 
in proportions of hernia recurrences between the two groups. A p-value of less than 
0.05 was considered significant. 
reSultS
Study population
Between January 1990 and December 2011 a total of 717 liver transplantations was 
performed; 27 of these patients underwent umbilical hernia repair simultaneously 
(4%). The mean labMELD score of these 27 patients was 16.8 (SD 4.6). At the time of 
LT, 19 of them had at least mild-to-moderate ascites. Seventeen patients were included 
in the separate incision group and 10 in the same incision group. Age and sex did not 
differ significantly between the two groups. A total of six patients (22%) died during 
follow-up due to causes not related to the umbilical hernia or its repair. In Table 1, the 
demography of the studied population is shown. 
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Table 1. Demography of the patient groups.
Separate incision group Same incision group
N 17 10
Male (%) 12 (71%) 5 (50%)
Mean age (SD) 51.6 (11.3) 47.2 (14.5)
Mean labMELD score (SD) 16.5 (4.7) 17.3 (4.8)
Follow up in months (SD) 31.1 (29.2) 25.7 (33.1)
Duration of follow-up did not differ between both groups: 25.7 (months; SD 33.1, 
same incision group) versus 31.1 (SD 29.2, separate incision group), P = 0.659. Overall 
complication rate did not differ significantly between the same incision group and the 
separate incision group (50% vs 24%; P = 0.219). Recurrence rate in the separate inci-
sion group and same incision group (6% vs 40%, respectively) differed significantly, P = 
0.047, whereas labMELD scores were comparable between the 2 groups. The outcomes 
are compared in Table 2.
Table 2. Complications reported after initial management.
Hernia management Recurrence 
rate
Overall complications 
rate
Nature of complications
Separate incision 
group (n = 17)
1 (6%) 4 (24%) Seroma (n = 2)
Wound infection (n = 1)
Recurrence (n = 1)
Same incision 
group (n = 10)
4 (40%) 5 (50%) Relaparotomy for postoperative 
hemorrhage (n = 1)
Recurrence (n = 4); including 1 
incarcerated hernia followed by emergency 
surgery.  
The recurrence rate (6% versus 40%) differed significantly between the two groups (P = 0.047). 
Separate incision group 
In 10 out of 17 patients (59%), the presence of ascites was confirmed during LT. The 
mean (SD) labMELD score for the separate incision group was 16.5 (4.7). Umbilical 
hernia repair was performed with primary suturing in 15 out of 17 patients (88%); in 
2 patients, abdominal wall reconstruction consisted of preperitoneal polypropylene 
onlay mesh repair. The skin of the separate incision was closed using intracutane-
ous running absorbable monofilament sutures (Monocryl 4.0, Ethicon). Local wound 
complications occurred in 3 of 17 patients (18%); 2 patients had a seroma and 1 who 
underwent mesh repair suffered a wound infection, which was treated locally with-
out negative sequelae. Four out of 17 (24%) patients died during follow-up. Hernia 
correction-related mortality was not observed in this group. One of 17 patients in the 
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separate incision group suffered a hernia recurrence (6%) 19 months after primary 
repair, which was operated upon electively. The two patients who underwent hernia 
repair using mesh prosthesis did not suffer recurrence.
Same incision group
In 9 out of 10 patients (90%), the presence of ascites was confirmed during LT. The 
mean (SD) labMELD score for the separate incision group was 17.3 (4.8). In all cases 
umbilical hernia repair was performed with primary suturing. Two deaths (20%) were 
recorded during follow-up, which were not related to the hernia correction. In four 
out of ten patients (40%), a recurrent umbilical hernia was diagnosed at follow-up. 
Two recurrent hernias (50%) were corrected; one patient was operated on electively 
and one patient (25%) presented with an incarcerated hernia necessitating emergency 
surgery. One patient in the same incision group suffered postoperative hemorrhage at 
the site of the hernia correction. The patient had to undergo a re-laparotomy through 
the same incision used for LT to control the bleeding.
diScuSSion
Umbilical hernia correction during LT results in high rates of hernia recurrence. This 
retrospective cohort study suggests that correction of the umbilical hernia during LT 
through a separate infra-umbilical incision is to be preferred over correction from 
within the abdominal cavity without a separate incision. 
Management of an umbilical hernia in patients with liver cirrhosis is subject of de-
bate.8-10 Historically, elective hernia repair was deemed hazardous for patients with an 
umbilical hernia, because of the presumed high surgical risks and the high recurrence 
rates after repair. Instead, a wait-and-see approach was commonly advised, particularly 
in asymptomatic patients.3,4 
More recent publications, however, have shown that patients treated conservatively 
are at risk of developing complications of the hernia due to incarceration, rupture of 
the overlying skin or recurrent infections of ascites.6-8 This awareness has changed the 
management of these patients to a more aggressive approach of correcting umbilical 
hernias electively, even for patients awaiting LT if the expected waiting time exceeds 
three to six months.6-8
Despite this growing awareness of potential hazards of umbilical hernias in patients 
with liver cirrhosis and a more aggressive approach to elective repair, most patients 
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with an asymptomatic umbilical hernia are still treated conservatively, particularly 
those with more advanced liver disease.10,11 This results in patients presenting with a 
concurrent umbilical hernia in up to 20% of liver transplantations. If left uncorrected, 
these hernias can lead to serious postoperative morbidity and even mortality after 
LT.6-8
One specific group of patients still warrants conservative treatment of umbilical 
hernia or repair only during LT: patients with a patent umbilical vein. A reopened um-
bilical vein can be an important rout of outflow for the portal circulation in patients 
with severe portal hypertension. In these patients, elective repair without LT has been 
reported to result in acute portal vein thrombosis and subsequent liver failure necessi-
tating emergency LT, because of ligation of the umbilical vein during hernia repair.2,7,12
The present study has several limitations. The first limitation is the relatively small 
sample size. Due to this, adjusting or stratifying for possible confounders that could 
explain the difference in recurrences between the two groups was not possible. De-
spite this small sample size, the difference in recurrence between the two types of 
surgical correction was found to be significant. Secondly, it could be argued that the 
choice of a surgeon to use a certain technique was biased by patient characteristics 
that could influence recurrence rate. Patients in the two groups, however, were shown 
to be comparable with respect to severity of liver disease as labMELD was comparable 
in both groups. In addition, due to the retrospective nature of the study and the fact 
that no strict protocols were used to correct the hernias, the conclusion should be 
interpreted with further caution. 
Intraoperative ascites is a known risk factor for postoperative hernia recurrence.6,10,13 
Although preoperative ascites was observed more frequently in the same incision 
group, this difference was not statically significant. Furthermore, neither technique 
was standardized, which restricts the comparability between the groups. The hernia 
sac was not resected in all patients in the same incision group and only two of the 
patients in the separate incision group underwent mesh-repair. 
The use of mesh under these conditions is controversial. However, routine use of 
mesh repair in patients undergoing concomitant LT and umbilical hernia repair has 
never been studied. It is often believed that under those circumstances, the use of 
mesh could potentially lead to higher incidences of infection of the wound, infection 
of the mesh, and postoperative leakage of ascites through the mesh.8,14,15 In 2010, 
however, a randomized controlled trial conducted by Ammar et al. showed that mesh 
repair was superior to suture repair with respect to recurrence (2.7% vs 14.2%, P < 0.05) 
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in patients with liver cirrhosis who underwent umbilical hernia repair outside the LT 
setting.16 However, in that study, mesh repairs were more likely to become infected 
(16.2% vs. 8.5%), but this result was not statistically significant.16 In the current study, 
one of the two patients who underwent mesh repair suffered wound infection, which 
was treated locally; neither patient suffered hernia recurrence.
In conclusion, this study shows high recurrence rates of umbilical hernia repairs 
during LT and it suggests that correction during LT using a separate infra-umbilical 
incision leads to fewer recurrences of umbilical hernias during follow-up compared 
to correction of the umbilical hernia from within the abdominal cavity without a 
separate incision. Future studies, preferably randomized multicenter studies with 
standardized operation techniques using non-absorbable sutures and more liberal use 
of prosthesis in the absence of septic complications, are warranted to provide more 
robust evidence for the difference in recurrence and allow for adjusting for possible 
confounders.
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AbStrAct
The aim of this cross-sectional study was to analyze the incidence of incisional hernia 
after liver transplantation (LT), to determine potential risk factors for their develop-
ment and to assess their impact of incisional hernia on health-related quality of life 
(HRQoL). 
Patients who underwent LT through a J-shaped incision with a minimum follow-up of 
3 months were included. Follow-up was conducted at the outpatient clinic. Short form 
36 (SF-36) and body image questionnaire (BIQ) were used for the assessment of HRQoL.
A total of 140 patients was evaluated. The mean follow-up period was 33 (SD 20) 
months. Sixty patients (43%) were diagnosed with an incisional hernia. Multivariate 
analysis revealed surgical site infection (OR 5.27, p = 0.001), advanced age (OR 1.05, 
p = 0.003), and prolonged ICU stay (OR 1.54, p = 0.022) to be independent risk factors 
for development of incisional hernia after LT. Patients with an incisional hernia expe-
rienced significantly diminished HRQoL with respect to physical, social, and mental 
aspects. 
In conclusion, patients who undergo LT exhibit a high incidence of incisional hernia, 
which has a considerable impact on HRQoL. Development of incisional hernia was 
shown to be related to surgical site infection, advanced age and prolonged ICU stay.
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introduction
Liver transplantation (LT) has evolved from a life-saving operation with high mortality 
in the 70’s and 80’s of the past century to a standardized procedure with a reported 
1-year survival rate of over 90%, depending on the initial indication.1,2 During this 
evolution, focus has shifted from preventing peri-operative mortality and major 
complications to managing long-term side-effects of immune suppressive therapy and 
improving quality of life after LT.3-6
With improved long-term survival after LT, incisional hernia has become a frequently 
diagnosed and clinically more relevant complication with incidences varying between 
1.7 and 34.3%.7-16 Incisional hernias form not only an aesthetic problem, but they may 
also reduce quality of life and can lead to serious morbidity due to incarceration or 
strangulation.16-18 Therefore, prevention of this late complication has become increas-
ingly important. Many causative factors for incisional hernias have been identified 
retrospectively in patients after LT: recipient’s age, male sex, body mass index (BMI), 
indication for transplantation and underlying liver disease, pulmonary complications, 
wound infections, number of reoperations, immunosuppressive regimen, and inci-
sion type.14,16,19,20
Traditionally, the classic ‘Mercedes Benz star’ incision or ‘rooftop’ incision was used 
predominantly to perform LT. More recently, smaller incisions like a subcostal incision 
with or without a mediocranial extension (‘J-shaped’ or ‘hockey-stick’ incision) are 
now preferred, since they have been shown to provide adequate access for LT with 
presumably less abdominal wall trauma, resulting in a reported lower incidence of 
incisional hernia.1,11,21,22 
Prospective data on independent risk factors for the development of incisional hernia 
after LT are sparse and none have evaluated the impact of incisional hernia after LT 
on health-related quality of life (HRQoL). The aim of this cross-sectional study was to 
assess the incidence of clinically detectable incisional hernias, to evaluate risk factors 
for the development of incisional hernia, and to determine the impact of incisional 
hernia on HRQoL in patients all of whom underwent LT through a J-shaped incision.
methodS
A cross-sectional study was performed of patients who underwent LT between January 
2004 and November 2010 at the Erasmus University Medical Center. All patients who 
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underwent LT through a J-shaped incision with a minimum follow-up of 3 months 
were asked to participate in the study and invited to the outpatient clinic for a physi-
cal examination. The medical ethics committee at Erasmus University of Rotterdam 
approved the study, and written informed consent was obtained from all participants. 
All patients who participated in the study were examined by an experienced surgeon 
to assess the incidence of incisional hernias after LT. In each patient, the physical 
examination was performed in both a supine and erect position, in rest and during 
the Valsalva maneuver. Incisional hernia was defined as a palpable defect in the ab-
dominal wall of the incision used for LT, performed during the initial study period, 
resulting in a herniation of abdominal contents. If an incisional hernia was diagnosed, 
data on hernia location, hernia size and if corrected data on recurrence were collected. 
If patients underwent repair of an incisional hernia, a flat heavyweight polypropylene 
mesh was used if gross contamination was not present at the time of correction. This 
mesh was placed in the pre-peritoneal plane preferably. Antibiotic prophylaxis was 
administered to prevent infection of the prosthesis. 
The J-shaped incision, consisting of a right subcostal incision combined with a me-
diocranial extension towards the xyphoid, was used primarily to gain access to the 
abdominal cavity in all cases. Routinely, a table-mounted abdominal wall retractor 
(Thompson Surgical Instruments, Incorporated, Traverse City, MI, USA) was used dur-
ing the entire procedure. At completion of the procedure the abdominal wall fascia 
was closed by a single-layer mass closure technique with a running, slowly absorbable, 
monofilament suture loop (PDS 0, Ethicon). The skin was closed using intracutaneous 
running absorbable monofilament sutures (Monocryl 4.0, Ethicon). Thirty minutes 
preoperatively, a single dose Cefalozine (1500mg) was administered as antibiotic 
prophylaxis unless another antibiotic regimen was prescribed because of earlier infec-
tions in the patient’s recent medical history. An additional dose of Metronidazole (500 
mg) in case of expected bilioenteric reconstruction. When patients had considerable 
ascites at the first exposure of the abdominal cavity, passive abdominal drainage was 
only performed after LT. No T-tubes or stents were used during the biliary reconstruc-
tion. All biliary reconstructions were duct-to-duct unless primary sclerosing cholangitis 
or another disease was present affecting the extrahepatic bile duct. In these patients a 
bilio-enteric reconstruction was created, using a Roux-en-Y loop. Relaparotomies were 
always performed through the same incision created during LT. Postoperatively, dual 
or triple immunosuppressive therapy consisting of low-dose steroids, and Tacrolimus 
(Prograf, Astellas Pharma) and/or Mycophenolate Mofetil (MMF, CellCept, Roche), was 
administered for three months. All patients were withdrawn from steroid therapy 
except those with an underlying immune-regulated liver disease.
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Patient characteristics and clinical data were collected prospectively in the search 
for potential risk factors, including: age, sex, underlying liver disease, cardiovascular 
diseases (cardiac arrhythmia, ischemic heart disease or other cardiovascular disease), 
chronic obstructive pulmonary disease (COPD), diabetes mellitus (DM), medical his-
tory of other hernia (inguinal-/umbilical hernia/acute dehiscence), Body Mass Index 
(BMI) at time of LT, Child-Turcotte-Pugh (CTP) score at time of LT, Model of End-stage 
Liver Disease score based on laboratory findings solely at the time of LT (labMELD), 
intraoperative presence of ascites, procedure time of LT, intra-operative blood loss, 
length of hospital stay, length of postoperative intensive care unit (ICU) admission, 
immunosuppressive regimen (dual or triple), postoperative complications including 
wound complications, surgical site infection, pneumonia, biopsy-proven acute graft 
rejection, and number of relaparotomies. 
To compare HRQoL among patients with an incisional hernia after LT to those with-
out, patients were asked to fill in quality of life questionnaires, the Short Form (36) 
Health Survey (SF-36) and the Body Image Questionnaire (BIQ) prior to physical ex-
amination.23-25 The SF-36 consists of 36 items that allow measurement of eight health 
domains, including: physical functioning, physical role functioning, bodily pain, 
general health perception, vitality, social functioning, emotional role functioning, 
and mental health.25 In addition, physical and mental health are scored with the SF-36 
physical component summary and SF-36 mental component summary, respectively. 
SF-36 scores range from 0 to 100, with higher scores implying a better quality of life. 
The BIQ consists of eight items evaluating body image and cosmetics after surgery, 
and two items evaluating self-confidence.23-25 The body image scale measures patients’ 
perception of and satisfaction with their own body and it explores patients’ attitude 
towards their bodily appearance (items 1, 2, 3, 4, 5); each item can be awarded 1 to 
4 points (1 = “no, not at all” to 4 = “yes, extremely”). The cosmetic scale assesses the 
degree of satisfaction of the patient with respect to the physical appearance of the 
scar (items 6–8); item 6 ranges from 1 (“very unsatisfied”) to 7 (“very satisfied”), item 
7 ranges from 1 (“revolting”) to 7 (“beautiful”) and item 8 is a scoring scale from 1 
to 10, with higher scores implying more satisfaction. Two items (9, 10) evaluate self-
confidence of the patient before and after LT; both items can be awarded 1 to 10 points 
(1 = “not very confident” to 10 = “very confident”).
Statistical analysis
SPSS 17.0 (SPSS Inc., Chicago, IL, USA) was used for statistical analysis. Chi-square 
test, Mann-Whitney U-test and independent sample t-test were used for categorical, 
continuous variables and analysis of quality of life. Univariate and multivariate analy-
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ses of various factors were performed with logistic regression analysis to determine 
HRQoL, potential and independent risk factors for the occurrence of incisional hernia. 
In univariate and multivariate analysis, risk factors were adjusted for length of follow-
up; SF-36 components and BIQ questions were adjusted for age and sex. Values were 
considered statistically significant at p-values less than 0.05. 
reSultS
Of all 201 patients who were transplanted through a J-shaped incision, 140 provided 
informed consent and were examined. The remaining 61 were deceased (n = 40) or 
emigrated/refused to participate (n = 21) and could not be included. Patient character-
istics and clinical data are set out in table 1. The mean follow-up period was 33 (SD 
20) months. Sixty patients (43%) were diagnosed with a clinically detectable incisional 
hernia after physical examination. Twenty-one of those 60 incisional hernias (35%) 
were located in the subxyphoidal part of the incision, 18 (30%) were located in the 
middle part of the incision, and 9 (15%) were located laterally. In 12 patients (20%) the 
incisional hernia was located at more than one location. The mean diameter of the 
incisional hernia was 3.4 cm (SD 5.5). 
Ten of the 60 patients (17%) who developed an incisional hernia underwent hernia 
repair during follow-up; eight patients of these ten were operated electively and 
one patient in an emergency setting due to incarceration of the small bowel after a 
mean follow-up of 17 months (SD 12). Furthermore, four patients underwent acute 
dehiscence repair after LT. All four patients developed an incisional hernia after acute 
dehiscence repair during follow-up; one of these four patients underwent an elective 
incisional hernia repair 19 months after LT. In all incisional hernia repairs a mesh 
was used. Two patients developed an infection of the mesh; in both cases the infected 
mesh had to be removed. 
Univariate analysis (adjusted for follow-up duration) demonstrated age (p = 0.02), pre-
operative BMI (p = 0.012), ICU stay (p = 0.022), surgical site infection (p = 0.004), and 
hernia in the medical history (p = 0.036) to be potential risk factors for development 
of incisional hernia after LT. Sex (p = 0.133), follow-up time (p = 0.076), labMELD score 
at time of LT (p = 0.423), relaparotomy frequency (p = 0.057), immunosuppressive regi-
men (p = 0.772), and biopsy-proven acute graft rejection (p = 0.078) were not identified 
as risk factors for incisional hernia after LT. (Table 2) 
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Table 1. Patient characteristics and clinical data.
Characteristics 
Total
(n = 140)
Sex, (%)
Male 90 (64)
Female 50 (36)
Age (years), mean (SD) 49 (12)
Body mass index (at LT), mean (SD) 26 (4)
Follow-up (months), mean (SD) 33 (20)
Total # with Liver Disease, (%)
Hepatitis 41 (29)
Alcoholic 30 (21)
HCC 33 (24)
Cryptogenic 13 (9)
PSC 37 (26)
PBC 5 (4)
Autoimmune 2 (1)
Acute liver failure 20 (14)
Budd-Chiari syndrome 1 (0.7)
Other 10 (7)
Child Pugh Score, (%)
A 24 (17)
B 57 (41)
C 59 (42)
labMELD, median (range) 15 (6-40)
Preoperative ascites, (%) 93 (66)
Procedure time LT (min), median (range) 441 (254-822)
Blood loss (liter), median (range) 3.2 (0.1-25.0)
Duration hospital stay (days), median (range) 20 (10-77)
Duration ICU stay (days), median (range) 4 (2-70)
Relaparotomy, (%) 53 (38)
Immunosuppressive regimen, (%)
Dual 29 (21)
Triple 111 (79)
Acute graft rejection, (%) 30 (21)
Surgical site infection, (%) 28 (20)
Diabetes, (%) 45 (32)
Cardiovascular disease, (%) 42 (30)
COPD, (%) 12 (9)
Other hernia in medical history, (%) 47 (34)
LT, liver transplantation; PBC, primary biliary cirrhosis; labMELD, Model of End-stage Liver Disease, only 
based on laboratory variables; COPD, Chronic obstructive pulmonary disease; Other hernia in medical history 
includes: inguinal-/umbilical hernia/acute dehiscence.
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Multivariate logistic regression analysis after adjustment for follow-up duration re-
vealed surgical site infection (OR 5.27, 95% CI 1.94 to 14.35; p = 0.001), older age (OR 
1.05, 95% CI 1.02 to 1.09; p = 0.003) and prolonged ICU stay (OR 1.54, 95% CI 1.06 to 
2.22; p = 0.022) to be independent risk factors for incisional hernia in patients who 
underwent LT through a J-shaped incision. 
A total of 122 patients (87%) completed quality of life questionnaires. Patients with an 
incisional hernia scored significantly lower (i.e. experienced worse quality of life) on 
the SF-36 components: physical role functioning (p = 0.026), vitality (p = 0.004), social 
functioning (p = 0.002), emotional role functioning (p = 0.005), mental health (p = 
0.042) and mental component summary (p = 0.001). (Table 3)
Table 2. Univariate analysis: potential risk factors for incisional hernia development.
Patients with 
IH
(n = 60)
Patients without 
IH
(n = 80)
p – value*
Follow-up (months), mean (SD) 37 (19) 31 (20) 0.076
Sex, mean (SD)
Male 43 (72) 47 (59) 0.113
Female 17 (28) 33 (41)
Age (years), mean (SD) 51 (10) 47 (14) 0.020
Body mass index (at LT), mean (SD) 26 (5) 25 (4) 0.012
labMELD, median (range) 11 (6-40) 11 (6-40) 0.423
Surgical site infection, percentages (%) 19 (32) 9 (11) 0.004
Relaparotomy, percentages (%) 28 (47) 25 (31) 0.057
Duration ICU stay (days), median (range) 5 (2-70) 4 (2-46) 0.022
Immunosuppressive regimen, percentages (%)
Dual 13 (22) 16 (20) 0.772
Triple 47 (78) 64 (80)
Acute graft rejection, percentages (%) 8 (13) 22 (28) 0.078
Other hernia, percentages (%) 26 (43) 21 (26) 0.036
*p-values are adjusted for follow-up duration. IH, incisional hernia; LT, liver transplantation; labMELD, Model 
of End-stage Liver Disease, only based on laboratory variables; Other hernia in medical history includes: ingui-
nal-/umbilical hernia/acute dehiscence.
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Patients with an incisional hernia after LT were significantly less satisfied with the 
body image (p = 0.016). These patients answered significantly less favorably the item: 
“Do you think the surgery has damaged your body? “ (p = 0.007). Patients with an incisional 
hernia after LT also scored significantly lower on the cosmetic scale (p = 0.033). These 
patients answered significantly less favorably the item: “How satisfied are you with your 
scar?” (p = 0.036). Within the group of patients with an incisional hernia, no difference 
in HRQoL was observed with regard to the location of the diagnosed incisional hernia.
Table 3. Mean SF-36 scores and SD for patients with and without an incisional hernia.
Short form 36 component Patients with IH Patients without IH
N Mean SD N Mean SD p - 
value*
(p – 
value)
Physical functioning 54 65.9 26.2 65 73.2 28.0 0.053 0.204
Role physical 51 43.6 42.4 60 62.9 42.6 0.026 0.020
Bodily pain 53 72.3 26.7 65 79.2 24.2 0.149 0.113
General health perceptions 54 52.5 23.2 65 58.0 22.8 0.139 0.197
Vitality 54 51.9 22.6 65 63.5 18.9 0.004 0.003
Social functioning 54 66.9 26.5 66 80.1 23.3 0.002 0.003
Role emotional 50 68.7 44.9 61 90.7 26.1 0.005 0.003
Mental health 54 73.5 18.3 65 79.9 17.0 0.042 0.028
Physical component summary 50 41.4 11.5 59 44.8 10.9 0.138 0.137
Mental component summary 50 48.2 11.7 59 54.9 8.4 0.001 0.001
*Mann-Whitney U test (univariate); p-values after adjustment for age and gender (multivariate) are shown in 
parentheses; SF 36, short form 36; SD, standard deviation; IH, incisional hernia.
Multivariate analysis of SF-36 components, the body image scale and the cosmetic 
scale, after adjustment for age and gender, did not change the results significantly, 
except for the body image item: “Is it difficult to look at yourself naked?” After adjustment 
for age and sex, patients with an incisional hernia scored significantly more points (i.e. 
had more difficulty looking at their body naked, p = 0.016). (Table 4)
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diScuSSion
This cross-sectional study shows that patients who undergo LT through a J-shaped 
incision have a high incidence of incisional hernia and that these patients experience 
diminished HRQoL compared to those who do not develop an incisional hernia. Fur-
thermore, the presence of an incisional hernia was shown to be related to surgical site 
infection, older age and prolonged ICU stay. These results underscore the importance 
of this late complication in patients after LT. Especially, because these patients are 
often not considered to be at high risk typically for an incisional hernia in contrast 
to patients with obesity or abdominal aneurysms.25-31 Poor preoperative nutritional 
status, long duration of the operation, poor immunologic status due to postoperative 
immunosuppressive medication and the underlying liver disease in patients undergo-
ing LT could all contribute.
Incisional hernias after LT have been reported with growing incidence in recent years, 
reflecting improved survival after LT and probably greater awareness of the develop-
ment of incisional hernias.11,14-16,21 However, in contrast to the current study, several 
studies have shown lower incidences of incisional hernia after LT.12,13,20,22 If incisional 
hernias are asymptomatic, it is conceivable that patients are often not examined with 
a specific focus on incisional hernias at the outpatient clinic, which could have led 
to an underestimation of the incidence in these studies. Furthermore, diagnosing 
abdominal wall hernias retrospectively solely based on questionnaires have also been 
shown to be unreliable and follow-up must be done by physical examination.32 There-
fore, all patients included in this study underwent physical examination with a special 
focus on incisional hernia.
A recent retrospective study also reported a high overall incidence (32.4%) of incisional 
hernias after LT.16 The authors identified early use of mammalian target of rapamycin 
inhibitors as the most important independent risk factor for incisional hernia devel-
opment after LT. The current study reports an even higher incidence of incisional 
hernia but without use of this immunosuppressive regimen. In addition to rapamycin, 
Montalti et al. identified MELD scores higher than or equal to 22 and male sex as 
independent risk factors for the development of incisional hernia after LT.16 Whereas, 
the current study identified surgical site infection, older age and prolonged ICU stay 
as risk factors related to incisional hernia development after LT, which is more in line 
with previous studies of risk factors for incisional hernia development after abdomi-
nal surgery for other indications.14,20,22 
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In this cross-sectional study, 20% of patients developed surgical site infections. Several 
studies suggested PSC as risk factor for surgical site infections after LT due to the 
frequent presence of infected bile and the need for bilioenteric anastomoses in the 
majority of these transplant patients.33-35 However, the association between PSC and 
the presence of surgical site infections could not be found in this study. Infection 
of the surgical site is already considered to be an important risk factor contributing 
to the development of incisional hernia in non-transplant patients.18,36,37 This study 
provides evidence that surgical site infections are the most important risk factor 
for the development of incisional hernias in LT patients as well. Negative effects of 
immunosuppressive therapy after LT on the patient’s immune system can further 
contribute to the high incidence of surgical site infections and therefore the increased 
incidence of incisional hernia due to disturbed and delayed wound healing in the early 
postoperative period after LT.3,14 However, intensity of immunosuppressive therapy 
could not be verified as an independent risk factor for the development of incisional 
hernia after LT in the current study.
Aging is also associated with a decline in many functions of the immune system.38 It 
has been argued that changes in the immune system may lead to more surgical site 
infections.39 Although, the current study found older age to be an independent risk 
factor for incisional hernia development in patients after LT, changes in the immune 
system leading to infection in patients of older age are not fully understood.38,39 This 
has also been suggested, but not as independent risk factor, in an earlier study by 
Gomez et al.19 
Malnutrition, with an incidence of up to 40% of patients in the ICU, is shown to be as-
sociated with impaired immune function, impaired ventilatory drive, and weakened 
respiratory muscles, leading to prolonged need for ventilator support in critically-ill 
patients.40 This might explain the association found in the current study between 
prolonged ICU stay and incisional hernia development after LT. Muller et al. also sug-
gested this association in an earlier report.1
Although most incisional hernias in patients included in this study were without 
symptoms, HRQoL assessed by both SF-36 and BIQ (body image scale and cosmetic 
scale) revealed impaired outcomes for patients with an incisional hernia after LT com-
pared to those without an incisional hernia. Patients with LT and an incisional hernia 
experienced worse HRQoL as given by the SF-36 components: physical role function-
ing, vitality, social functioning, emotional role functioning, mental health and mental 
component summary and were reported to be generally less satisfied according to 
both the body image scale and the cosmetic scale. The highest impact on HRQoL 
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according to the SF-36 was observed for the component ‘role emotional’, which scored 
22 points lower on a 0 – 100 scoring scale in the presence of an incisional hernia in 
patients after LT. Patients suffering from an incisional hernia were reported to be less 
satisfied with their scar. This negative impact of incisional hernias after LT on HRQoL 
further underscores the importance of prevention of this complication. 
In the current study, only patients operated through a J-shaped incision with a 
minimum follow-up of 3 months were included. In our institution the J-shaped inci-
sion is considered to be the optimal incision since it combines minimal abdominal 
wall trauma with sufficient access to the abdominal cavity to perform LT safely. The 
optimal incision to perform an LT however is still a subject of debate.11,16,22 It is hy-
pothesized that this small incision may also have contributed to the high incidence 
of incisional hernias in the current study because of increased mechanical strain on 
the wound due to wound retractors, necessary to provide adequate access.1 Therefore, 
conversion of the J-shaped incision into the Mercedes incision may be of additional 
value in specific cases, such as very obese patients, in order to provide an adequate 
access but to avoid the wound damage caused by excessive traction. It may also be that 
in the current study, in contrast to other studies, irrespective of which incision type 
was used, the higher incidence can be explained by the fact that all incisional hernias 
were diagnosed and addressed because of the special focus on finding an incisional 
hernia. This may also have contributed to the high rate of elective incisional hernia 
repairs in this study. Unfortunately, the optimal incision type, that combines adequate 
access to the suprahepatic inferior vena cava, liver hilum and both liver lobes with 
prevention of long-term complications, such as incisional hernias after LT, remains to 
be determined, just like the optimal closing technique. As reported in this study, 65% 
of the incisional hernias diagnosed, were located in the subxyphoidal part and in the 
middle part of the incision. Presumably, in the J-shaped incision, the point of higher 
tension is at the junction of the subcostal incision with the midline incision. There-
fore, it might be advantageous to apply one additional stich using a non-absorbable/
absorbable suture in this point in order to reinforce the closing, as a possible measure 
to decrease the incidence of the incisional hernia using the J-shaped incision. Random-
ized controlled trials on incision types, closure techniques, and prophylactic mesh use 
and studies that focus on prevention of surgical site infections are needed to tackle 
this often underestimated complication after LT.
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Inguinal hernia repair is the most frequently performed general surgical procedure 
worldwide.1,2 The incidence of inguinal hernias is positively correlated with the pa-
tients’ age.3 With advancing age, there is a disbalance in collagen synthesis towards 
more collagen degradation and less collagen formation and cross-linking.4-7 On the 
other side of the age spectrum, very young patients are also at risk for developing an 
inguinal hernia. The reason for this increased risk is the presence of a patent proces-
sus vaginalis which seems not only associated with congenital inguinal hernias in 
premature born infants, but also associated with indirect inguinal hernias which are 
acquired later in life.8,9 Other factors that are found to be associated with the incidence 
of inguinal hernias are male sex, smoking, diabetes mellitus, physical activities, and 
a positive family history.3,10-17 In a post-hoc analysis of a large population based cohort 
study, we focussed on incidence and risk factors for inguinal hernias in men aged 45 
years and older. The hazard ratio was approximately 2 in men aged 75 years and older 
compared to men aged under 65 years. Literature suggests that excess body weight is 
associated with an increased risk of inguinal hernias, because it is believed to affect 
the intra-abdominal pressure.18 Interestingly, subgroup analysis in our study showed 
that a BMI over 30 kg/m2 was associated with a lower incidence of inguinal hernia 
compared to participants with a BMI under 25 kg/m2. These results were supported by 
data of two earlier published large population based cohort studies.3,14
As mentioned before the incidence of an inguinal hernia increases with age, especially 
in men from the fifth to the seventh decade of life. Interestingly, in this population 
more than one-third of inguinal hernias are reported to be mildly symptomatic or 
asymptomatic at first presentation.19-21 Two randomized trial already focussed on the 
role of a watchful waiting strategy compared to elective surgery in treatment of men 
with minimally symptomatic inguinal hernias. These trials, however, could not show 
superiority of one treatment over the other with respect to inguinal hernia pain or 
discomfort.22,23 We decided to perform a non-inferiority trial comparing watchful wait-
ing and elective repair of mildly symptomatic or asymptomatic inguinal hernias with 
special focus on men aged 50 years and older. This specific group was chosen because 
they particularly have more concomitant diseases and usually tend to have less physi-
cal constraints in their daily activities compared to their younger and more mobile 
counterparts. It can be imagined that especially at this age the risk of complications 
due to the procedure may not outweigh the benefits of surgery if an inguinal hernia is 
asymptomatic at first presentation. Using a 0.20-point difference as a clinically relevant 
margin, it was hypothesized that watchful waiting was non-inferior to elective repair. 
The results of our trial showed that the mean pain/discomfort score over 24 months 
is on average 0.23 points lower in the elective repair group (95% CI -0.32 to -0.14). As 
such, our data could not rule out a relevant difference in favor of elective repair with 
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regard to the primary endpoint. Because the 95 percent confidence interval of the 
difference of means ranged from -0.32 to -0.14, a difference of the pre-defined margin 
of 0.20 points or greater cannot be excluded and, therefore our trial is inconclusive in 
this respect. Secondary endpoints included quality of life questionnaires which were 
slightly in favor of elective repair. These differences, however, were too small to be 
clinically relevant. About one-third of the patients, initially assigned to watchful wait-
ing, crossed over to surgery. This was mostly driven by an increase in pain or discomfort 
and in only 2.3 percent of the patients an emergent repair had to be performed due 
to an incarceration. The long-term results of the earlier mentioned randomized trial 
reported crossover rates up to 80 percent in men aged over 65 years old after 10 years 
of follow-up.19,24 It recommended surgical repair of asymptomatic inguinal hernias in 
medically fit men as most men will develop symptoms over time. However, subgroup 
analyses of our data found no differences in crossover rates between men aged 50-65 
or 65 years and older. Although our data could not rule out a relevant difference in 
favor of elective repair with regard to the primary endpoint, we conclude , in view of 
all other findings, that our results justify watchful waiting as a reasonable alternative 
compared to surgery in frail patients. 
The risk of an inguinal hernia is not only increased in middle-aged and elderly indi-
viduals, but also in the youngest amongst us.25,26 Factors that are associated with an 
increased risk of inguinal hernias in premature born infants include a patent pro-
cesses vaginalis, male sex, gestational age, low birth weight, and prolonged mechani-
cal ventilation.26,27 Many paediatric surgeons prefer to perform a herniotomy when 
the prematurely born infant reach a certain weight or age. Although this somewhat 
conservative approach may minimize the risk of surgical and anaesthetic complica-
tions, it might also increase the risk of incarceration forcing an emergency procedure 
with a potential risk of ischemia of the bowel or testicular atrophy.26,28-32 In literature 
very little is known on timing of inguinal hernia repair in prematurely born infants. 
In our retrospective study we showed an association between very low birth weight 
(birth weight under 1500g) and risk of incarceration. Prematurely born infants of 1500 
grams or less had a 3-fold greater risk of incarceration with subsequent emergent 
repair compared to prematurely born infants over 1500 grams. 
Another group of frail individuals who are generally advised to refrain from surgery 
unless it is absolutely necessary are patients with liver cirrhosis and ascites. Patients 
with liver cirrhosis and refractory ascites have a 20 percent risk of developing an um-
bilical hernia during the course of their disease.33 Possible factors that contribute to 
umbilical hernia formation in this group of patients include increased intra-abdominal 
pressure due to ascites, weakening of the abdominal wall due to muscle wasting as a 
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result of poor nutritional status and dilatation of the umbilical vein that enlarges the 
preexistent umbilical opening in patients with portal hypertension.34 Currently there 
are no guidelines for umbilical hernia management and timing of repair in patients 
with liver cirrhosis and ascites. Again, surgical dogma dictates not to perform um-
bilical hernia repair in these patients.35-37 However, refraining from umbilical hernia 
repair in patients with liver cirrhosis could lead to complications such as incarceration 
or strangulation of the bowel leading to emergency surgery.38,39 Even a relative simple 
procedure such as the repair of an umbilical hernia could have deleterious effects 
on the remaining liver function. In these patients the timing of the umbilical hernia 
repair is also essential, because concordant progression of the cirrhosis could hamper 
the possibility of future surgery. Currently a randomized controlled trial is managed 
comparing watchful waiting and elective repair, which will provide evidence that will 
help to create guidelines for management of umbilical hernias in patients with liver 
cirrhosis and ascites.
In contrast to inguinal and umbilical hernias, incisional hernias are postoperative 
complications after abdominal surgery with incidences between 11 and 20 percent 
and even up to 35 percent in several high risk groups.40-42 With improved long-term 
survival after liver transplantation, an incisional hernia has become a frequently 
diagnosed and clinically more relevant complication with reported incidences as high 
as 34 percent.43,44 Factors that are found to be associated with incisional hernias after 
liver transplantation include age, male sex, body mass index, pulmonary complica-
tions, wound infections, immunosuppressive regimen and incision type.45-48 Tradi-
tionally the classic ‘chevron’ incision (a bilateral subcostal laparotomy with medial 
extension) was the incision of choice to enter the abdominal cavity. More recently 
smaller incisions like a subcostal incision with or without a mediocranial extension 
(J-shaped incision) are preferred. The J-shaped incision still provides sufficient access 
to the abdominal cavity but with less abdominal wall trauma, which should theoreti-
cally reduce the incidence of incisional hernias.44,49-51 Despite promising results of the 
J-shaped incision reported in an earlier published retrospective study, the incidence of 
incisional hernias found in our prospective study was unexpectedly high. An incidence 
of 43 percent was reported, while only 7 percent was found in the previous published 
retrospective study.44 In contrast to prospective studies, it should be mentioned that 
retrospective studies on incisional hernias after surgery tend to underestimate the 
incidence of incisional hernias as most of the asymptomatic hernias are often not 
diagnosed and therefore not reported by those studies. Surgical site infections and age 
were found to be associated with the presence of an incisional hernia. Except for these 
factors, a clear explanation for the high incidence in this study could not be given. It 
was hypothesized that the increased mechanical strain on the laparotomy wound due 
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to wound retractors, which were used to provide adequate access to the abdominal 
activity, could have compromised vascularization and subsequent wound healing. 
The well vascularized abdominal wall, however, should provide sufficient wound 
healing in contrast to the aponeurotic closure in midline laparotomies. Recently, a 
randomized controlled trial focusing on the optimal suture technique after midline 
laparotomies showed that the small bites suture technique is more effective than 
the traditional large bites technique for prevention of incisional hernias in midline 
incisions.52 In liver transplantation meticulous closure of the fascia is recommended 
to further reduce the incidence of incisional hernias.
To conclude, surgical repair of abdominal wall hernias such as the inguinal hernia, 
umbilical hernia and incisional hernia are the most frequently performed general sur-
gical procedures worldwide and considered the ideal learning procedures for young 
residents. In a generally healthy population, the odds of serious complications due to 
the procedure are fairly low. However, there are groups of frail individuals who are 
more prone to complications and morbidity, even if it involves a procedure such as the 
one at hand. Refraining from surgery in these individuals however, could also lead to 
complications such as incarceration or strangulation of the bowel, which subsequently 
could result in emergency surgery with an even higher risk of serious complications. 
In these individuals, timing of the surgical procedure is essential, because concordant 
progression of the underlying disease (such as liver cirrhosis) could hamper the pos-
sibility of future surgery. As an example, even a relatively simple procedure such as 
the repair of an umbilical hernia could have deleterious effects on the remaining liver 
function in patients suffering from liver cirrhosis.
f u ture directionS And Policy imPlicAtionS
History has taught us that knowledge of anatomy is the cornerstone of abdominal 
wall surgery and treatment of abdominal wall hernias. Abdominal wall surgery with 
all its anatomical complexities is still mostly practised by general surgeons and resi-
dents. But there is a growing tendency to perform abdominal wall and hernia surgery 
in dedicated hernia centers. Experts in the field of hernia surgery tend to have less 
complications compared to general surgeons and residents.53 As this is still at an early 
stage, more extensive anatomical training by cadaver dissections and personal tuition 
for residents should be incorporated – especially in the beginning of their training, in 
order to lay a solid foundation, and later, further reduce preventable complications 
such as recurrent inguinal hernias and chronic pain as this is no longer acceptable 
in modern hernia surgery. As such, training modules for abdominal wall surgery for 
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residents should be designed and incorporated by these dedicated hernia surgeons. To 
improve knowledge and technical skills, abdominal wall hernia registration systems 
should be implemented to centralize data of patients with complex hernias from her-
nia centers, as these patients are currently operated by a few dedicated hernia experts 
with a tailor-made approach for each individual patient. Together we can further stan-
dardize care with regard to the numerous and still rising amount of techniques and 
materials. In modern times like these abdominal wall hernias with all its complexity 
should be considered and treated as a separate surgical entity and performed in hernia 
centers by dedicated experts in the field to further improve care of patients with 
(complex) abdominal wall hernias.
This thesis addresses some of the questions raised by the European Hernia Society 
in the latest draft of the upcoming guidelines on management of asymptomatic 
individuals with inguinal hernias. Our data conforms that the risk of complications 
– incarceration or strangulation of the bowel, following a watchful waiting strategy 
is low in asymptomatic individuals with inguinal hernias and, therefore, could be 
recommended safely. It provides information on the crossover rate from watchful 
waiting to surgery, which is mostly driven by an increase in pain or discomfort and 
not due to an emergent repair. The question then arises if most asymptomatic indi-
viduals with inguinal hernias will indeed develop symptoms over time and, will they 
also require hernia surgery in the future? This is a more difficult question to answer. 
One could argue that a substantial part of the asymptomatic or mildly symptomatic 
individuals with inguinal hernias are treated conservatively by their general practi-
tioners and only a fraction of these patients are eventually referred to a hospital. The 
supposedly asymptomatic individuals that were included in our trial could therefore 
be more symptomatic compared to the population visiting their general practitioners. 
This could result in higher crossover rates as observed in our study. Nevertheless, 
our data still showed that the majority of patients randomized to watchful waiting 
remained asymptomatic and did not need surgery after 3 years of follow-up. One could 
argue that with more statistical power and the pre-defined margin of 0.20 points for 
the 4-point pain scale, we might be able to prove that elective repair is ‘superior’ 
compared to watchful waiting. Instead of just concluding this thesis with a standard-
ized statement such as ‘more  extensive trials are needed to replicate our results’, our 
methodology and results could be translated and add to the discussion on treatment 
of asymptomatic individuals with inguinal hernias. This should involve information 
on development on pain and discomfort and quality of life over time, which can be 
used for a more tailor-made approach in this group of patients in light of personal-
ized medicine. Not only patient’s health-related quality of life, but also life style and 
social factors should be incorporated in this shared decision-making process leading 
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up to the optimal decision in hernia management on the individual level – instead of 
focussing solely on group level results, which are likely to be small given our results, 
and more likely to be close to our cut off value of 0.2. For shared decision making, 
physicians need to communicate to the patient personalized information about the 
possible outcomes of their inguinal hernia management. Whether the magnitude of 
the expected benefit (e.g. the risk of incarceration or strangulation of the bowel lead-
ing to emergency repair) would outweigh the disadvantages of immediate inguinal 
hernia surgery (e.g. co-morbidities, risk of postoperative complications, recurrence, 
and chronic pain) can be discussed with the individual patient sitting in front of the 
physician in order to reach agreement on the inguinal hernia management. 
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Abdominal wall surgery is comprised of surgical procedures used in the treatment of 
abdominal wall hernias. Abdominal wall hernias discussed in this thesis are inguinal 
hernias, umbilical hernias, and incisional hernias. In general, repair of these hernias 
are considered relatively simple procedures with a low risk of serious complications. 
There are, however, groups of frail patients prone to abdominal wall hernias due 
their age or underlying disease in which hernia repair should be carefully planned or 
sometimes avoided as not only surgery, but also a watchful waiting strategy can lead 
to serious complications. In Chapter 1 a general outline of this thesis is given and the 
topic of abdominal wall surgery is introduced with a special focus on incidence, risk 
factors and hernia management in specific groups of frail patients.
The incidence of an inguinal hernia appears to increase with age, especially in men 
through the fifth to seventh decade of life. In Chapter 2 the results on incidence and 
risk factors for inguinal hernias among Dutch males aged 45 years and older who 
participated in the Rotterdam Study are presented. A total of 416 incident cases (7.2%) 
of inguinal hernia in 5,780 male participants were found after a follow-up of more 
than 20 years. The age-adjusted hazard ratio was 12.4 in favour of men compared to 
women. Multivariate analysis showed ageing to be a risk factor for inguinal hernias 
with an increase in hazard of 1.03 per year. The hazard of an inguinal hernia almost 
doubled in men aged 75 years and older compared to men aged under 65 years. In-
creased body mass index showed to have a protective effect on inguinal hernias.
In Chapter 3 the results of a multicenter randomized trial are described which 
compared watchful waiting to elective repair of asymptomatic or mildly symptomatic 
inguinal hernias in male patients aged 50 years and older after a follow-up of 3 years. 
Two hundred and thirty-four patients were randomized to elective repair and 262 
to watchful waiting. Using a 0.20-point difference as a clinically relevant margin, 
it was hypothesized that watchful waiting was non-inferior to elective repair. The 
results of our trial showed a difference in means (watchful waiting minus elective 
repair) of -0.23 (95% CI -0.32 to -0.14) with regard to the primary endpoint (4-point pain 
and discomfort score) after 2 years of follow-up. Because the 95 percent confidence 
interval of the difference of means ranged from -0.32 to -0.14, a difference of 0.20 or 
greater cannot be excluded and, therefore, the trial was inconclusive in this respect. 
In the watchful waiting group 35.4 percent underwent inguinal hernia repair due to 
some degree of pain or discomfort and 2.3 percent required emergency surgery due 
to incarceration or strangulation of the bowel. Postoperative morbidity and mortal-
ity were comparable between the elective repair group and operated men initially 
assigned to the watchful waiting group. Recurrence rates of inguinal hernias were 
approximately 9.0 percent in both groups after 3 years of follow-up. No difference in 
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recurrence rates could be found between different surgical techniques, types of mesh 
and between participating centers.
The risk of an inguinal hernia is not only increased in the middle-aged and elderly, but 
also in the youngest amongst us. In Chapter 4 risk factors for emergency surgery in 
prematurely born infants with an inguinal hernia were studied. In this retrospective 
study, data from 142 prematurely born infants (gestational age less than 37 weeks) 
who underwent inguinal hernia repair within 3 months after birth were analyzed. 
More than half of these prematurely born infants presented at the hospital with a 
symptomatic inguinal hernia, of which 55.7 percent required emergency surgery be-
cause of incarceration. Postoperative complication rates and recurrence rates were sig-
nificantly higher in prematurely born infants following emergency surgery compared 
to prematurely born infants who underwent elective repair. Multivariate analysis 
showed ‘very low birth weight’ (birth weight of 1,500g or less) to be an independent 
risk factor with a 3-fold greater risk of incarceration with subsequent emergent repair 
compared to prematurely born infants weighing over 1,500 grams.
Another group of frail patients who are generally advised to refrain from surgery 
unless it is absolutely necessary are patients with liver cirrhosis and ascites. In Chap-
ter 5 an overview of morbidity and mortality for different non-hepatic procedures, 
including abdominal wall hernia repair in patients with liver cirrhosis is provided. The 
level of evidence of included studies in this review varied greatly. Postoperative mor-
tality and morbidity were higher in patients suffering from liver cirrhosis compared 
to matched patients without liver cirrhosis who underwent non-hepatic surgery. In 
addition to the Child-Turcotte-Pugh (CTP) score the preoperative model for end stage 
liver disease (MELD) was found to be an adequate prediction model for assessment of 
the 30-day postoperative mortality in patients with liver cirrhosis after non-hepatic 
procedures (c-statistic = 0.80). With regards to abdominal wall hernia management, 
reported overall morbidity after elective umbilical hernia repair in patients with liver 
cirrhosis ranged between 7 and 20 percent and the overall mortality ranged between 
0 and 5.5 percent. In the presence of portal hypertension or in case of emergency 
surgery, the results were even less favorable. In the presence of refractory ascites the 
risk of a recurrent umbilical hernia was increased with a relative risk of 8.5 percent 
after primary umbilical hernia repair. One randomized trial was performed compar-
ing primary suture versus mesh repair in patients with liver cirrhosis. Recurrence rate 
was 2.7 percent in the mesh repair group compared to 14.2 percent in the primary 
suture group. In the mesh repair group the number of surgical site infections was 
almost doubled compared to the primary suture group. The percentage of surgical 
site infection was not significantly different between groups. The reported overall 
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morbidity after inguinal hernia repair was comparable to patients without liver cir-
rhosis. The overall mortality ranged between 0 and 2.7 percent. Complications after 
inguinal hernia repair appeared to be independent of CTP grade and not affected by 
the presence of (refractory) ascites. The majority of non-hepatic surgical procedures 
could be performed safely in patients with liver cirrhosis and low MELD scores or CTP 
grade A without portal hypertension. It was suggested that inguinal hernia repair 
could even be performed in patients with CTP grade C liver cirrhosis and in the pres-
ence of refractory ascites. 
Patients with liver cirrhosis and refractory ascites have a 20 percent risk of develop-
ing an umbilical hernia in the course of their disease. In Chapter 6 the results of a 
prospective study on the feasibility and safety of elective repair of an umbilical hernia 
in patients with liver cirrhosis and ascites are presented. A total of 30 patients under-
went elective umbilical hernia repair. In 33 percent of patients a mesh was used. More 
than two-third of patients were classified as CTP grade B or C with a median MELD 
score of 12. Complications occurred in only 2 patients without negative sequelae. 
After a median follow-up period of 25 months 2 deaths occurred, of which none were 
related to the surgical procedure. 
In Chapter 7 the study protocol of a multicenter randomized controlled trial, which 
stems from the previously mentioned prospective study, is presented. This trial was 
designed to compare watchful waiting to elective repair of an umbilical hernia in 
patients with liver cirrhosis and ascites. The trial was designed to include a total of 
100 patients to be randomized between the two strategies, stratified for participat-
ing center and MELD score. The primary endpoint consisted of a composite endpoint 
of overall morbidity related to the umbilical hernia treatment after 24 months of 
follow-up. Secondary endpoints included cumulative recurrence rate, classification of 
complications obtained during follow-up, pain and quality of life. The objective of 
this trial was to determine the superiority of elective repair to watchful waiting in 
management of umbilical hernias in patients with liver cirrhosis and ascites.
Candidates for liver transplantation who did not undergo umbilical hernia repair 
prior to the transplantation should be corrected during transplantation. In Chapter 8 
two different approaches for umbilical hernia repair during liver transplantation are 
compared. In a retrospective study patients who underwent umbilical hernia repair 
through a separate umbilical incision and patients who underwent umbilical hernia 
correction from within the abdominal cavity without a separate incision through the 
subcostal laparotomy wound used for the transplantation were compared. A total of 
27 patients were included in the analysis with a mean MELD score of 17. In the group 
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in which the umbilical hernia was repaired through the laparotomy wound 40 per-
cent of patients were diagnosed with a recurrent umbilical hernia compared to only 
6 percent in the group in which a separate umbilical incision was used. The results 
of our study suggest that umbilical hernia repair during liver transplantation using a 
separate umbilical incision is associated with less recurrent umbilical hernias com-
pared to repair from within the abdominal cavity through the subcostal laparotomy 
used for transplantation.
In contrast to inguinal and umbilical hernias, incisional hernias are postoperative 
complications after abdominal surgery. In Chapter 9 the results of a cross-sectional 
study in which the incidence of an incisional hernia was assessed, identified potential 
risk factors are presented and its impact on quality of life after liver transplantation 
using a right-sided subcostal (J-shaped) incision was evaluated. The incidence of inci-
sional hernias after liver transplantation through a J-shaped incision was 43 percent, 
which was 6 times higher compared to the retrospective data published prior to this 
study. Surgical site infection and age were found to be the most important risk factors 
for incisional hernias after liver transplantation.
chAPter 12
Dutch summary
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Buikwandchirurgie omvat operatieve ingrepen ter behandeling van buikwandbreu-
ken. De buikwandbreuken die in dit proefschrift worden besproken zijn liesbreuken, 
navelbreuken en littekenbreuken. In het algemeen worden operaties die bedoeld 
zijn om een buikwandbreuk te corrigeren als relatief simpele operaties beschouwd 
met een laag risico op ernstige complicaties. Er zijn echter groepen van kwetsbare 
patiënten bij wie chirurgische correctie van een buikwandbreuk zorgvuldig gepland 
of zelfs vermeden dient te worden omdat de keuze om wel of juist niet te opereren 
kan leiden tot ernstige complicaties. In Hoofdstuk 1 wordt een overzicht van het 
proefschrift gegeven en wordt het onderwerp buikwandchirurgie geïntroduceerd. Er 
wordt daarbij in het bijzonder op incidentie, risicofactoren en behandeling (operatief 
of niet-operatief) van buikwandbreuken bij specifieke groepen van kwetsbare patiën-
ten ingegaan.
De incidentie van liesbreuken lijkt toe te nemen met de leeftijd, met name bij man-
nen in de leeftijdsgroep van 50 tot 70 jaar. In Hoofdstuk 2 worden de incidentie 
en risicofactoren van liesbreuken bij Nederlandse mannen van 45 jaar en ouder 
binnen de ‘Rotterdam Study’ beschreven. Er werden 416 liesbreuken gevonden bij 
5780 mannelijke deelnemers (7.2%) gedurende een tijdsperiode van meer dan 20 jaar. 
In vergelijking met vrouwen is het risico op het krijgen van een liesbreuk zo’n 12 
keer hoger – gecorrigeerd voor leeftijd. In een model waarin meerdere risicofactoren 
tegelijkertijd werden meegenomen, bleek dat met elk kalenderjaar de hazard (een 
maat voor het risico) op het krijgen van een liesbreuk met 3 procent toeneemt. De 
hazard met betrekking tot het krijgen van een liesbreuk was bijna twee maal zo hoog 
bij mannen van 75 jaar en ouder in vergelijking met mannen jonger dan 65 jaar. Een 
verhoogde ‘body mass index’ leek een beschermend effect op het ontstaan van een 
liesbreuk te hebben. 
In Hoofdstuk 3 worden de resultaten van een gerandomiseerde studie beschreven, 
waarin een afwachtend beleid versus een electieve operatieve behandeling vergeleken 
werd bij mannen van 50 jaar en ouder met een asymptomatische of mild symptomati-
sche liesbreuk gedurende een periode van 3 jaar. In totaal hadden 234 mannen geloot 
voor operatie en 262 mannen voor een afwachtend beleid ten aanzien van hun lies-
breuk. Vooraf werd bepaald dat een verschil van 0.2 punten op een 4-punts pijnschaal 
als klinisch relevant moest worden gezien. De resultaten van deze studie laten zien dat 
de waarschijnlijke werkelijke waarde van het verschil tussen opereren en afwachten 
met 95 procent betrouwbaarheid tussen de 0.14 en 0.32 punten ligt. Hoewel het lijkt 
dat een electieve operatie beter in termen van de genoemde pijnschaal is, kan niet 
worden uitgesloten dat het werkelijke verschil kleiner is dan 0.2 punten. In de groep 
van patiënten waarbij een afwachtend beleid werd gevoerd, onderging 35 procent van 
164
Chapter 12
de mannen alsnog een operatie door toename van ongemak en/of pijnklachten. Bij 
deze groep moest bij 2.3 procent vanwege een beklemde liesbreuk een spoedoperatie 
uitgevoerd worden. Het aantal postoperatieve complicaties bij de geopereerde groep 
en bij patiënten van de ‘observatie’ groep, die alsnog een operatie ondergingen, ver-
schilden niet. Een recidief liesbreuk werd bij 9.0 procent van de deelnemers na 3 jaar 
follow-up vastgesteld, ongeacht de groep, waarvoor zij initieel hadden geloot. 
Het risico op het krijgen van een liesbreuk is niet alleen verhoogd bij mannen van 50 
jaar en ouder, maar ook bij pasgeborenen. In Hoofdstuk 4 worden de risicofactoren 
voor een spoedoperatie met betrekking tot liesbreuken bij prematuur geboren baby’s 
besproken. In dit retrospectieve onderzoek werden de statussen geanalyseerd van 
142 prematuur geboren baby’s (geboren na een zwangerschapsduur van minder dan 
37 weken), bij wie een liesbreukoperatie binnen 3 maanden na de geboorte werd 
verricht. Meer dan de helft van de prematuur geboren baby’s presenteerde zich in 
het ziekenhuis met een symptomatische liesbreuk waarvan bij ruim de helft een 
spoedoperatie in verband met een beklemde liesbreuk werd verricht. Het aantal po-
stoperatieve complicaties en recidief liesbreuken waren significant hoger in de groep 
van prematuren na een spoedoperatie in vergelijking met de groep van prematuren 
bij wie een geplande liesbreukoperatie werd uitgevoerd. In de multivariate analyse 
was ‘zeer laag geboortegewicht’ (geboortegewicht van 1500 gram of minder) een 
risicofactor voor het ondergaan van een spoedoperatie als gevolg van een beklemde 
liesbreuk met een 3 maal hoger risico ten opzichte van prematuren met een hoger 
geboortegewicht (meer dan 1500 gram). 
Een andere groep van kwetsbare patiënten, bij wie over het algemeen geadviseerd 
wordt om niet te opereren – tenzij absoluut noodzakelijk – zijn patiënten met lever-
cirrose en ascites. In Hoofdstuk 5 wordt een overzicht gegeven van de morbiditeit 
en mortaliteit bij patiënten met levercirrose na niet-hepatische chirurgie. In het over-
zicht worden ook patienten besproken die operaties ondergaan die niet de buikwand 
betreffen. De kwaliteit van de geïncludeerde studies in dit review varieerde sterk. 
Er werden bij patiënten met levercirrose een hogere postoperatieve morbiditeit en 
mortaliteit geobserveerd in vergelijking met patiënten zonder levercirrose na niet-
hepatische chirurgie. In aanvulling op de Child-Turcotte-Pugh (CTP) score bleek het 
pre-operatieve model voor eindstadium leverziekte (MELD) score een betrouwbaar 
model voor de voorspelling van de 30-daagse postoperatieve sterfte in deze patiën-
tengroep (c-statistic = 0.80). In de beschreven studies varieerde de morbiditeit na een 
electieve navelbreukcorrectie tussen de 7 en 20 procent; de mortaliteit varieerde 
tussen 0 en 5,5 procent. Het risico op postoperatieve complicaties was nog hoger in 
de aanwezigheid van portale hypertensie of in het geval van een spoedoperatie bij 
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patiënten met levercirrose. In de aanwezigheid van refractaire ascites was het rela-
tieve risico op een recidief navelbreuk na een primaire navelbreukcorrectie bijna 9 
maal hoger in vergelijking met patiënten met levercirrose zonder refractaire ascites. 
Een gerandomiseerd onderzoek werd verricht bij patiënten met levercirrose, waarin 
een primaire navelbreukcorrectie met ‘mesh repair’, waarbij een polypropyleen mat 
wordt ingehecht in de verzwakte buikwand, vergeleken werd. Het percentage recidief 
navelbreuken was 2.7 procent in de groep met ‘mesh repair’ in vergelijking met 
14.2 procent in de groep na primaire navelbreukcorrectie. In de groep met ‘mesh 
repair’ was het aantal wondinfecties bijna verdubbeld ten opzichte van de groep na 
primare navelbreukcorrectie; dit verschil was echter niet significant verschillend. De 
morbiditeit na liesbreukchirurgie bij patiënten met levercirrose was niet verhoogd in 
vergelijking met patiënten zonder levercirrose. De mortaliteit na liesbreukchirurgie 
varieerde tussen 0 en 2.7 procent. Het aantal complicaties na liesbreukchirurgie was 
onafhankelijk van de CTP score of de aanwezigheid van (refractaire) ascites. 
Patiënten met levercirrose en refractaire ascites hebben een kans van 20 procent 
op het ontwikkelen van een navelbreuk gedurende het ziektebeloop. In Hoofd-
stuk 6 worden de resultaten van een prospectieve studie over de haalbaarheid en 
de veiligheid van electieve navelbreukchirurgie bij patiënten met levercirrose en 
ascites beschreven. In totaal 30 opeenvolgende patiënten onderging een electieve 
navelbreukcorrectie. In een derde van de patiënten werd gebruik gemaakt van ‘mesh 
repair’. Meer dan tweederde van de patiënten werd geclassificeerd als CTP score B of C 
met een gemiddelde MELD score van 12. Bij slechts 2 patiënten werden complicaties 
gezien met voorspoedig herstel, waarbij geen interventie noodzakelijk was. Er werd 
geen mortaliteit gerelateerd aan de navelbreukcorrectie gezien. 
In Hoofdstuk 7 wordt het onderzoeksprotocol van een gerandomiseerde studie 
gepresenteerd, die voortvloeide uit de eerder genoemde prospectieve studie. Deze 
studie werd ontworpen om observatie met electieve correctie van een navelbreuk te 
vergelijken bij patiënten met levercirrose en ascites. Het primaire eindpunt bestond 
uit een samengestelde eindpunt van totale morbiditeit gerelateerd aan de navelbreuk-
behandeling met een follow-up van 2 jaar. Secundaire eindpunten omvatten het totaal 
aantal recidief navelbreuken, de ernst van de complicaties, gerapporteerd tijdens de 
follow-up en geanalyseerd met behulp van de landelijke complicatie registratie, en 
kwaliteit van leven. Het doel van deze studie was om de superioriteit van een electieve 
operatieve behandeling ten opzichte van een afwachtend beleid van navelbreuken bij 
patiënten met levercirrose en ascites aan te tonen. 
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Chapter 12
Patienten die nog een navelbreuk hebben terwijl ze een levertransplantatie ondergaan, 
hebben een groot risico op beklemming van die navelbreuk na de transplantatie. Dit 
komt mogelijk doordat er na de levertransplantatie minder ascites wordt gevormd, 
waardoor de buik samenvalt en er een risico bestaat dat de inhoud van de buik wordt 
‘gevangen’ in de breukpoort. Het wordt dan ook geadviseerd om een dergelijke breuk 
tijdens de levertransplantatie te corrigeren. Dat kan op twee manieren. In Hoofdstuk 
8 werden deze twee verschillende benaderingen voor navelbreukcorrectie tijdens 
levertransplantatie vergeleken. In een retrospectieve studie werden patiënten geana-
lyseerd bij wie een navelbreukcorrectie via een aparte incisie onder de navel werd 
verricht en patiënten bij wie een navelbreukcorrectie vanuit de buikholte via dezelfde 
subcostale laparotomie, zoals gebruikt voor transplantatie, werd verricht. In totaal 
27 patiënten werden geanalyseerd met een gemiddelde MELD score van 17. In de 
groep waarbij de breuk werd gecorrigeerd via de subcostale incisie werd in 40 procent 
van de patiënten door middel van een echo een recidief navelbreuk geconstateerd, in 
vergelijking met slechts 6 procent in de groep waarbij de navelbreukcorrectie werd 
verricht via een aparte incisie rond de navel. De resultaten van deze studie suggereer-
den dat een navelbreukcorrectie tijdens levertransplantatie via een aparte inciesie 
rond de navel met minder recidief navelbreuken geassocieerd was in vergelijk met 
correctie vanuit de buikholte via dezelfde subcostale laparotomie, zoals gebruikt voor 
levertransplantatie. 
In tegenstelling tot een liesbreuk en een navelbreuk wordt een littekenbreuk als een 
postoperatieve complicatie na een buikoperatie beschouwd. In Hoofdstuk 9 worden 
de resultaten van een crossectionele studie gepresenteerd, waarin de incidentie op, 
risicofactoren van en impact van littekenbreuken op de kwaliteit van leven na le-
vertransplantatie met gebruik van een rechtszijdige subcostale (‘J-vormige’) incisie 
geëvalueerd werden. De incidentie van littekenbreuken was 43 procent na levertrans-
plantatie door middel van een J-vormige incisie. Deze incidentie was 6 maal hoger dan 
in de retrospectieve data, voorafgaand gepubliceerd. In de multivariate analyse bleken 
‘wondinfectie’ en ‘leeftijd’ de belangrijkste risicofactoren voor het krijgen van een 
littekenbreuk na levertransplantatie middels een J-vormige incisie te zijn.
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